{
  "metadata": {
    "config": {
      "backend": {
        "_target_": "cotlab.backends.VLLMBackend",
        "tensor_parallel_size": 1,
        "dtype": "bfloat16",
        "trust_remote_code": true,
        "max_model_len": 4096
      },
      "model": {
        "name": "google/medgemma-27b-text-it",
        "variant": "27b",
        "max_new_tokens": 1024,
        "temperature": 0.7,
        "top_p": 0.9,
        "safe_name": "medgemma_27b"
      },
      "prompt": {
        "_target_": "cotlab.prompts.OncologyPromptStrategy",
        "name": "oncology",
        "contrarian": true,
        "few_shot": true,
        "answer_first": false,
        "output_format": "json"
      },
      "dataset": {
        "_target_": "cotlab.datasets.OncologyDataset",
        "name": "oncology",
        "path": "data/oncology.json"
      },
      "experiment": {
        "_target_": "cotlab.experiments.RadiologyExperiment",
        "name": "radiology",
        "description": "Pathological fracture detection from radiology reports",
        "num_samples": -1
      },
      "seed": 42,
      "verbose": true,
      "dry_run": false
    },
    "start_time": "2026-01-10T20:49:02.948380"
  },
  "experiment": "radiology",
  "model": "google/medgemma-27b-text-it",
  "prompt_strategy": "oncology",
  "metrics": {
    "correct": 99,
    "incorrect": 1,
    "true_positives": 49,
    "true_negatives": 50,
    "false_positives": 0,
    "false_negatives": 1,
    "parse_errors": 0,
    "accuracy": 0.99,
    "parse_error_rate": 0.0,
    "precision": 1.0,
    "recall": 0.98,
    "f1": 0.98989898989899
  },
  "raw_outputs": [
    {
      "sample_idx": 0,
      "input": "02/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"Clinical improvement noted\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical analysis: The report explicitly states 'No malignancy identified' and 'Clinical improvement noted' following a 'Resolved febrile illness' with 'Blood counts normalized'. While a skeptical oncologist always considers occult disease, the provided information strongly points towards a benign resolution. The lack of any abnormal findings, coupled with the explicit negative conclusion by the consulting oncologist, makes malignancy highly unlikely. There is no evidence to support a malignant diagnosis.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical analysis: The report explicitly states 'No malignancy identified' and 'Clinical improvement noted' following a 'Resolved febrile illness' with 'Blood counts normalized'. While a skeptical oncologist always considers occult disease, the provided information strongly points towards a benign resolution. The lack of any abnormal findings, coupled with the explicit negative conclusion by the consulting oncologist, makes malignancy highly unlikely. There is no evidence to support a malignant diagnosis.",
      "findings": [
        "Resolved febrile illness",
        "Blood counts normalized",
        "No organomegaly",
        "Clinical improvement noted",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 0,
      "timestamp": "2026-01-10T20:50:27.408261"
    },
    {
      "sample_idx": 1,
      "input": "26/10/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Skeptical approach: Could the posterior fossa mass be a non-malignant lesion like an abscess or inflammatory process? While enhancement and hydrocephalus can occur in benign conditions, restricted diffusion is highly suggestive of high cellularity, often seen in malignancy. Crucially, the histology explicitly confirms 'High-grade medulloblastoma'. Although skepticism is warranted, the definitive histological diagnosis overrides alternative interpretations. Conclusion: Malignancy confirmed by histology.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical approach: Could the posterior fossa mass be a non-malignant lesion like an abscess or inflammatory process? While enhancement and hydrocephalus can occur in benign conditions, restricted diffusion is highly suggestive of high cellularity, often seen in malignancy. Crucially, the histology explicitly confirms 'High-grade medulloblastoma'. Although skepticism is warranted, the definitive histological diagnosis overrides alternative interpretations. Conclusion: Malignancy confirmed by histology.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 1,
      "timestamp": "2026-01-10T20:50:27.408292"
    },
    {
      "sample_idx": 2,
      "input": "03/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly describes 'reactive lymphadenopathy secondary to viral infection'. While lymphadenopathy can be a sign of malignancy, the report provides strong counter-evidence: decreasing node size (suggesting resolution of the underlying cause), absence of atypical features, and a direct statement 'No malignancy identified'. Although one might question if a viral infection could mask an underlying malignancy, the decreasing size and lack of atypical features argue strongly against this. The conclusion of reactive lymphadenopathy is supported by the clinical context (follow-up post-treatment, no previous oncology history) and the imaging findings. Therefore, despite the presence of lymphadenopathy (an abnormal finding), malignancy is confidently excluded based on the provided report.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly describes 'reactive lymphadenopathy secondary to viral infection'. While lymphadenopathy can be a sign of malignancy, the report provides strong counter-evidence: decreasing node size (suggesting resolution of the underlying cause), absence of atypical features, and a direct statement 'No malignancy identified'. Although one might question if a viral infection could mask an underlying malignancy, the decreasing size and lack of atypical features argue strongly against this. The conclusion of reactive lymphadenopathy is supported by the clinical context (follow-up post-treatment, no previous oncology history) and the imaging findings. Therefore, despite the presence of lymphadenopathy (an abnormal finding), malignancy is confidently excluded based on the provided report.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 2,
      "timestamp": "2026-01-10T20:50:27.408319"
    },
    {
      "sample_idx": 3,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy with mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"High LDH levels\"],\n        \"rationale\": \"Skeptical reasoning: Could lymphadenopathy be reactive? The report explicitly states 'Burkitt lymphoma confirmed on biopsy'. This is a definitive pathological diagnosis, overriding any possibility of reactive changes. High LDH is consistent with high cell turnover seen in aggressive lymphomas like Burkitt. While LDH can be elevated in other conditions, the biopsy confirmation is the key evidence. Conclusion: Malignancy confirmed by biopsy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical reasoning: Could lymphadenopathy be reactive? The report explicitly states 'Burkitt lymphoma confirmed on biopsy'. This is a definitive pathological diagnosis, overriding any possibility of reactive changes. High LDH is consistent with high cell turnover seen in aggressive lymphomas like Burkitt. While LDH can be elevated in other conditions, the biopsy confirmation is the key evidence. Conclusion: Malignancy confirmed by biopsy.",
      "findings": [
        "abdominal lymphadenopathy with mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "High LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 3,
      "timestamp": "2026-01-10T20:50:27.408339"
    },
    {
      "sample_idx": 4,
      "input": "04/05/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 04/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"Pancytopenia\", \"Suspected Acute Lymphoblastic Leukemia\"],\n        \"rationale\": \"Skeptical review: Could 85% lymphoblasts be reactive? Highly unlikely. The specific immunophenotype (B-cell ALL) confirms the malignant lineage. Pancytopenia is a classic symptom of bone marrow failure due to infiltration. The clinical suspicion of ALL aligns with the findings. While always seeking alternative explanations, the combination of high blast percentage, specific immunophenotype, and clinical presentation strongly points to malignancy. Alternative benign causes for such high blast counts are virtually non-existent in this context.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical review: Could 85% lymphoblasts be reactive? Highly unlikely. The specific immunophenotype (B-cell ALL) confirms the malignant lineage. Pancytopenia is a classic symptom of bone marrow failure due to infiltration. The clinical suspicion of ALL aligns with the findings. While always seeking alternative explanations, the combination of high blast percentage, specific immunophenotype, and clinical presentation strongly points to malignancy. Alternative benign causes for such high blast counts are virtually non-existent in this context.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL",
        "Pancytopenia",
        "Suspected Acute Lymphoblastic Leukemia"
      ],
      "fracture_mentioned": null,
      "idx": 4,
      "timestamp": "2026-01-10T20:50:27.408360"
    },
    {
      "sample_idx": 5,
      "input": "17/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 17/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could reactive lymphadenopathy mask an underlying malignancy? While reactive nodes can sometimes be associated with lymphoma, the report explicitly states 'No atypical features', 'No malignancy identified', and importantly, 'Node size decreasing on follow-up'. This decrease is highly suggestive of a resolving inflammatory/infectious process rather than progressive malignancy. The history also notes 'No previous oncology history'. The conclusion of reactive lymphadenopathy secondary to viral infection, supported by the decreasing size and lack of atypical features, makes malignancy highly unlikely. Skepticism satisfied: the evidence strongly points towards a benign process.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could reactive lymphadenopathy mask an underlying malignancy? While reactive nodes can sometimes be associated with lymphoma, the report explicitly states 'No atypical features', 'No malignancy identified', and importantly, 'Node size decreasing on follow-up'. This decrease is highly suggestive of a resolving inflammatory/infectious process rather than progressive malignancy. The history also notes 'No previous oncology history'. The conclusion of reactive lymphadenopathy secondary to viral infection, supported by the decreasing size and lack of atypical features, makes malignancy highly unlikely. Skepticism satisfied: the evidence strongly points towards a benign process.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 5,
      "timestamp": "2026-01-10T20:50:27.408384"
    },
    {
      "sample_idx": 6,
      "input": "11/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Suspected Neuroblastoma\"],\n        \"rationale\": \"Initial skepticism: Could a suprarenal mass be benign? Playing devil's advocate against malignancy: A heterogeneous mass with calcifications could potentially represent a benign adrenal tumor (e.g., adrenal cortical adenoma, although less common in children) or a congenital mass. However, the MIBG avidity is highly characteristic of neuroblastoma, a malignant tumor derived from neural crest cells. Elevated urinary catecholamines further support this diagnosis, as neuroblastomas often secrete these hormones. The clinical suspicion and staging (Stage III) strongly point towards malignancy. While benign possibilities exist, the combination of imaging (heterogeneous mass, calcifications, MIBG avidity) and biochemical findings (elevated catecholamines) makes neuroblastoma the most likely diagnosis, outweighing benign alternatives. Conclusion: Malignancy is strongly suspected and highly likely based on the provided evidence.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a suprarenal mass be benign? Playing devil's advocate against malignancy: A heterogeneous mass with calcifications could potentially represent a benign adrenal tumor (e.g., adrenal cortical adenoma, although less common in children) or a congenital mass. However, the MIBG avidity is highly characteristic of neuroblastoma, a malignant tumor derived from neural crest cells. Elevated urinary catecholamines further support this diagnosis, as neuroblastomas often secrete these hormones. The clinical suspicion and staging (Stage III) strongly point towards malignancy. While benign possibilities exist, the combination of imaging (heterogeneous mass, calcifications, MIBG avidity) and biochemical findings (elevated catecholamines) makes neuroblastoma the most likely diagnosis, outweighing benign alternatives. Conclusion: Malignancy is strongly suspected and highly likely based on the provided evidence.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Suspected Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 6,
      "timestamp": "2026-01-10T20:50:27.408411"
    },
    {
      "sample_idx": 7,
      "input": "21/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The request is to rule out malignancy, which inherently biases towards finding something. However, the report explicitly states 'No malignancy identified' based on imaging findings (normal chest X-ray, clear lungs, no mediastinal mass, normal heart size). While imaging isn't perfectly sensitive, the absence of any focal lesions or suspicious findings, coupled with the explicit negative conclusion by the oncologist, makes malignancy unlikely based on this specific report. Alternative explanation: Could a subtle malignancy be missed? Possible, but the report provides no evidence for it and explicitly states none was found. Conclusion: Based on the provided imaging report, no evidence of malignancy is present.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The request is to rule out malignancy, which inherently biases towards finding something. However, the report explicitly states 'No malignancy identified' based on imaging findings (normal chest X-ray, clear lungs, no mediastinal mass, normal heart size). While imaging isn't perfectly sensitive, the absence of any focal lesions or suspicious findings, coupled with the explicit negative conclusion by the oncologist, makes malignancy unlikely based on this specific report. Alternative explanation: Could a subtle malignancy be missed? Possible, but the report provides no evidence for it and explicitly states none was found. Conclusion: Based on the provided imaging report, no evidence of malignancy is present.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 7,
      "timestamp": "2026-01-10T20:50:27.408444"
    },
    {
      "sample_idx": 8,
      "input": "08/02/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report explicitly states normal CBC, adequate platelets, normal hemoglobin, and absence of blast cells. The consultant paediatric oncologist explicitly states 'No malignancy identified' and provides reassurance. While early or occult malignancy cannot be absolutely ruled out without further investigation in some contexts, based *solely* on this report, there is no evidence supporting malignancy. The findings are consistent with a benign state.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report explicitly states normal CBC, adequate platelets, normal hemoglobin, and absence of blast cells. The consultant paediatric oncologist explicitly states 'No malignancy identified' and provides reassurance. While early or occult malignancy cannot be absolutely ruled out without further investigation in some contexts, based *solely* on this report, there is no evidence supporting malignancy. The findings are consistent with a benign state.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 8,
      "timestamp": "2026-01-10T20:50:27.408467"
    },
    {
      "sample_idx": 9,
      "input": "25/04/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Skeptical review: The report explicitly identifies a 'large heterogeneous left renal mass'. While some renal masses can be benign (e.g., angiomyolipoma, oncocytoma), the clinical context ('Suspected Wilms Tumor', 'Paediatric oncology assessment', 'Wilms Tumor' diagnosis) and biopsy confirmation ('Favorable histology') strongly point towards malignancy. The term 'pseudocapsule' is common in Wilms Tumor. The staging ('Stage II') further supports a malignant process requiring treatment. Although playing devil's advocate, could a benign mass mimic Wilms? Extremely unlikely given the biopsy results confirming favorable histology, characteristic of Wilms Tumor. Therefore, despite the need for skepticism, the evidence overwhelmingly supports malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical review: The report explicitly identifies a 'large heterogeneous left renal mass'. While some renal masses can be benign (e.g., angiomyolipoma, oncocytoma), the clinical context ('Suspected Wilms Tumor', 'Paediatric oncology assessment', 'Wilms Tumor' diagnosis) and biopsy confirmation ('Favorable histology') strongly point towards malignancy. The term 'pseudocapsule' is common in Wilms Tumor. The staging ('Stage II') further supports a malignant process requiring treatment. Although playing devil's advocate, could a benign mass mimic Wilms? Extremely unlikely given the biopsy results confirming favorable histology, characteristic of Wilms Tumor. Therefore, despite the need for skepticism, the evidence overwhelmingly supports malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 9,
      "timestamp": "2026-01-10T20:50:27.408491"
    },
    {
      "sample_idx": 10,
      "input": "26/12/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could mediastinal mass be reactive or infectious (e.g., TB, sarcoidosis)? However, the presence of FDG-avid nodes strongly suggests metabolic activity typical of malignancy. The specific histological subtype (Classical Hodgkin, nodular sclerosing) is highly characteristic of Hodgkin Lymphoma. While other conditions can cause lymphadenopathy, the combination of bulky mass, FDG avidity, and specific histology points towards malignancy. Conclusion: malignancy likely despite considering reactive/infectious causes.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could mediastinal mass be reactive or infectious (e.g., TB, sarcoidosis)? However, the presence of FDG-avid nodes strongly suggests metabolic activity typical of malignancy. The specific histological subtype (Classical Hodgkin, nodular sclerosing) is highly characteristic of Hodgkin Lymphoma. While other conditions can cause lymphadenopathy, the combination of bulky mass, FDG avidity, and specific histology points towards malignancy. Conclusion: malignancy likely despite considering reactive/infectious causes.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 10,
      "timestamp": "2026-01-10T20:50:27.408510"
    },
    {
      "sample_idx": 11,
      "input": "18/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 18/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could the suprarenal mass be a benign adrenal tumor (e.g., adenoma, hemorrhage) or inflammatory process? However, the combination of a large, heterogeneous mass with calcifications (common in neuroblastoma), MIBG avidity (highly specific for neuroblastoma), elevated urinary catecholamines (characteristic biochemical marker), and staging as Stage III strongly points towards malignancy. While benign adrenal masses exist, the constellation of findings, particularly MIBG avidity and catecholamine elevation, makes a benign explanation highly unlikely. The clinical context of suspected neuroblastoma further supports this conclusion.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the suprarenal mass be a benign adrenal tumor (e.g., adenoma, hemorrhage) or inflammatory process? However, the combination of a large, heterogeneous mass with calcifications (common in neuroblastoma), MIBG avidity (highly specific for neuroblastoma), elevated urinary catecholamines (characteristic biochemical marker), and staging as Stage III strongly points towards malignancy. While benign adrenal masses exist, the constellation of findings, particularly MIBG avidity and catecholamine elevation, makes a benign explanation highly unlikely. The clinical context of suspected neuroblastoma further supports this conclusion.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 11,
      "timestamp": "2026-01-10T20:50:27.408532"
    },
    {
      "sample_idx": 12,
      "input": "15/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 15/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Skeptical analysis: Could the hepatic mass be a benign lesion like focal nodular hyperplasia or inflammatory pseudotumor? Could elevated AFP be due to liver regeneration or other non-malignant causes? However, the combination of a large, heterogeneous mass in a child with pancytopenia, markedly elevated AFP (a known tumor marker for hepatoblastoma), specific fetal histology subtype, and staging (PRETEXT II) strongly points towards hepatoblastoma. Alternative benign explanations are less likely given the constellation of findings. Conclusion: Malignancy highly probable, requiring MDT discussion.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical analysis: Could the hepatic mass be a benign lesion like focal nodular hyperplasia or inflammatory pseudotumor? Could elevated AFP be due to liver regeneration or other non-malignant causes? However, the combination of a large, heterogeneous mass in a child with pancytopenia, markedly elevated AFP (a known tumor marker for hepatoblastoma), specific fetal histology subtype, and staging (PRETEXT II) strongly points towards hepatoblastoma. Alternative benign explanations are less likely given the constellation of findings. Conclusion: Malignancy highly probable, requiring MDT discussion.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 12,
      "timestamp": "2026-01-10T20:50:27.408551"
    },
    {
      "sample_idx": 13,
      "input": "26/02/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Langerhans Cell Histiocytosis.\n\nFrom clinical notes: Langerhans Cell Histiocytosis. Paediatric oncology assessment.\n\nFindings: multiple lytic skull lesions with soft tissue component. CD1a and Langerin positive. Multisystem disease. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\", \"Multisystem disease\", \"Suspected Langerhans Cell Histiocytosis\"],\n        \"rationale\": \"Skeptical assessment: Lytic bone lesions are concerning for malignancy, but Langerhans Cell Histiocytosis (LCH) is explicitly mentioned as the suspected diagnosis, supported by the positive CD1a and Langerin markers, which are characteristic of LCH, not typically primary malignancy. While LCH can behave aggressively, it's classified as a non-malignant proliferative disorder, not a cancer. The presence of 'multisystem disease' confirms LCH involvement beyond a single site. Although LCH requires aggressive treatment, the specific immunophenotyping points away from a typical malignancy. Therefore, despite the concerning appearance of lytic lesions, the evidence strongly suggests LCH, a non-malignant condition.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "Skeptical assessment: Lytic bone lesions are concerning for malignancy, but Langerhans Cell Histiocytosis (LCH) is explicitly mentioned as the suspected diagnosis, supported by the positive CD1a and Langerin markers, which are characteristic of LCH, not typically primary malignancy. While LCH can behave aggressively, it's classified as a non-malignant proliferative disorder, not a cancer. The presence of 'multisystem disease' confirms LCH involvement beyond a single site. Although LCH requires aggressive treatment, the specific immunophenotyping points away from a typical malignancy. Therefore, despite the concerning appearance of lytic lesions, the evidence strongly suggests LCH, a non-malignant condition.",
      "findings": [
        "multiple lytic skull lesions with soft tissue component",
        "CD1a and Langerin positive",
        "Multisystem disease",
        "Suspected Langerhans Cell Histiocytosis"
      ],
      "fracture_mentioned": null,
      "idx": 13,
      "timestamp": "2026-01-10T20:50:27.408574"
    },
    {
      "sample_idx": 14,
      "input": "08/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 08/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states 'No malignancy identified' following screening. The findings described (post-viral lymphocytosis, resolving atypical lymphocytes, positive Monospot, confirmed EBV) are classic signs of infectious mononucleosis, a benign condition. While atypical lymphocytes can sometimes raise concern, the context of confirmed EBV infection and resolution strongly points away from malignancy. Alternative explanation considered: Could this be a lymphoma mimicking EBV? The report explicitly rules this out, and the clinical picture fits a self-limiting viral illness. Conclusion: No malignancy based on explicit report statement and characteristic benign findings.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states 'No malignancy identified' following screening. The findings described (post-viral lymphocytosis, resolving atypical lymphocytes, positive Monospot, confirmed EBV) are classic signs of infectious mononucleosis, a benign condition. While atypical lymphocytes can sometimes raise concern, the context of confirmed EBV infection and resolution strongly points away from malignancy. Alternative explanation considered: Could this be a lymphoma mimicking EBV? The report explicitly rules this out, and the clinical picture fits a self-limiting viral illness. Conclusion: No malignancy based on explicit report statement and characteristic benign findings.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 14,
      "timestamp": "2026-01-10T20:50:27.408597"
    },
    {
      "sample_idx": 15,
      "input": "14/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 14/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"Skeptical approach: Could high blast count be reactive? The 70% myeloblast count is significantly elevated beyond reactive states. The specific t(8;21) translocation is a known diagnostic marker for Acute Myeloid Leukemia (AML). While considering alternative diagnoses for bone pain, the combination of high blast percentage and a specific chromosomal abnormality strongly points towards AML. Initial suspicion of AML is confirmed by the report.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical approach: Could high blast count be reactive? The 70% myeloblast count is significantly elevated beyond reactive states. The specific t(8;21) translocation is a known diagnostic marker for Acute Myeloid Leukemia (AML). While considering alternative diagnoses for bone pain, the combination of high blast percentage and a specific chromosomal abnormality strongly points towards AML. Initial suspicion of AML is confirmed by the report.",
      "findings": [
        "myeloblasts 70% of marrow cellularity",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 15,
      "timestamp": "2026-01-10T20:50:27.408613"
    },
    {
      "sample_idx": 16,
      "input": "07/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 07/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Skeptical assessment: Could the mass be inflammatory or infectious? However, the biopsy explicitly identifies Embryonal rhabdomyosarcoma, a malignant tumor. While PAX-FOXO1 negativity might suggest a specific subtype or prognosis, it doesn't negate the malignant diagnosis. The clinical context (unexplained fever, weight loss) and the explicit biopsy result confirm malignancy despite initial skepticism about non-malignant causes of a mass.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical assessment: Could the mass be inflammatory or infectious? However, the biopsy explicitly identifies Embryonal rhabdomyosarcoma, a malignant tumor. While PAX-FOXO1 negativity might suggest a specific subtype or prognosis, it doesn't negate the malignant diagnosis. The clinical context (unexplained fever, weight loss) and the explicit biopsy result confirm malignancy despite initial skepticism about non-malignant causes of a mass.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 16,
      "timestamp": "2026-01-10T20:50:27.408630"
    },
    {
      "sample_idx": 17,
      "input": "06/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states 'No malignancy identified' after screening. While screening tests can miss things, the comprehensive nature of the report (chest radiograph, lung fields, mediastinal mass, heart size) and the definitive statement by the consultant paediatric oncologist argue strongly against malignancy. There are no abnormal findings mentioned. Alternative explanations for potential concerns (e.g., subtle radiographic changes) are implicitly ruled out by the 'normal' and 'clear' descriptions and the final conclusion.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states 'No malignancy identified' after screening. While screening tests can miss things, the comprehensive nature of the report (chest radiograph, lung fields, mediastinal mass, heart size) and the definitive statement by the consultant paediatric oncologist argue strongly against malignancy. There are no abnormal findings mentioned. Alternative explanations for potential concerns (e.g., subtle radiographic changes) are implicitly ruled out by the 'normal' and 'clear' descriptions and the final conclusion.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 17,
      "timestamp": "2026-01-10T20:50:27.408649"
    },
    {
      "sample_idx": 18,
      "input": "23/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 23/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Skeptical reasoning: Could the posterior fossa mass be an inflammatory lesion or abscess? While possible, the enhancement pattern, restricted diffusion (suggesting high cellularity), and definitive histology confirming high-grade medulloblastoma strongly point towards malignancy. Hydrocephalus is a consequence of the mass effect. Although the clinical suspicion was medulloblastoma, the imaging and histology confirm this diagnosis. Alternative explanations for a posterior fossa mass in a child (e.g., pilocytic astrocytoma, ependymoma) are less likely given the 'high-grade medulloblastoma' histology. Conclusion: Malignancy is confirmed by histological evidence, despite considering alternative diagnoses for the mass.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical reasoning: Could the posterior fossa mass be an inflammatory lesion or abscess? While possible, the enhancement pattern, restricted diffusion (suggesting high cellularity), and definitive histology confirming high-grade medulloblastoma strongly point towards malignancy. Hydrocephalus is a consequence of the mass effect. Although the clinical suspicion was medulloblastoma, the imaging and histology confirm this diagnosis. Alternative explanations for a posterior fossa mass in a child (e.g., pilocytic astrocytoma, ependymoma) are less likely given the 'high-grade medulloblastoma' histology. Conclusion: Malignancy is confirmed by histological evidence, despite considering alternative diagnoses for the mass.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 18,
      "timestamp": "2026-01-10T20:50:27.408674"
    },
    {
      "sample_idx": 19,
      "input": "09/07/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could a suprarenal mass be benign (e.g., adrenal adenoma, hemorrhage)? However, the combination of a large, heterogeneous mass with calcifications, MIBG avidity (characteristic of neuroblastic tumors), and elevated urinary catecholamines strongly points towards neuroblastoma. Stage III designation further supports malignancy. While rare benign conditions might mimic some features, the constellation of findings makes malignancy highly probable. Alternative explanations are less likely given the specific combination of imaging and biochemical markers.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a suprarenal mass be benign (e.g., adrenal adenoma, hemorrhage)? However, the combination of a large, heterogeneous mass with calcifications, MIBG avidity (characteristic of neuroblastic tumors), and elevated urinary catecholamines strongly points towards neuroblastoma. Stage III designation further supports malignancy. While rare benign conditions might mimic some features, the constellation of findings makes malignancy highly probable. Alternative explanations are less likely given the specific combination of imaging and biochemical markers.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 19,
      "timestamp": "2026-01-10T20:50:27.408694"
    },
    {
      "sample_idx": 20,
      "input": "18/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial skepticism: Could a large renal mass be something other than Wilms Tumor? Benign renal masses in children are rare but possible (e.g., angiomyolipoma, juxtaglomerular tumor). However, the clinical context (pancytopenia, pediatric oncology assessment) and the specific diagnosis of 'Wilms Tumor' confirmed by biopsy with 'favorable histology' strongly point towards malignancy. The staging (Stage II) further supports a malignant process requiring treatment. Alternative explanations are less likely given the biopsy results. Conclusion: Malignancy confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a large renal mass be something other than Wilms Tumor? Benign renal masses in children are rare but possible (e.g., angiomyolipoma, juxtaglomerular tumor). However, the clinical context (pancytopenia, pediatric oncology assessment) and the specific diagnosis of 'Wilms Tumor' confirmed by biopsy with 'favorable histology' strongly point towards malignancy. The staging (Stage II) further supports a malignant process requiring treatment. Alternative explanations are less likely given the biopsy results. Conclusion: Malignancy confirmed.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 20,
      "timestamp": "2026-01-10T20:50:27.408712"
    },
    {
      "sample_idx": 21,
      "input": "13/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 13/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical approach: Could a subtle malignancy be missed on MRI? The report explicitly states 'No malignancy identified' after evaluating for mass lesions and abnormal enhancement, which are key indicators. Given the context of routine surveillance with no prior history and the explicit negative findings, the conclusion of no malignancy is strongly supported. Alternative explanations for headaches (migraine) are provided. Therefore, despite the inherent limitations of imaging, the report provides no evidence suggestive of malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical approach: Could a subtle malignancy be missed on MRI? The report explicitly states 'No malignancy identified' after evaluating for mass lesions and abnormal enhancement, which are key indicators. Given the context of routine surveillance with no prior history and the explicit negative findings, the conclusion of no malignancy is strongly supported. Alternative explanations for headaches (migraine) are provided. Therefore, despite the inherent limitations of imaging, the report provides no evidence suggestive of malignancy.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 21,
      "timestamp": "2026-01-10T20:50:27.408730"
    },
    {
      "sample_idx": 22,
      "input": "18/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Suspected Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial skepticism: Could a large renal mass be a benign entity like a renal abscess or a complex cyst? However, the clinical suspicion of Wilms Tumor, confirmed by biopsy showing favorable histology, and staging as Stage II strongly points towards malignancy. While pseudocapsules can occur in benign conditions, the overall picture including biopsy results makes malignancy the most likely diagnosis. Alternative benign explanations are less likely given the biopsy findings.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a large renal mass be a benign entity like a renal abscess or a complex cyst? However, the clinical suspicion of Wilms Tumor, confirmed by biopsy showing favorable histology, and staging as Stage II strongly points towards malignancy. While pseudocapsules can occur in benign conditions, the overall picture including biopsy results makes malignancy the most likely diagnosis. Alternative benign explanations are less likely given the biopsy findings.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Suspected Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 22,
      "timestamp": "2026-01-10T20:50:27.408748"
    },
    {
      "sample_idx": 23,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"Headaches attributed to migraine\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical reasoning: Could headaches be a symptom of a subtle brain tumor missed on MRI? Playing devil's advocate against a benign conclusion: The report explicitly states 'No mass lesion' and 'No abnormal enhancement' on a brain MRI. The headaches are attributed to a common benign condition (migraine). The report concludes 'No malignancy identified'. While headaches can be a red flag, the imaging findings are explicitly normal, and a benign cause is identified. No evidence supports malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical reasoning: Could headaches be a symptom of a subtle brain tumor missed on MRI? Playing devil's advocate against a benign conclusion: The report explicitly states 'No mass lesion' and 'No abnormal enhancement' on a brain MRI. The headaches are attributed to a common benign condition (migraine). The report concludes 'No malignancy identified'. While headaches can be a red flag, the imaging findings are explicitly normal, and a benign cause is identified. No evidence supports malignancy.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "Headaches attributed to migraine",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 23,
      "timestamp": "2026-01-10T20:50:27.408766"
    },
    {
      "sample_idx": 24,
      "input": "16/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"Headaches attributed to migraine\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical reasoning: Could the 'normal' MRI miss a subtle malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states 'No mass lesion' and 'No abnormal enhancement', with a concluding statement 'No malignancy identified'. The headaches are attributed to a known benign condition (migraine). While vigilance is necessary, the report provides no objective evidence supporting malignancy. Conclusion: benign findings dominate.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical reasoning: Could the 'normal' MRI miss a subtle malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states 'No mass lesion' and 'No abnormal enhancement', with a concluding statement 'No malignancy identified'. The headaches are attributed to a known benign condition (migraine). While vigilance is necessary, the report provides no objective evidence supporting malignancy. Conclusion: benign findings dominate.",
      "findings": [
        "Normal brain MRI",
        "No mass lesion",
        "No abnormal enhancement",
        "Headaches attributed to migraine",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 24,
      "timestamp": "2026-01-10T20:50:27.408783"
    },
    {
      "sample_idx": 25,
      "input": "16/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could permeative bone destruction and soft tissue mass be due to infection (e.g., osteomyelitis) or inflammatory process? Could onion-skin reaction be reactive? However, the presence of EWSR1 fusion positivity is highly specific for Ewing Sarcoma. While infection can cause bone destruction, the combination of features, especially the genetic marker, strongly points towards malignancy. Alternative benign explanations are unlikely given the specific genetic finding. Conclusion: Malignancy is highly likely.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could permeative bone destruction and soft tissue mass be due to infection (e.g., osteomyelitis) or inflammatory process? Could onion-skin reaction be reactive? However, the presence of EWSR1 fusion positivity is highly specific for Ewing Sarcoma. While infection can cause bone destruction, the combination of features, especially the genetic marker, strongly points towards malignancy. Alternative benign explanations are unlikely given the specific genetic finding. Conclusion: Malignancy is highly likely.",
      "findings": [
        "permeative bone destruction",
        "large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 25,
      "timestamp": "2026-01-10T20:50:27.408801"
    },
    {
      "sample_idx": 26,
      "input": "13/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 13/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"High LDH levels\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states 'Burkitt lymphoma confirmed on biopsy'. While lymphadenopathy can be reactive, the definitive biopsy result overrides this possibility. High LDH is non-specific but consistent with high cell turnover seen in Burkitt lymphoma. The clinical context (pancytopenia, suspected NHL) aligns with the confirmed diagnosis. Conclusion: Despite the need for skepticism, the biopsy confirmation is unequivocal evidence of malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states 'Burkitt lymphoma confirmed on biopsy'. While lymphadenopathy can be reactive, the definitive biopsy result overrides this possibility. High LDH is non-specific but consistent with high cell turnover seen in Burkitt lymphoma. The clinical context (pancytopenia, suspected NHL) aligns with the confirmed diagnosis. Conclusion: Despite the need for skepticism, the biopsy confirmation is unequivocal evidence of malignancy.",
      "findings": [
        "abdominal lymphadenopathy",
        "mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "High LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 26,
      "timestamp": "2026-01-10T20:50:27.408819"
    },
    {
      "sample_idx": 27,
      "input": "25/06/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"Bone density normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: Could a fracture be a pathological fracture masking malignancy? The report explicitly states 'normal process', 'no pathological features', and 'no malignancy identified'. The history is consistent with trauma, and bone density is normal. While vigilance is always necessary, the findings directly contradict malignancy. No evidence supports a malignant interpretation.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: Could a fracture be a pathological fracture masking malignancy? The report explicitly states 'normal process', 'no pathological features', and 'no malignancy identified'. The history is consistent with trauma, and bone density is normal. While vigilance is always necessary, the findings directly contradict malignancy. No evidence supports a malignant interpretation.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "Bone density normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 27,
      "timestamp": "2026-01-10T20:50:27.408835"
    },
    {
      "sample_idx": 28,
      "input": "01/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 01/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states 'No malignancy identified' and describes a resolved benign finding. Could a malignancy be missed? Playing devil's advocate: the imaging shows a resolved benign cyst with no aggressive features and no recurrence. Normal bone density further supports a benign process. While imaging has limitations, the explicit statement of 'no malignancy identified' combined with the benign nature of the findings makes malignancy highly unlikely. No evidence supports a malignant diagnosis.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states 'No malignancy identified' and describes a resolved benign finding. Could a malignancy be missed? Playing devil's advocate: the imaging shows a resolved benign cyst with no aggressive features and no recurrence. Normal bone density further supports a benign process. While imaging has limitations, the explicit statement of 'no malignancy identified' combined with the benign nature of the findings makes malignancy highly unlikely. No evidence supports a malignant diagnosis.",
      "findings": [
        "Benign bone cyst - resolved",
        "No aggressive features",
        "Normal bone density",
        "No recurrence on imaging",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 28,
      "timestamp": "2026-01-10T20:50:27.408853"
    },
    {
      "sample_idx": 29,
      "input": "04/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could a suprarenal mass be benign (e.g., adrenal adenoma, pheochromocytoma)? Could calcifications be incidental? Could MIBG avidity be seen in other conditions? However, the combination of a large, heterogeneous suprarenal mass (characteristic morphology), MIBG avidity (highly specific for neuroblastic tumors), and elevated urinary catecholamines (biochemical marker for neuroblastoma) strongly points towards neuroblastoma. The clinical suspicion and staging further support malignancy. Alternative benign explanations are less likely given the constellation of findings.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a suprarenal mass be benign (e.g., adrenal adenoma, pheochromocytoma)? Could calcifications be incidental? Could MIBG avidity be seen in other conditions? However, the combination of a large, heterogeneous suprarenal mass (characteristic morphology), MIBG avidity (highly specific for neuroblastic tumors), and elevated urinary catecholamines (biochemical marker for neuroblastoma) strongly points towards neuroblastoma. The clinical suspicion and staging further support malignancy. Alternative benign explanations are less likely given the constellation of findings.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 29,
      "timestamp": "2026-01-10T20:50:27.408887"
    },
    {
      "sample_idx": 30,
      "input": "15/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 15/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement\", \"hydrocephalus\", \"restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the posterior fossa mass be a non-malignant lesion like an abscess or inflammatory process? However, the combination of enhancement, restricted diffusion (suggesting high cellularity), hydrocephalus (indicating mass effect), and definitive histology confirming 'High-grade medulloblastoma' strongly points towards malignancy. While imaging findings alone can sometimes be ambiguous, the histological confirmation provides compelling evidence. Alternative benign explanations are highly unlikely given the specific histological diagnosis. Conclusion: malignancy confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the posterior fossa mass be a non-malignant lesion like an abscess or inflammatory process? However, the combination of enhancement, restricted diffusion (suggesting high cellularity), hydrocephalus (indicating mass effect), and definitive histology confirming 'High-grade medulloblastoma' strongly points towards malignancy. While imaging findings alone can sometimes be ambiguous, the histological confirmation provides compelling evidence. Alternative benign explanations are highly unlikely given the specific histological diagnosis. Conclusion: malignancy confirmed.",
      "findings": [
        "posterior fossa mass with enhancement",
        "hydrocephalus",
        "restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 30,
      "timestamp": "2026-01-10T20:50:27.408907"
    },
    {
      "sample_idx": 31,
      "input": "02/04/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: While the report explicitly states 'No malignancy identified' and describes a 'Normal chest radiograph', could subtle findings be missed? Playing devil's advocate: Even with a 'normal' radiograph, microscopic disease or early-stage malignancy might not be visible. However, the report's explicit negative findings ('Clear lung fields', 'No mediastinal mass') combined with the 'Benign presentation' history strongly suggest the absence of detectable malignancy on this imaging modality. Conclusion: Based on the provided report, there is no evidence of malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: While the report explicitly states 'No malignancy identified' and describes a 'Normal chest radiograph', could subtle findings be missed? Playing devil's advocate: Even with a 'normal' radiograph, microscopic disease or early-stage malignancy might not be visible. However, the report's explicit negative findings ('Clear lung fields', 'No mediastinal mass') combined with the 'Benign presentation' history strongly suggest the absence of detectable malignancy on this imaging modality. Conclusion: Based on the provided report, there is no evidence of malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 31,
      "timestamp": "2026-01-10T20:50:27.408926"
    },
    {
      "sample_idx": 32,
      "input": "04/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could the mass be a benign teratoma or a non-malignant germ cell tumor? However, the presence of yolk sac tumor elements is highly indicative of malignancy. Elevated AFP and beta-hCG are tumor markers strongly associated with malignant germ cell tumors, particularly yolk sac tumors and choriocarcinoma components respectively. While some benign germ cell tumors can have elevated markers, the combination of a solid/cystic mass, specific tumor histology (yolk sac), and elevated markers strongly points towards malignancy. Alternative benign explanations are less likely given the specific histological findings and marker elevation.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mass be a benign teratoma or a non-malignant germ cell tumor? However, the presence of yolk sac tumor elements is highly indicative of malignancy. Elevated AFP and beta-hCG are tumor markers strongly associated with malignant germ cell tumors, particularly yolk sac tumors and choriocarcinoma components respectively. While some benign germ cell tumors can have elevated markers, the combination of a solid/cystic mass, specific tumor histology (yolk sac), and elevated markers strongly points towards malignancy. Alternative benign explanations are less likely given the specific histological findings and marker elevation.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 32,
      "timestamp": "2026-01-10T20:50:27.408947"
    },
    {
      "sample_idx": 33,
      "input": "24/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Skeptical reasoning: Could lymphadenopathy be reactive? While reactive lymphadenopathy is common, the presence of a 'bulky anterior mediastinal mass' and 'FDG-avid nodes' on PET-CT strongly suggests a neoplastic process. The specific histological subtype 'Classical Hodgkin, nodular sclerosing type' provides definitive evidence of malignancy. Alternative benign explanations (infection, inflammation) are less likely given the bulky mass and FDG avidity pattern characteristic of lymphoma. Conclusion: malignancy confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical reasoning: Could lymphadenopathy be reactive? While reactive lymphadenopathy is common, the presence of a 'bulky anterior mediastinal mass' and 'FDG-avid nodes' on PET-CT strongly suggests a neoplastic process. The specific histological subtype 'Classical Hodgkin, nodular sclerosing type' provides definitive evidence of malignancy. Alternative benign explanations (infection, inflammation) are less likely given the bulky mass and FDG avidity pattern characteristic of lymphoma. Conclusion: malignancy confirmed.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 33,
      "timestamp": "2026-01-10T20:50:27.408965"
    },
    {
      "sample_idx": 34,
      "input": "07/03/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 07/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical analysis: The report explicitly states 'No malignancy identified' based on a normal CBC, adequate platelets, normal hemoglobin, and absence of blast cells. While routine surveillance might raise suspicion, the findings are unequivocally normal. Could this be a false negative? The report provides no features suggestive of occult disease. The conclusion of 'No malignancy identified' is strongly supported by the presented data. Alternative explanations for the surveillance (e.g., family history, benign cytopenias) are not provided, but the current findings do not indicate malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical analysis: The report explicitly states 'No malignancy identified' based on a normal CBC, adequate platelets, normal hemoglobin, and absence of blast cells. While routine surveillance might raise suspicion, the findings are unequivocally normal. Could this be a false negative? The report provides no features suggestive of occult disease. The conclusion of 'No malignancy identified' is strongly supported by the presented data. Alternative explanations for the surveillance (e.g., family history, benign cytopenias) are not provided, but the current findings do not indicate malignancy.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 34,
      "timestamp": "2026-01-10T20:50:27.408985"
    },
    {
      "sample_idx": 35,
      "input": "04/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign soft tissue mass - lipoma confirmed\", \"Well-circumscribed\", \"No enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a lipoma mimic a malignant tumor? The report explicitly describes a benign soft tissue mass, confirmed as a lipoma, which is well-circumscribed and shows no enhancement. The radiologist explicitly states 'No malignancy identified' and provides reassurance. While skepticism is warranted in ruling out malignancy, the findings are highly characteristic of a benign lipoma, making malignancy extremely unlikely. No further investigation is indicated based on this report.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a lipoma mimic a malignant tumor? The report explicitly describes a benign soft tissue mass, confirmed as a lipoma, which is well-circumscribed and shows no enhancement. The radiologist explicitly states 'No malignancy identified' and provides reassurance. While skepticism is warranted in ruling out malignancy, the findings are highly characteristic of a benign lipoma, making malignancy extremely unlikely. No further investigation is indicated based on this report.",
      "findings": [
        "Benign soft tissue mass - lipoma confirmed",
        "Well-circumscribed",
        "No enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 35,
      "timestamp": "2026-01-10T20:50:27.409003"
    },
    {
      "sample_idx": 36,
      "input": "04/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical review: The report is explicitly for screening with no prior history. Could a screening report miss subtle signs? The findings are overwhelmingly negative: normal chest X-ray, clear lungs, no mass, normal heart size, and a direct statement 'No malignancy identified'. While screening can miss things, the report provides no positive findings to suggest malignancy. The conclusion of 'no malignancy identified' is supported by the lack of any abnormal findings.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: The report is explicitly for screening with no prior history. Could a screening report miss subtle signs? The findings are overwhelmingly negative: normal chest X-ray, clear lungs, no mass, normal heart size, and a direct statement 'No malignancy identified'. While screening can miss things, the report provides no positive findings to suggest malignancy. The conclusion of 'no malignancy identified' is supported by the lack of any abnormal findings.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 36,
      "timestamp": "2026-01-10T20:50:27.409020"
    },
    {
      "sample_idx": 37,
      "input": "02/04/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"Sunburst periosteal reaction\", \"Elevated alkaline phosphatase\"],\n        \"rationale\": \"Skeptical review: Could the destructive lesion be infection (osteomyelitis) or benign bone tumor? The 'sunburst' periosteal reaction is highly suggestive of aggressive bone lesion, often malignancy like osteosarcoma. Elevated alkaline phosphatase is non-specific but common in bone turnover, including malignancy. While infection is possible, the combination of a destructive lesion with a soft tissue component and the classic sunburst pattern strongly points towards osteosarcoma, especially given the clinical suspicion. Alternative explanations like benign fibrous dysplasia are less likely with this aggressive appearance. Conclusion: High suspicion for malignancy, likely osteosarcoma, warrants MDT discussion.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical review: Could the destructive lesion be infection (osteomyelitis) or benign bone tumor? The 'sunburst' periosteal reaction is highly suggestive of aggressive bone lesion, often malignancy like osteosarcoma. Elevated alkaline phosphatase is non-specific but common in bone turnover, including malignancy. While infection is possible, the combination of a destructive lesion with a soft tissue component and the classic sunburst pattern strongly points towards osteosarcoma, especially given the clinical suspicion. Alternative explanations like benign fibrous dysplasia are less likely with this aggressive appearance. Conclusion: High suspicion for malignancy, likely osteosarcoma, warrants MDT discussion.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "Sunburst periosteal reaction",
        "Elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 37,
      "timestamp": "2026-01-10T20:50:27.409041"
    },
    {
      "sample_idx": 38,
      "input": "05/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 05/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"Sunburst periosteal reaction\", \"Elevated alkaline phosphatase\", \"Suspected Osteosarcoma\"],\n        \"rationale\": \"Skeptical assessment: Could the destructive lesion be infectious (osteomyelitis) or inflammatory? Sunburst periosteal reaction is classic for osteosarcoma, but can rarely be seen in other conditions like Ewing sarcoma or infection. Elevated alkaline phosphatase is non-specific, often elevated in growing children or bone healing, but also common in bone tumors. However, the combination of a destructive lesion with a soft tissue component and the highly suggestive 'sunburst' pattern in a pediatric patient with suspected osteosarcoma strongly points towards malignancy. While alternative diagnoses like infection are possible, the overall picture is highly suspicious for osteosarcoma.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical assessment: Could the destructive lesion be infectious (osteomyelitis) or inflammatory? Sunburst periosteal reaction is classic for osteosarcoma, but can rarely be seen in other conditions like Ewing sarcoma or infection. Elevated alkaline phosphatase is non-specific, often elevated in growing children or bone healing, but also common in bone tumors. However, the combination of a destructive lesion with a soft tissue component and the highly suggestive 'sunburst' pattern in a pediatric patient with suspected osteosarcoma strongly points towards malignancy. While alternative diagnoses like infection are possible, the overall picture is highly suspicious for osteosarcoma.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "Sunburst periosteal reaction",
        "Elevated alkaline phosphatase",
        "Suspected Osteosarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 38,
      "timestamp": "2026-01-10T20:50:27.409063"
    },
    {
      "sample_idx": 39,
      "input": "01/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 01/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could atypical lymphocytes be blasts? The report explicitly states 'atypical lymphocytes resolving' in the context of 'post-viral lymphocytosis' and confirmed EBV infection (Monospot positive, EBV serology confirms). While atypical lymphocytes can sometimes mimic blasts, the resolution, confirmed viral etiology, and explicit statement 'No malignancy identified' strongly argue against malignancy. Alternative explanations (e.g., viral infection) are confirmed. Conclusion: No malignancy, despite the presence of atypical lymphocytes which initially require careful consideration.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could atypical lymphocytes be blasts? The report explicitly states 'atypical lymphocytes resolving' in the context of 'post-viral lymphocytosis' and confirmed EBV infection (Monospot positive, EBV serology confirms). While atypical lymphocytes can sometimes mimic blasts, the resolution, confirmed viral etiology, and explicit statement 'No malignancy identified' strongly argue against malignancy. Alternative explanations (e.g., viral infection) are confirmed. Conclusion: No malignancy, despite the presence of atypical lymphocytes which initially require careful consideration.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 39,
      "timestamp": "2026-01-10T20:50:27.409082"
    },
    {
      "sample_idx": 40,
      "input": "26/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass\", \"Suspected Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Skeptical analysis: Could the renal mass be a benign condition like a renal cyst or hamartoma? However, the clinical suspicion of Wilms Tumor, favorable histology on biopsy (characteristic of Wilms), and staging (Stage II) strongly point towards malignancy. While benign renal masses exist, the specific context (pediatric patient, suspected Wilms, biopsy results) makes malignancy the most likely diagnosis despite considering alternatives.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical analysis: Could the renal mass be a benign condition like a renal cyst or hamartoma? However, the clinical suspicion of Wilms Tumor, favorable histology on biopsy (characteristic of Wilms), and staging (Stage II) strongly point towards malignancy. While benign renal masses exist, the specific context (pediatric patient, suspected Wilms, biopsy results) makes malignancy the most likely diagnosis despite considering alternatives.",
      "findings": [
        "large heterogeneous left renal mass",
        "Suspected Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 40,
      "timestamp": "2026-01-10T20:50:27.409099"
    },
    {
      "sample_idx": 41,
      "input": "18/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could lymphadenopathy be reactive? However, the presence of a 'bulky' anterior mediastinal mass, combined with FDG-avid nodes on PET-CT, strongly suggests malignancy. The specific histological subtype 'Classical Hodgkin, nodular sclerosing type' provides definitive evidence. Alternative benign explanations (infection, inflammatory conditions) are less likely given the PET-CT findings and specific histology. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could lymphadenopathy be reactive? However, the presence of a 'bulky' anterior mediastinal mass, combined with FDG-avid nodes on PET-CT, strongly suggests malignancy. The specific histological subtype 'Classical Hodgkin, nodular sclerosing type' provides definitive evidence. Alternative benign explanations (infection, inflammatory conditions) are less likely given the PET-CT findings and specific histology. Conclusion: malignancy confirmed despite initial skepticism.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 41,
      "timestamp": "2026-01-10T20:50:27.409116"
    },
    {
      "sample_idx": 42,
      "input": "20/04/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 20/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: While lymphocytosis and atypical lymphocytes can sometimes be associated with lymphoma (e.g., T-cell lymphoma), the context here is strongly suggestive of a benign process. The positive Monospot test and confirmed EBV serology point directly to infectious mononucleosis, a common cause of these findings. The report explicitly states 'No malignancy identified' and 'resolving' atypical lymphocytes, indicating a transient, self-limiting condition. Despite the potential overlap in morphology, the clinical and serological context overwhelmingly supports a benign infectious etiology rather than malignancy. The conclusion of 'no malignancy' is well-supported by the available evidence.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: While lymphocytosis and atypical lymphocytes can sometimes be associated with lymphoma (e.g., T-cell lymphoma), the context here is strongly suggestive of a benign process. The positive Monospot test and confirmed EBV serology point directly to infectious mononucleosis, a common cause of these findings. The report explicitly states 'No malignancy identified' and 'resolving' atypical lymphocytes, indicating a transient, self-limiting condition. Despite the potential overlap in morphology, the clinical and serological context overwhelmingly supports a benign infectious etiology rather than malignancy. The conclusion of 'no malignancy' is well-supported by the available evidence.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 42,
      "timestamp": "2026-01-10T20:50:27.409137"
    },
    {
      "sample_idx": 43,
      "input": "20/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 20/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"Headaches attributed to migraine\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical analysis: The report explicitly states 'No malignancy identified' based on a normal brain MRI. Could the headaches be a symptom of an undetected brain tumor? While headaches are a common migraine symptom, they can also be associated with brain tumors. However, the MRI, which is the gold standard for detecting brain masses, is normal. The absence of mass lesions or abnormal enhancement makes malignancy highly unlikely. The report concludes with reassurance, further supporting a benign interpretation. The lack of any identified abnormality strongly argues against malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical analysis: The report explicitly states 'No malignancy identified' based on a normal brain MRI. Could the headaches be a symptom of an undetected brain tumor? While headaches are a common migraine symptom, they can also be associated with brain tumors. However, the MRI, which is the gold standard for detecting brain masses, is normal. The absence of mass lesions or abnormal enhancement makes malignancy highly unlikely. The report concludes with reassurance, further supporting a benign interpretation. The lack of any identified abnormality strongly argues against malignancy.",
      "findings": [
        "Normal brain MRI",
        "No mass lesion",
        "No abnormal enhancement",
        "Headaches attributed to migraine",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 43,
      "timestamp": "2026-01-10T20:50:27.409156"
    },
    {
      "sample_idx": 44,
      "input": "22/11/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 22/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could bone destruction be infectious (osteomyelitis) or inflammatory? Could the soft tissue mass be an abscess or hematoma? However, the combination of permeative bone destruction (characteristic of aggressive infiltrative processes), onion-skin periosteal reaction (classic sign of aggressive bone tumors like Ewing Sarcoma), a large soft tissue mass (suggesting local extension), and crucially, the positive EWSR1 fusion gene (a highly specific molecular marker for Ewing Sarcoma family of tumors) makes a benign explanation extremely unlikely. While infection can cause bone destruction, the specific pattern and the genetic marker strongly point towards malignancy. Conclusion: Malignancy confirmed, specifically Ewing Sarcoma, despite considering alternative diagnoses like infection.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could bone destruction be infectious (osteomyelitis) or inflammatory? Could the soft tissue mass be an abscess or hematoma? However, the combination of permeative bone destruction (characteristic of aggressive infiltrative processes), onion-skin periosteal reaction (classic sign of aggressive bone tumors like Ewing Sarcoma), a large soft tissue mass (suggesting local extension), and crucially, the positive EWSR1 fusion gene (a highly specific molecular marker for Ewing Sarcoma family of tumors) makes a benign explanation extremely unlikely. While infection can cause bone destruction, the specific pattern and the genetic marker strongly point towards malignancy. Conclusion: Malignancy confirmed, specifically Ewing Sarcoma, despite considering alternative diagnoses like infection.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis",
        "large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 44,
      "timestamp": "2026-01-10T20:50:27.409179"
    },
    {
      "sample_idx": 45,
      "input": "06/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a subtle malignancy be missed on MRI? Playing devil's advocate against a benign conclusion: the report explicitly states 'Normal brain MRI for age', 'No mass lesion', 'No abnormal enhancement', and directly concludes 'No malignancy identified'. While MRI has limitations, the absence of any suspicious findings, coupled with the explicit negative conclusion by the consulting paediatric oncologist, strongly supports a benign interpretation. There is no evidence presented to suggest malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a subtle malignancy be missed on MRI? Playing devil's advocate against a benign conclusion: the report explicitly states 'Normal brain MRI for age', 'No mass lesion', 'No abnormal enhancement', and directly concludes 'No malignancy identified'. While MRI has limitations, the absence of any suspicious findings, coupled with the explicit negative conclusion by the consulting paediatric oncologist, strongly supports a benign interpretation. There is no evidence presented to suggest malignancy.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 45,
      "timestamp": "2026-01-10T20:50:27.409197"
    },
    {
      "sample_idx": 46,
      "input": "24/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\"],\n        \"rationale\": \"Applying skeptical reasoning: Could physiological splenomegaly mask an underlying malignancy? The report explicitly states 'physiological splenomegaly for age' and 'benign finding'. While splenomegaly can be associated with malignancy, the description 'physiological' strongly suggests a normal variant. The report explicitly rules out malignancy. Conclusion: No malignancy identified based on the report's findings and explicit statement.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could physiological splenomegaly mask an underlying malignancy? The report explicitly states 'physiological splenomegaly for age' and 'benign finding'. While splenomegaly can be associated with malignancy, the description 'physiological' strongly suggests a normal variant. The report explicitly rules out malignancy. Conclusion: No malignancy identified based on the report's findings and explicit statement.",
      "findings": [
        "Physiological splenomegaly for age"
      ],
      "fracture_mentioned": null,
      "idx": 46,
      "timestamp": "2026-01-10T20:50:27.409212"
    },
    {
      "sample_idx": 47,
      "input": "01/02/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 01/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the reactive lymphadenopathy mask an underlying malignancy? Playing devil's advocate against a benign conclusion: the report explicitly states reactive lymphadenopathy secondary to viral infection, which is a common benign cause. Furthermore, the nodes are decreasing in size, which is characteristic of a resolving inflammatory process, not typically seen with malignancy. The absence of atypical features and the explicit statement 'No malignancy identified' strongly support a benign interpretation. While vigilance is always necessary, the current evidence points away from malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could the reactive lymphadenopathy mask an underlying malignancy? Playing devil's advocate against a benign conclusion: the report explicitly states reactive lymphadenopathy secondary to viral infection, which is a common benign cause. Furthermore, the nodes are decreasing in size, which is characteristic of a resolving inflammatory process, not typically seen with malignancy. The absence of atypical features and the explicit statement 'No malignancy identified' strongly support a benign interpretation. While vigilance is always necessary, the current evidence points away from malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 47,
      "timestamp": "2026-01-10T20:50:27.409233"
    },
    {
      "sample_idx": 48,
      "input": "03/10/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Skeptical analysis: Could the destructive lesion be infection (osteomyelitis) or trauma? The sunburst periosteal reaction is highly suggestive of osteosarcoma but can rarely be seen in other conditions. Elevated alkaline phosphatase is non-specific but common in bone turnover, including malignancy. However, the combination of a destructive lesion with a soft tissue component and a sunburst pattern in a pediatric patient with suspected osteosarcoma strongly points towards malignancy. Alternative benign explanations like infection or trauma are less likely given the classic radiographic features described. Conclusion: malignancy highly probable.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical analysis: Could the destructive lesion be infection (osteomyelitis) or trauma? The sunburst periosteal reaction is highly suggestive of osteosarcoma but can rarely be seen in other conditions. Elevated alkaline phosphatase is non-specific but common in bone turnover, including malignancy. However, the combination of a destructive lesion with a soft tissue component and a sunburst pattern in a pediatric patient with suspected osteosarcoma strongly points towards malignancy. Alternative benign explanations like infection or trauma are less likely given the classic radiographic features described. Conclusion: malignancy highly probable.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 48,
      "timestamp": "2026-01-10T20:50:27.409252"
    },
    {
      "sample_idx": 49,
      "input": "05/08/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states reactive lymphadenopathy likely due to viral infection, a common benign cause. The decreasing node size on follow-up further supports a reactive process rather than malignancy. The absence of atypical features and the explicit statement 'No malignancy identified' by the consulting oncologist strongly argue against malignancy. While screening PET-CTs can occasionally miss malignancy, the findings here are classic for a benign reactive process. No evidence points towards malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states reactive lymphadenopathy likely due to viral infection, a common benign cause. The decreasing node size on follow-up further supports a reactive process rather than malignancy. The absence of atypical features and the explicit statement 'No malignancy identified' by the consulting oncologist strongly argue against malignancy. While screening PET-CTs can occasionally miss malignancy, the findings here are classic for a benign reactive process. No evidence points towards malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 49,
      "timestamp": "2026-01-10T20:50:27.409271"
    },
    {
      "sample_idx": 50,
      "input": "02/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"Skeptical review: The report explicitly states 'No malignancy identified' and provides 'Reassurance'. While a single imaging study isn't foolproof, the findings are consistently normal across multiple assessed areas (chest, lungs, mediastinum, heart size). The reason for request was 'Benign presentation' and there's no history of oncology. Playing devil's advocate: Could a subtle malignancy be missed? The report is quite definitive in its negative findings and conclusion. Without any suspicious features described, the conclusion of no malignancy is strongly supported by the provided evidence. Therefore, despite the inherent limitations of imaging, the report provides no basis to suspect malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: The report explicitly states 'No malignancy identified' and provides 'Reassurance'. While a single imaging study isn't foolproof, the findings are consistently normal across multiple assessed areas (chest, lungs, mediastinum, heart size). The reason for request was 'Benign presentation' and there's no history of oncology. Playing devil's advocate: Could a subtle malignancy be missed? The report is quite definitive in its negative findings and conclusion. Without any suspicious features described, the conclusion of no malignancy is strongly supported by the provided evidence. Therefore, despite the inherent limitations of imaging, the report provides no basis to suspect malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 50,
      "timestamp": "2026-01-10T20:50:27.409292"
    },
    {
      "sample_idx": 51,
      "input": "26/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign soft tissue mass - lipoma confirmed\", \"Well-circumscribed\", \"No enhancement\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"Skeptical analysis: The report explicitly states 'No malignancy identified' and confirms the finding as a benign lipoma. While follow-up suggests prior concern, the current findings are definitively benign. Could a lipoma mask a deeper malignancy? Highly unlikely given the well-circumscribed nature and lack of enhancement, typical features of benign lipomas. The report provides clear reassurance. Conclusion: No malignancy based on definitive benign findings.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical analysis: The report explicitly states 'No malignancy identified' and confirms the finding as a benign lipoma. While follow-up suggests prior concern, the current findings are definitively benign. Could a lipoma mask a deeper malignancy? Highly unlikely given the well-circumscribed nature and lack of enhancement, typical features of benign lipomas. The report provides clear reassurance. Conclusion: No malignancy based on definitive benign findings.",
      "findings": [
        "Benign soft tissue mass - lipoma confirmed",
        "Well-circumscribed",
        "No enhancement",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 51,
      "timestamp": "2026-01-10T20:50:27.409309"
    },
    {
      "sample_idx": 52,
      "input": "25/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 25/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Skeptical assessment: Could the renal mass be a benign entity like a congenital mesoblastic nephroma or a renal abscess? The description 'large heterogeneous mass' is concerning. However, the biopsy explicitly states 'favorable histology', which strongly points towards Wilms Tumor, a malignancy. The staging (Stage II) further supports a malignant diagnosis. While benign renal masses exist, the biopsy result is key. Conclusion: Malignancy highly likely given the biopsy result, despite the possibility of benign mimics based solely on imaging.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical assessment: Could the renal mass be a benign entity like a congenital mesoblastic nephroma or a renal abscess? The description 'large heterogeneous mass' is concerning. However, the biopsy explicitly states 'favorable histology', which strongly points towards Wilms Tumor, a malignancy. The staging (Stage II) further supports a malignant diagnosis. While benign renal masses exist, the biopsy result is key. Conclusion: Malignancy highly likely given the biopsy result, despite the possibility of benign mimics based solely on imaging.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 52,
      "timestamp": "2026-01-10T20:50:27.409327"
    },
    {
      "sample_idx": 53,
      "input": "05/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy\", \"Node size decreasing\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: While 'reactive lymphadenopathy' is often benign, could it mask an underlying malignancy? However, the report explicitly states 'Node size decreasing', 'No atypical features', and 'No malignancy identified'. The decreasing size argues against progressive malignancy. The lack of atypical features further reduces suspicion. Conclusion: Despite the presence of lymphadenopathy (an abnormal finding), the report provides strong evidence against malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: While 'reactive lymphadenopathy' is often benign, could it mask an underlying malignancy? However, the report explicitly states 'Node size decreasing', 'No atypical features', and 'No malignancy identified'. The decreasing size argues against progressive malignancy. The lack of atypical features further reduces suspicion. Conclusion: Despite the presence of lymphadenopathy (an abnormal finding), the report provides strong evidence against malignancy.",
      "findings": [
        "Reactive lymphadenopathy",
        "Node size decreasing",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 53,
      "timestamp": "2026-01-10T20:50:27.409344"
    },
    {
      "sample_idx": 54,
      "input": "23/03/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 23/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Skeptical analysis: Could the hepatic mass be benign (e.g., hemangioma, focal nodular hyperplasia)? While these are possibilities in children, the combination of a large, heterogeneous mass, significantly elevated AFP (a known tumor marker for hepatoblastoma), and the specific fetal histology subtype strongly points towards malignancy. PRETEXT staging further supports a malignant process requiring treatment. Alternative benign explanations are less likely given the constellation of findings.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical analysis: Could the hepatic mass be benign (e.g., hemangioma, focal nodular hyperplasia)? While these are possibilities in children, the combination of a large, heterogeneous mass, significantly elevated AFP (a known tumor marker for hepatoblastoma), and the specific fetal histology subtype strongly points towards malignancy. PRETEXT staging further supports a malignant process requiring treatment. Alternative benign explanations are less likely given the constellation of findings.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 54,
      "timestamp": "2026-01-10T20:50:27.409361"
    },
    {
      "sample_idx": 55,
      "input": "31/08/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 31/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical review: The report explicitly states 'No malignancy identified' and describes normal findings throughout the chest and abdomen. While a CT scan can miss small lesions, the comprehensive description of normal anatomy (lungs, mediastinum, heart) and the explicit negative conclusion by the consultant oncologist provide strong evidence against malignancy. Alternative explanations for a 'benign presentation' are not suggested by the imaging. Conclusion: No malignancy identified based on the provided report.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: The report explicitly states 'No malignancy identified' and describes normal findings throughout the chest and abdomen. While a CT scan can miss small lesions, the comprehensive description of normal anatomy (lungs, mediastinum, heart) and the explicit negative conclusion by the consultant oncologist provide strong evidence against malignancy. Alternative explanations for a 'benign presentation' are not suggested by the imaging. Conclusion: No malignancy identified based on the provided report.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 55,
      "timestamp": "2026-01-10T20:50:27.409378"
    },
    {
      "sample_idx": 56,
      "input": "26/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the decreasing lymphadenopathy be masking an underlying malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states 'No malignancy identified' and describes the findings as 'Reactive lymphadenopathy secondary to viral infection' with decreasing node size. While reactive changes can sometimes mimic malignancy, the explicit negative finding and description of a benign cause (viral infection) with resolution strongly support a non-malignant diagnosis. No evidence points towards malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could the decreasing lymphadenopathy be masking an underlying malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states 'No malignancy identified' and describes the findings as 'Reactive lymphadenopathy secondary to viral infection' with decreasing node size. While reactive changes can sometimes mimic malignancy, the explicit negative finding and description of a benign cause (viral infection) with resolution strongly support a non-malignant diagnosis. No evidence points towards malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 56,
      "timestamp": "2026-01-10T20:50:27.409397"
    },
    {
      "sample_idx": 57,
      "input": "24/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"Skeptical assessment: Could the mass be a benign teratoma or other non-malignant developmental anomaly? While germ cell tumors can be benign, the presence of 'Yolk sac tumor elements' is highly suggestive of malignancy. Elevated AFP and beta-hCG are tumor markers strongly associated with germ cell malignancies, particularly yolk sac tumors and embryonal carcinomas. The combination of imaging findings, tumor markers, and histological elements points strongly towards malignancy, despite the potential for benign germ cell components. Alternative explanations (e.g., infection, inflammation) are unlikely given the specific tumor markers and histological description. Conclusion: Malignancy is highly probable.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical assessment: Could the mass be a benign teratoma or other non-malignant developmental anomaly? While germ cell tumors can be benign, the presence of 'Yolk sac tumor elements' is highly suggestive of malignancy. Elevated AFP and beta-hCG are tumor markers strongly associated with germ cell malignancies, particularly yolk sac tumors and embryonal carcinomas. The combination of imaging findings, tumor markers, and histological elements points strongly towards malignancy, despite the potential for benign germ cell components. Alternative explanations (e.g., infection, inflammation) are unlikely given the specific tumor markers and histological description. Conclusion: Malignancy is highly probable.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 57,
      "timestamp": "2026-01-10T20:50:27.409418"
    },
    {
      "sample_idx": 58,
      "input": "01/01/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 01/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could the sacrococcygeal mass be a benign teratoma or congenital cyst? Could elevated tumor markers be due to other causes (e.g., liver disease, ectopic hormone production)? However, the presence of specific 'Yolk sac tumor elements' points strongly towards malignancy. Yolk sac tumors are a type of germ cell tumor, often associated with elevated AFP and beta-hCG. The combination of a mass in a typical location for germ cell tumors, elevated markers, and histological elements consistent with yolk sac tumor makes malignancy highly probable. Alternative benign explanations are less likely given the specific histological findings.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the sacrococcygeal mass be a benign teratoma or congenital cyst? Could elevated tumor markers be due to other causes (e.g., liver disease, ectopic hormone production)? However, the presence of specific 'Yolk sac tumor elements' points strongly towards malignancy. Yolk sac tumors are a type of germ cell tumor, often associated with elevated AFP and beta-hCG. The combination of a mass in a typical location for germ cell tumors, elevated markers, and histological elements consistent with yolk sac tumor makes malignancy highly probable. Alternative benign explanations are less likely given the specific histological findings.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 58,
      "timestamp": "2026-01-10T20:50:27.409438"
    },
    {
      "sample_idx": 59,
      "input": "16/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Pancytopenia\", \"Suspected Rhabdomyosarcoma\", \"Parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"Initial skepticism: Pancytopenia could be due to various causes, including infections or aplastic anemia. However, the clinical suspicion of Rhabdomyosarcoma, confirmed by biopsy showing Embryonal rhabdomyosarcoma, and the presence of a parameningeal mass with intracranial extension strongly point towards malignancy. While pancytopenia itself is non-specific, the context of a confirmed embryonal rhabdomyosarcoma makes it highly likely to be related to bone marrow infiltration or treatment effects (though treatment hasn't started yet). The biopsy result is definitive. Conclusion: Malignancy confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Pancytopenia could be due to various causes, including infections or aplastic anemia. However, the clinical suspicion of Rhabdomyosarcoma, confirmed by biopsy showing Embryonal rhabdomyosarcoma, and the presence of a parameningeal mass with intracranial extension strongly point towards malignancy. While pancytopenia itself is non-specific, the context of a confirmed embryonal rhabdomyosarcoma makes it highly likely to be related to bone marrow infiltration or treatment effects (though treatment hasn't started yet). The biopsy result is definitive. Conclusion: Malignancy confirmed.",
      "findings": [
        "Pancytopenia",
        "Suspected Rhabdomyosarcoma",
        "Parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 59,
      "timestamp": "2026-01-10T20:50:27.409458"
    },
    {
      "sample_idx": 60,
      "input": "08/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"Headaches attributed to migraine\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical review: The primary reason for the request was to rule out malignancy. The report explicitly states 'No malignancy identified' based on a normal brain MRI. While headaches can be a symptom of brain tumors, the MRI findings are normal for age, showing no mass or abnormal enhancement. The headaches are attributed to migraines, a common benign cause. Playing devil's advocate: Could a subtle malignancy be missed? The report states 'normal' and explicitly rules out malignancy. Without any abnormal findings on imaging, concluding malignancy is unwarranted. Conclusion: The report provides clear evidence against malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: The primary reason for the request was to rule out malignancy. The report explicitly states 'No malignancy identified' based on a normal brain MRI. While headaches can be a symptom of brain tumors, the MRI findings are normal for age, showing no mass or abnormal enhancement. The headaches are attributed to migraines, a common benign cause. Playing devil's advocate: Could a subtle malignancy be missed? The report states 'normal' and explicitly rules out malignancy. Without any abnormal findings on imaging, concluding malignancy is unwarranted. Conclusion: The report provides clear evidence against malignancy.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "Headaches attributed to migraine",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 60,
      "timestamp": "2026-01-10T20:50:27.409478"
    },
    {
      "sample_idx": 61,
      "input": "09/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states 'No malignancy identified'. While atypical lymphocytes can be concerning, the context of post-viral lymphocytosis with positive Monospot and confirmed EBV serology points strongly towards a benign reactive process (infectious mononucleosis). The finding of resolving atypical lymphocytes further supports this. Although skepticism demands considering alternative diagnoses, the clear infectious etiology and explicit negative finding for malignancy by the consulting paediatric oncologist make malignancy highly improbable.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states 'No malignancy identified'. While atypical lymphocytes can be concerning, the context of post-viral lymphocytosis with positive Monospot and confirmed EBV serology points strongly towards a benign reactive process (infectious mononucleosis). The finding of resolving atypical lymphocytes further supports this. Although skepticism demands considering alternative diagnoses, the clear infectious etiology and explicit negative finding for malignancy by the consulting paediatric oncologist make malignancy highly improbable.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 61,
      "timestamp": "2026-01-10T20:50:27.409497"
    },
    {
      "sample_idx": 62,
      "input": "08/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical review: The report explicitly states 'No malignancy identified' and attributes the lymphadenopathy to a 'viral infection' with resolution ('decreasing on follow-up'). While ruling out malignancy requires thoroughness, the findings point strongly towards a benign, reactive process. The absence of atypical features further supports this. Alternative explanation (occult malignancy presenting as reactive nodes) is considered but contradicted by the clinical course (decreasing size) and explicit negative findings. Conclusion: No evidence of malignancy based on the provided report.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: The report explicitly states 'No malignancy identified' and attributes the lymphadenopathy to a 'viral infection' with resolution ('decreasing on follow-up'). While ruling out malignancy requires thoroughness, the findings point strongly towards a benign, reactive process. The absence of atypical features further supports this. Alternative explanation (occult malignancy presenting as reactive nodes) is considered but contradicted by the clinical course (decreasing size) and explicit negative findings. Conclusion: No evidence of malignancy based on the provided report.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 62,
      "timestamp": "2026-01-10T20:50:27.409516"
    },
    {
      "sample_idx": 63,
      "input": "04/12/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"Clinical improvement noted\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states 'No malignancy identified' and 'Blood counts normalized'. While routine surveillance might raise suspicion, the findings are explicitly benign. The resolved febrile illness is a common pediatric condition, not indicative of malignancy. The clinical improvement and normalization of blood counts further argue against an underlying malignant process. Despite the context of surveillance, the report provides no positive findings suggestive of malignancy, only reassurance. Therefore, based on the provided text, the conclusion is no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states 'No malignancy identified' and 'Blood counts normalized'. While routine surveillance might raise suspicion, the findings are explicitly benign. The resolved febrile illness is a common pediatric condition, not indicative of malignancy. The clinical improvement and normalization of blood counts further argue against an underlying malignant process. Despite the context of surveillance, the report provides no positive findings suggestive of malignancy, only reassurance. Therefore, based on the provided text, the conclusion is no malignancy.",
      "findings": [
        "Resolved febrile illness",
        "Blood counts normalized",
        "No organomegaly",
        "Clinical improvement noted",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 63,
      "timestamp": "2026-01-10T20:50:27.409536"
    },
    {
      "sample_idx": 64,
      "input": "29/09/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 29/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states 'Reactive lymphadenopathy secondary to viral infection' and 'No malignancy identified'. While lymphadenopathy itself is abnormal, the provided explanation points towards a benign cause. The decreasing node size on follow-up further supports a reactive process rather than malignancy. The explicit statement 'No atypical features' and 'No malignancy identified' by the consultant oncologist strongly suggests a benign conclusion. Despite the initial request to 'Rule out malignancy', the findings and interpretation strongly favor a non-malignant diagnosis. Alternative explanations for lymphadenopathy (e.g., lymphoma) are explicitly ruled out by the report.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states 'Reactive lymphadenopathy secondary to viral infection' and 'No malignancy identified'. While lymphadenopathy itself is abnormal, the provided explanation points towards a benign cause. The decreasing node size on follow-up further supports a reactive process rather than malignancy. The explicit statement 'No atypical features' and 'No malignancy identified' by the consultant oncologist strongly suggests a benign conclusion. Despite the initial request to 'Rule out malignancy', the findings and interpretation strongly favor a non-malignant diagnosis. Alternative explanations for lymphadenopathy (e.g., lymphoma) are explicitly ruled out by the report.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 64,
      "timestamp": "2026-01-10T20:50:27.409558"
    },
    {
      "sample_idx": 65,
      "input": "09/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 09/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Skeptical review: Could the intraocular mass be a benign lesion (e.g., Coats' disease, persistent hyperplastic primary vitreous)? While possible, the presence of calcifications, bilateral involvement, a positive family history, and crucially, the detection of an RB1 germline mutation strongly point towards Retinoblastoma. The RB1 mutation is highly specific for this malignancy. Alternative benign explanations are significantly less likely given the constellation of findings, especially the genetic confirmation. Conclusion: Malignancy highly probable despite considering differential diagnoses.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical review: Could the intraocular mass be a benign lesion (e.g., Coats' disease, persistent hyperplastic primary vitreous)? While possible, the presence of calcifications, bilateral involvement, a positive family history, and crucially, the detection of an RB1 germline mutation strongly point towards Retinoblastoma. The RB1 mutation is highly specific for this malignancy. Alternative benign explanations are significantly less likely given the constellation of findings, especially the genetic confirmation. Conclusion: Malignancy highly probable despite considering differential diagnoses.",
      "findings": [
        "intraocular mass with calcifications",
        "bilateral disease",
        "family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 65,
      "timestamp": "2026-01-10T20:50:27.409577"
    },
    {
      "sample_idx": 66,
      "input": "16/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Skeptical review: A suprarenal mass in a child immediately raises suspicion for neuroblastoma. Could the mass be benign? While other adrenal masses exist (e.g., adrenal hemorrhage, cysts), the heterogeneity, calcifications, and MIBG avidity strongly point towards neuroblastoma. Elevated urinary catecholamines are a classic biochemical marker for this tumor. Stage III implies regional spread, further supporting malignancy. Although benign adrenal masses can occur, the combination of imaging features (heterogeneity, calcification, MIBG uptake) and biochemical evidence (catecholamines) makes a benign explanation highly unlikely. Conclusion: Malignancy (Neuroblastoma) is strongly supported by the evidence.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical review: A suprarenal mass in a child immediately raises suspicion for neuroblastoma. Could the mass be benign? While other adrenal masses exist (e.g., adrenal hemorrhage, cysts), the heterogeneity, calcifications, and MIBG avidity strongly point towards neuroblastoma. Elevated urinary catecholamines are a classic biochemical marker for this tumor. Stage III implies regional spread, further supporting malignancy. Although benign adrenal masses can occur, the combination of imaging features (heterogeneity, calcification, MIBG uptake) and biochemical evidence (catecholamines) makes a benign explanation highly unlikely. Conclusion: Malignancy (Neuroblastoma) is strongly supported by the evidence.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 66,
      "timestamp": "2026-01-10T20:50:27.409599"
    },
    {
      "sample_idx": 67,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a normal CBC mask underlying malignancy, especially post-treatment? The report explicitly states normal CBC with age-appropriate values, adequate platelets, normal hemoglobin, and crucially, no blast cells. The consultant explicitly states 'No malignancy identified'. While post-treatment follow-up warrants vigilance, the current findings provide no objective evidence for malignancy. The absence of abnormal cells or findings makes a conclusion of malignancy unsupported.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a normal CBC mask underlying malignancy, especially post-treatment? The report explicitly states normal CBC with age-appropriate values, adequate platelets, normal hemoglobin, and crucially, no blast cells. The consultant explicitly states 'No malignancy identified'. While post-treatment follow-up warrants vigilance, the current findings provide no objective evidence for malignancy. The absence of abnormal cells or findings makes a conclusion of malignancy unsupported.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 67,
      "timestamp": "2026-01-10T20:50:27.409617"
    },
    {
      "sample_idx": 68,
      "input": "27/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Skeptical review: Could the parameningeal mass be an inflammatory lesion or congenital anomaly? The biopsy explicitly identifies Embryonal rhabdomyosarcoma. While PAX-FOXO1 negativity is noted (relevant for prognosis/subtyping), it doesn't negate the diagnosis. The combination of clinical suspicion (Rhabdomyosarcoma), imaging findings (parameningeal mass with intracranial extension), and definitive histological diagnosis from biopsy strongly indicates malignancy. Alternative benign explanations for a mass with these characteristics and histological features are highly unlikely.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical review: Could the parameningeal mass be an inflammatory lesion or congenital anomaly? The biopsy explicitly identifies Embryonal rhabdomyosarcoma. While PAX-FOXO1 negativity is noted (relevant for prognosis/subtyping), it doesn't negate the diagnosis. The combination of clinical suspicion (Rhabdomyosarcoma), imaging findings (parameningeal mass with intracranial extension), and definitive histological diagnosis from biopsy strongly indicates malignancy. Alternative benign explanations for a mass with these characteristics and histological features are highly unlikely.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 68,
      "timestamp": "2026-01-10T20:50:27.409635"
    },
    {
      "sample_idx": 69,
      "input": "16/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 16/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states 'No malignancy identified' following investigations including a chest radiograph. While a chest X-ray has limitations, the combination of findings (clear lungs, normal heart, no mass) and the explicit conclusion by the consultant oncologist makes malignancy highly unlikely. Alternative explanations for the request (e.g., infection, benign growth) are not suggested by the findings. The report provides reassurance, which aligns with the absence of malignant features.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states 'No malignancy identified' following investigations including a chest radiograph. While a chest X-ray has limitations, the combination of findings (clear lungs, normal heart, no mass) and the explicit conclusion by the consultant oncologist makes malignancy highly unlikely. Alternative explanations for the request (e.g., infection, benign growth) are not suggested by the findings. The report provides reassurance, which aligns with the absence of malignant features.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 69,
      "timestamp": "2026-01-10T20:50:27.409653"
    },
    {
      "sample_idx": 70,
      "input": "29/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 29/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial skepticism: Could intraocular mass be a benign lesion like Coats' disease or persistent fetal vasculature? However, the presence of calcifications, bilateral involvement, positive family history, and confirmed RB1 germline mutation strongly point towards Retinoblastoma. While alternative diagnoses exist for unilateral masses, the combination of findings, particularly the genetic mutation, makes a benign explanation highly improbable. Conclusion: malignancy highly likely, supported by multiple converging pieces of evidence.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could intraocular mass be a benign lesion like Coats' disease or persistent fetal vasculature? However, the presence of calcifications, bilateral involvement, positive family history, and confirmed RB1 germline mutation strongly point towards Retinoblastoma. While alternative diagnoses exist for unilateral masses, the combination of findings, particularly the genetic mutation, makes a benign explanation highly improbable. Conclusion: malignancy highly likely, supported by multiple converging pieces of evidence.",
      "findings": [
        "intraocular mass with calcifications",
        "Bilateral disease",
        "Family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 70,
      "timestamp": "2026-01-10T20:50:27.409671"
    },
    {
      "sample_idx": 71,
      "input": "11/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Skeptical assessment: Could lymphadenopathy be reactive (e.g., infection)? While reactive lymphadenopathy is common, the presence of a 'bulky anterior mediastinal mass', 'FDG-avid nodes' on PET-CT, and the specific histological diagnosis of 'Classical Hodgkin, nodular sclerosing type' strongly points towards malignancy. The nodular sclerosing subtype is a well-recognized variant of Hodgkin Lymphoma. Alternative benign explanations are highly unlikely given the constellation of findings. Conclusion: Malignancy confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical assessment: Could lymphadenopathy be reactive (e.g., infection)? While reactive lymphadenopathy is common, the presence of a 'bulky anterior mediastinal mass', 'FDG-avid nodes' on PET-CT, and the specific histological diagnosis of 'Classical Hodgkin, nodular sclerosing type' strongly points towards malignancy. The nodular sclerosing subtype is a well-recognized variant of Hodgkin Lymphoma. Alternative benign explanations are highly unlikely given the constellation of findings. Conclusion: Malignancy confirmed.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 71,
      "timestamp": "2026-01-10T20:50:27.409689"
    },
    {
      "sample_idx": 72,
      "input": "13/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 13/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the parameningeal mass be inflammatory or infectious? However, the biopsy explicitly identifies Embryonal rhabdomyosarcoma, a specific type of malignant tumor. The intracranial extension further supports a malignant process. While PAX-FOXO1 negative might suggest a specific subtype or prognosis, it does not negate the malignancy diagnosis. The clinical suspicion of Rhabdomyosarcoma is confirmed by pathology. Conclusion: Malignancy is confirmed by biopsy results, overriding any potential alternative benign explanations for the mass.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the parameningeal mass be inflammatory or infectious? However, the biopsy explicitly identifies Embryonal rhabdomyosarcoma, a specific type of malignant tumor. The intracranial extension further supports a malignant process. While PAX-FOXO1 negative might suggest a specific subtype or prognosis, it does not negate the malignancy diagnosis. The clinical suspicion of Rhabdomyosarcoma is confirmed by pathology. Conclusion: Malignancy is confirmed by biopsy results, overriding any potential alternative benign explanations for the mass.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 72,
      "timestamp": "2026-01-10T20:50:27.409708"
    },
    {
      "sample_idx": 73,
      "input": "03/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 03/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\"],\n        \"rationale\": \"Applying skeptical reasoning: Splenomegaly can be associated with malignancy (lymphoma, leukemia). However, the report explicitly states 'physiological splenomegaly for age' and 'benign finding'. While skepticism demands considering malignancy, the explicit description as physiological and benign, coupled with the absence of other suspicious findings (focal lesions, abnormal echo texture), strongly points away from malignancy in this context. The report concludes 'No malignancy identified'. Conclusion: Despite the potential association of splenomegaly with malignancy, the report's description as physiological and benign, with no other supporting evidence, makes malignancy unlikely.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Splenomegaly can be associated with malignancy (lymphoma, leukemia). However, the report explicitly states 'physiological splenomegaly for age' and 'benign finding'. While skepticism demands considering malignancy, the explicit description as physiological and benign, coupled with the absence of other suspicious findings (focal lesions, abnormal echo texture), strongly points away from malignancy in this context. The report concludes 'No malignancy identified'. Conclusion: Despite the potential association of splenomegaly with malignancy, the report's description as physiological and benign, with no other supporting evidence, makes malignancy unlikely.",
      "findings": [
        "Physiological splenomegaly for age"
      ],
      "fracture_mentioned": null,
      "idx": 73,
      "timestamp": "2026-01-10T20:50:27.409726"
    },
    {
      "sample_idx": 74,
      "input": "11/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"Onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could permeative bone destruction be due to infection (osteomyelitis)? Could the soft tissue mass be a benign reactive process? However, the combination of permeative destruction (characteristic of aggressive processes), onion-skin periosteal reaction (highly suggestive of malignancy like Ewing Sarcoma), and crucially, the positive EWSR1 fusion gene (a specific genetic marker for Ewing Sarcoma) strongly points towards malignancy. Alternative benign explanations are unlikely given the constellation of imaging and genetic findings. Conclusion: Malignancy is highly likely despite considering benign differentials.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could permeative bone destruction be due to infection (osteomyelitis)? Could the soft tissue mass be a benign reactive process? However, the combination of permeative destruction (characteristic of aggressive processes), onion-skin periosteal reaction (highly suggestive of malignancy like Ewing Sarcoma), and crucially, the positive EWSR1 fusion gene (a specific genetic marker for Ewing Sarcoma) strongly points towards malignancy. Alternative benign explanations are unlikely given the constellation of imaging and genetic findings. Conclusion: Malignancy is highly likely despite considering benign differentials.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis",
        "large soft tissue mass",
        "Onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 74,
      "timestamp": "2026-01-10T20:50:27.409747"
    },
    {
      "sample_idx": 75,
      "input": "28/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 28/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states 'Reactive lymphadenopathy secondary to viral infection' and 'No malignancy identified'. Although lymphadenopathy is abnormal, the context points towards a benign reactive process. The decreasing node size further supports a reactive, resolving process rather than malignancy. Playing devil's advocate: Could this be an early lymphoma mimicking a reactive process? However, the report explicitly states 'No atypical features' and 'No malignancy identified' by a consultant paediatric oncologist, making malignancy highly unlikely despite the presence of lymphadenopathy. Conclusion: The evidence strongly supports a benign reactive process, ruling out malignancy based on the provided report.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states 'Reactive lymphadenopathy secondary to viral infection' and 'No malignancy identified'. Although lymphadenopathy is abnormal, the context points towards a benign reactive process. The decreasing node size further supports a reactive, resolving process rather than malignancy. Playing devil's advocate: Could this be an early lymphoma mimicking a reactive process? However, the report explicitly states 'No atypical features' and 'No malignancy identified' by a consultant paediatric oncologist, making malignancy highly unlikely despite the presence of lymphadenopathy. Conclusion: The evidence strongly supports a benign reactive process, ruling out malignancy based on the provided report.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 75,
      "timestamp": "2026-01-10T20:50:27.409768"
    },
    {
      "sample_idx": 76,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: Could a benign presentation mask an underlying malignancy? The report explicitly states normal CBC, adequate platelets, normal hemoglobin, and crucially, the absence of blast cells. The oncologist explicitly states 'No malignancy identified' and provides reassurance. While skepticism demands considering occult disease, the provided evidence overwhelmingly points towards a benign condition. No abnormal findings are reported.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: Could a benign presentation mask an underlying malignancy? The report explicitly states normal CBC, adequate platelets, normal hemoglobin, and crucially, the absence of blast cells. The oncologist explicitly states 'No malignancy identified' and provides reassurance. While skepticism demands considering occult disease, the provided evidence overwhelmingly points towards a benign condition. No abnormal findings are reported.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 76,
      "timestamp": "2026-01-10T20:50:27.409785"
    },
    {
      "sample_idx": 77,
      "input": "06/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"Bone density normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The primary reason for the request was to rule out malignancy. The report explicitly states 'No pathological features' and 'No malignancy identified'. While a healing fracture itself is a finding, it is described as a 'normal process' consistent with trauma history. Skeptical counterpoint: Could a fracture mask an underlying pathology? The report explicitly denies pathological features and normal bone density, making underlying malignancy highly unlikely. Conclusion: Despite the request to rule out malignancy, the findings strongly support a benign process.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The primary reason for the request was to rule out malignancy. The report explicitly states 'No pathological features' and 'No malignancy identified'. While a healing fracture itself is a finding, it is described as a 'normal process' consistent with trauma history. Skeptical counterpoint: Could a fracture mask an underlying pathology? The report explicitly denies pathological features and normal bone density, making underlying malignancy highly unlikely. Conclusion: Despite the request to rule out malignancy, the findings strongly support a benign process.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "Bone density normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 77,
      "timestamp": "2026-01-10T20:50:27.409804"
    },
    {
      "sample_idx": 78,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Initial skepticism: Could the high percentage of lymphoblasts be reactive? However, the specific immunophenotyping confirming B-cell ALL and the bone marrow infiltration pattern strongly suggest malignancy. While CNS involvement is negative, the primary finding of 85% lymphoblasts in the bone marrow is highly indicative of leukemia. Alternative benign explanations are unlikely given the specific cell type and high percentage. Conclusion: malignancy confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the high percentage of lymphoblasts be reactive? However, the specific immunophenotyping confirming B-cell ALL and the bone marrow infiltration pattern strongly suggest malignancy. While CNS involvement is negative, the primary finding of 85% lymphoblasts in the bone marrow is highly indicative of leukemia. Alternative benign explanations are unlikely given the specific cell type and high percentage. Conclusion: malignancy confirmed.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL",
        "CNS involvement negative"
      ],
      "fracture_mentioned": null,
      "idx": 78,
      "timestamp": "2026-01-10T20:50:27.409821"
    },
    {
      "sample_idx": 79,
      "input": "17/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 17/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"Skeptical review: While atypical lymphocytes can sometimes be associated with lymphoma, the context points strongly away from malignancy. The findings explicitly state 'post-viral lymphocytosis', 'resolving' atypical lymphocytes, and positive EBV serology, confirming infectious mononucleosis. The report explicitly states 'No malignancy identified'. Although a skeptical oncologist must always consider malignancy, the clear infectious etiology and resolution pattern strongly argue against it. The 'screening' reason for request might raise a slight flag, but the findings themselves are benign.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: While atypical lymphocytes can sometimes be associated with lymphoma, the context points strongly away from malignancy. The findings explicitly state 'post-viral lymphocytosis', 'resolving' atypical lymphocytes, and positive EBV serology, confirming infectious mononucleosis. The report explicitly states 'No malignancy identified'. Although a skeptical oncologist must always consider malignancy, the clear infectious etiology and resolution pattern strongly argue against it. The 'screening' reason for request might raise a slight flag, but the findings themselves are benign.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms"
      ],
      "fracture_mentioned": null,
      "idx": 79,
      "timestamp": "2026-01-10T20:50:27.409839"
    },
    {
      "sample_idx": 80,
      "input": "18/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 18/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could splenomegaly be reactive to an occult malignancy? The report explicitly states the splenomegaly is 'physiological for age', which is a benign finding. Furthermore, the report explicitly states 'no malignancy identified'. While one might initially question splenomegaly, the description clarifies it's a normal variant. The absence of focal lesions and normal echo texture further support a benign interpretation. Skeptical consideration of malignancy is ruled out by the direct statement and supporting benign findings.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could splenomegaly be reactive to an occult malignancy? The report explicitly states the splenomegaly is 'physiological for age', which is a benign finding. Furthermore, the report explicitly states 'no malignancy identified'. While one might initially question splenomegaly, the description clarifies it's a normal variant. The absence of focal lesions and normal echo texture further support a benign interpretation. Skeptical consideration of malignancy is ruled out by the direct statement and supporting benign findings.",
      "findings": [
        "physiological splenomegaly for age",
        "no focal lesions",
        "normal echo texture",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 80,
      "timestamp": "2026-01-10T20:50:27.409857"
    },
    {
      "sample_idx": 81,
      "input": "11/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign soft tissue mass - lipoma confirmed\", \"Well-circumscribed\", \"No enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a lipoma mask an underlying malignancy? While lipomas are typically benign, the report explicitly confirms it as a benign finding ('lipoma confirmed', 'No malignancy identified'). The description 'well-circumscribed' and 'no enhancement' further support a benign nature. Skeptical consideration: Is the 'benign presentation' mentioned in the history a red herring? However, the biopsy findings directly contradict malignancy. Conclusion: No evidence of malignancy despite the initial reason for request ('Benign presentation' might be interpreted as a trigger for investigation, not necessarily indicative of a problem).\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a lipoma mask an underlying malignancy? While lipomas are typically benign, the report explicitly confirms it as a benign finding ('lipoma confirmed', 'No malignancy identified'). The description 'well-circumscribed' and 'no enhancement' further support a benign nature. Skeptical consideration: Is the 'benign presentation' mentioned in the history a red herring? However, the biopsy findings directly contradict malignancy. Conclusion: No evidence of malignancy despite the initial reason for request ('Benign presentation' might be interpreted as a trigger for investigation, not necessarily indicative of a problem).",
      "findings": [
        "Benign soft tissue mass - lipoma confirmed",
        "Well-circumscribed",
        "No enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 81,
      "timestamp": "2026-01-10T20:50:27.409888"
    },
    {
      "sample_idx": 82,
      "input": "27/12/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 27/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Suspected Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial skepticism: Could a 'large heterogeneous mass' be something other than a tumor? Perhaps an inflammatory process or a benign cyst? However, the clinical context ('Suspected Wilms Tumor', 'Paediatric oncology assessment') and the biopsy result ('Favorable histology') strongly point towards malignancy. While 'favorable histology' is encouraging prognostically, it confirms the presence of a tumor, specifically Wilms Tumor, which is malignant. The staging (Stage II) further supports a malignant diagnosis requiring treatment. Alternative benign explanations are highly unlikely given the biopsy confirmation.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a 'large heterogeneous mass' be something other than a tumor? Perhaps an inflammatory process or a benign cyst? However, the clinical context ('Suspected Wilms Tumor', 'Paediatric oncology assessment') and the biopsy result ('Favorable histology') strongly point towards malignancy. While 'favorable histology' is encouraging prognostically, it confirms the presence of a tumor, specifically Wilms Tumor, which is malignant. The staging (Stage II) further supports a malignant diagnosis requiring treatment. Alternative benign explanations are highly unlikely given the biopsy confirmation.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Suspected Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 82,
      "timestamp": "2026-01-10T20:50:27.409908"
    },
    {
      "sample_idx": 83,
      "input": "05/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Skeptical assessment: Could the destructive lesion be a benign aggressive process like infection (osteomyelitis) or benign bone tumor (e.g., giant cell tumor)? The 'sunburst periosteal reaction' is highly suggestive of osteosarcoma, although it can rarely be seen in other conditions. Elevated alkaline phosphatase is non-specific but consistent with bone turnover seen in osteosarcoma. The combination of a destructive lesion with soft tissue extension and the characteristic sunburst pattern, in the context of a palpable mass and clinical suspicion of osteosarcoma, strongly points towards malignancy. While alternative benign causes are possible, the constellation of findings makes osteosarcoma the most likely diagnosis, warranting MDT discussion.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical assessment: Could the destructive lesion be a benign aggressive process like infection (osteomyelitis) or benign bone tumor (e.g., giant cell tumor)? The 'sunburst periosteal reaction' is highly suggestive of osteosarcoma, although it can rarely be seen in other conditions. Elevated alkaline phosphatase is non-specific but consistent with bone turnover seen in osteosarcoma. The combination of a destructive lesion with soft tissue extension and the characteristic sunburst pattern, in the context of a palpable mass and clinical suspicion of osteosarcoma, strongly points towards malignancy. While alternative benign causes are possible, the constellation of findings makes osteosarcoma the most likely diagnosis, warranting MDT discussion.",
      "findings": [
        "destructive lesion in distal femur",
        "soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 83,
      "timestamp": "2026-01-10T20:50:27.409929"
    },
    {
      "sample_idx": 84,
      "input": "23/11/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 23/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a healing fracture mask an underlying malignancy? The report explicitly states 'No pathological features' and 'No malignancy identified'. The findings are consistent with a benign process (healing fracture) and trauma history. While MRI can miss some lesions, the radiologist's conclusion, given the specific context of a healing fracture with normal bone density and absence of pathological features, strongly points away from malignancy. No evidence supports a malignant interpretation.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a healing fracture mask an underlying malignancy? The report explicitly states 'No pathological features' and 'No malignancy identified'. The findings are consistent with a benign process (healing fracture) and trauma history. While MRI can miss some lesions, the radiologist's conclusion, given the specific context of a healing fracture with normal bone density and absence of pathological features, strongly points away from malignancy. No evidence supports a malignant interpretation.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 84,
      "timestamp": "2026-01-10T20:50:27.409948"
    },
    {
      "sample_idx": 85,
      "input": "14/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 14/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical analysis: Could a subtle malignancy be missed on routine surveillance CT? The report explicitly states 'No malignancy identified' after a thorough review including chest and abdomen. While CT has limitations, the absence of any described abnormalities (masses, lymphadenopathy, infiltrates) and the explicit negative conclusion by the consultant oncologist strongly argue against malignancy. Alternative explanations for potential subtle findings (e.g., inflammation, benign cysts) are not mentioned, reinforcing the negative finding. Conclusion: Based on the provided report, malignancy is not identified.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical analysis: Could a subtle malignancy be missed on routine surveillance CT? The report explicitly states 'No malignancy identified' after a thorough review including chest and abdomen. While CT has limitations, the absence of any described abnormalities (masses, lymphadenopathy, infiltrates) and the explicit negative conclusion by the consultant oncologist strongly argue against malignancy. Alternative explanations for potential subtle findings (e.g., inflammation, benign cysts) are not mentioned, reinforcing the negative finding. Conclusion: Based on the provided report, malignancy is not identified.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 85,
      "timestamp": "2026-01-10T20:50:27.409967"
    },
    {
      "sample_idx": 86,
      "input": "11/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Skeptical review: Could the hepatic mass be a benign tumor (e.g., focal nodular hyperplasia, adenoma) or inflammatory process? However, the combination of a large, heterogeneous mass in a pediatric patient with pancytopenia, significantly elevated AFP (a known tumor marker for hepatoblastoma), specific fetal histology subtype, and PRETEXT staging strongly points towards hepatoblastoma. While benign hepatic lesions exist, they typically do not present with pancytopenia and markedly elevated AFP in this context. Conclusion: malignancy highly likely, despite considering benign differentials.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical review: Could the hepatic mass be a benign tumor (e.g., focal nodular hyperplasia, adenoma) or inflammatory process? However, the combination of a large, heterogeneous mass in a pediatric patient with pancytopenia, significantly elevated AFP (a known tumor marker for hepatoblastoma), specific fetal histology subtype, and PRETEXT staging strongly points towards hepatoblastoma. While benign hepatic lesions exist, they typically do not present with pancytopenia and markedly elevated AFP in this context. Conclusion: malignancy highly likely, despite considering benign differentials.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 86,
      "timestamp": "2026-01-10T20:50:27.409985"
    },
    {
      "sample_idx": 87,
      "input": "16/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 16/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts 70% of marrow\", \"t(8;21) translocation\"],\n        \"rationale\": \"Initial skepticism: Could a high percentage of myeloblasts be reactive or represent a transient phenomenon? However, 70% myeloblasts is highly abnormal for bone marrow and strongly indicative of acute leukemia. The specific t(8;21) translocation is a well-established cytogenetic marker for Acute Myeloid Leukemia (AML). While rare benign conditions might cause increased blasts, the combination of a very high percentage and a specific AML-associated translocation makes a benign explanation highly improbable. Conclusion: malignancy confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a high percentage of myeloblasts be reactive or represent a transient phenomenon? However, 70% myeloblasts is highly abnormal for bone marrow and strongly indicative of acute leukemia. The specific t(8;21) translocation is a well-established cytogenetic marker for Acute Myeloid Leukemia (AML). While rare benign conditions might cause increased blasts, the combination of a very high percentage and a specific AML-associated translocation makes a benign explanation highly improbable. Conclusion: malignancy confirmed.",
      "findings": [
        "myeloblasts 70% of marrow",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 87,
      "timestamp": "2026-01-10T20:50:27.410002"
    },
    {
      "sample_idx": 88,
      "input": "29/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 29/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor diagnosis\", \"Stage II\"],\n        \"rationale\": \"Initial skepticism: Could the renal mass be a benign entity like a congenital mesoblastic nephroma or cystic nephroma? However, the clinical context (pancytopenia, pediatric oncology assessment), the explicit diagnosis of Wilms Tumor (a known pediatric malignancy), and staging (Stage II) strongly point towards malignancy. While favorable histology is noted, Wilms Tumor itself is malignant. The pancytopenia might be related to the tumor or its treatment, but the mass itself is the primary finding indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the renal mass be a benign entity like a congenital mesoblastic nephroma or cystic nephroma? However, the clinical context (pancytopenia, pediatric oncology assessment), the explicit diagnosis of Wilms Tumor (a known pediatric malignancy), and staging (Stage II) strongly point towards malignancy. While favorable histology is noted, Wilms Tumor itself is malignant. The pancytopenia might be related to the tumor or its treatment, but the mass itself is the primary finding indicating malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor diagnosis",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 88,
      "timestamp": "2026-01-10T20:50:27.410020"
    },
    {
      "sample_idx": 89,
      "input": "16/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"Initial skepticism: Could the high percentage of lymphoblasts be reactive? However, the overwhelming proportion (85%) of lymphoblasts, coupled with specific immunophenotyping confirming B-cell ALL, strongly points towards malignancy. Alternative benign explanations, such as a severe reactive process, are highly unlikely given the specific lineage and high percentage. Conclusion: Malignancy confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the high percentage of lymphoblasts be reactive? However, the overwhelming proportion (85%) of lymphoblasts, coupled with specific immunophenotyping confirming B-cell ALL, strongly points towards malignancy. Alternative benign explanations, such as a severe reactive process, are highly unlikely given the specific lineage and high percentage. Conclusion: Malignancy confirmed.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL"
      ],
      "fracture_mentioned": null,
      "idx": 89,
      "timestamp": "2026-01-10T20:50:27.410036"
    },
    {
      "sample_idx": 90,
      "input": "06/09/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial skepticism: Could the intraocular mass be a benign calcified lesion or congenital anomaly? However, the combination of bilateral disease, positive family history, and crucially, the detection of an RB1 germline mutation strongly points towards hereditary retinoblastoma. While calcifications can occur in benign lesions, their presence within a bilateral intraocular mass in this context is highly suspicious. The RB1 mutation is pathognomonic for retinoblastoma. Alternative benign explanations are effectively ruled out by the genetic finding. Conclusion: Malignancy (Retinoblastoma) is confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the intraocular mass be a benign calcified lesion or congenital anomaly? However, the combination of bilateral disease, positive family history, and crucially, the detection of an RB1 germline mutation strongly points towards hereditary retinoblastoma. While calcifications can occur in benign lesions, their presence within a bilateral intraocular mass in this context is highly suspicious. The RB1 mutation is pathognomonic for retinoblastoma. Alternative benign explanations are effectively ruled out by the genetic finding. Conclusion: Malignancy (Retinoblastoma) is confirmed.",
      "findings": [
        "intraocular mass with calcifications",
        "bilateral disease",
        "family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 90,
      "timestamp": "2026-01-10T20:50:27.410057"
    },
    {
      "sample_idx": 91,
      "input": "30/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 30/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"Bone density normal\", \"Trauma history consistent\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a healing fracture mask underlying pathology? The report explicitly states 'no pathological features' and 'no malignancy identified'. The findings are consistent with a benign process (healing fracture) and trauma history. There is no evidence supporting malignancy; the conclusion of reassurance further supports a benign interpretation. Alternative explanations for bone pain (e.g., infection, inflammatory conditions) are not suggested by the report, and the stated findings are consistent with a benign fracture.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a healing fracture mask underlying pathology? The report explicitly states 'no pathological features' and 'no malignancy identified'. The findings are consistent with a benign process (healing fracture) and trauma history. There is no evidence supporting malignancy; the conclusion of reassurance further supports a benign interpretation. Alternative explanations for bone pain (e.g., infection, inflammatory conditions) are not suggested by the report, and the stated findings are consistent with a benign fracture.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "Bone density normal",
        "Trauma history consistent",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 91,
      "timestamp": "2026-01-10T20:50:27.410075"
    },
    {
      "sample_idx": 92,
      "input": "22/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 22/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical review: Could a resolved benign cyst mask underlying malignancy? The report explicitly states 'No malignancy identified' after review. The description of the cyst as 'resolved' and lacking 'aggressive features' supports a benign conclusion. Normal bone density and lack of recurrence further diminish suspicion. While vigilance is necessary, the report provides no evidence for malignancy. The primary finding is the resolution of a known benign condition.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: Could a resolved benign cyst mask underlying malignancy? The report explicitly states 'No malignancy identified' after review. The description of the cyst as 'resolved' and lacking 'aggressive features' supports a benign conclusion. Normal bone density and lack of recurrence further diminish suspicion. While vigilance is necessary, the report provides no evidence for malignancy. The primary finding is the resolution of a known benign condition.",
      "findings": [
        "Benign bone cyst - resolved",
        "No aggressive features",
        "Normal bone density",
        "No recurrence on imaging",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 92,
      "timestamp": "2026-01-10T20:50:27.410094"
    },
    {
      "sample_idx": 93,
      "input": "04/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 04/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture\", \"No pathological features\", \"Bone density normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical review: The report explicitly states 'No malignancy identified' and describes findings consistent with a 'Healing fracture - normal process'. While a fracture can sometimes be a pathological fracture secondary to malignancy, the report specifically rules this out ('No pathological features', 'Trauma history consistent'). The finding of normal bone density further argues against malignancy causing bone destruction. The request was for 'Screening' with no prior history, which might raise suspicion, but the report findings are definitively benign. Conclusion: No evidence of malignancy despite the screening context.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: The report explicitly states 'No malignancy identified' and describes findings consistent with a 'Healing fracture - normal process'. While a fracture can sometimes be a pathological fracture secondary to malignancy, the report specifically rules this out ('No pathological features', 'Trauma history consistent'). The finding of normal bone density further argues against malignancy causing bone destruction. The request was for 'Screening' with no prior history, which might raise suspicion, but the report findings are definitively benign. Conclusion: No evidence of malignancy despite the screening context.",
      "findings": [
        "Healing fracture",
        "No pathological features",
        "Bone density normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 93,
      "timestamp": "2026-01-10T20:50:27.410114"
    },
    {
      "sample_idx": 94,
      "input": "05/08/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"Headaches attributed to migraine\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical reasoning: Could a normal MRI miss a subtle malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states 'No malignancy identified' after a specific search for it. Findings are described as 'Normal' and absence of key features like 'mass lesion' or 'abnormal enhancement' strongly support a benign interpretation. While headaches warrant investigation, attributing them to migraine in the absence of imaging findings is a reasonable clinical conclusion. There is no evidence presented to suggest malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical reasoning: Could a normal MRI miss a subtle malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states 'No malignancy identified' after a specific search for it. Findings are described as 'Normal' and absence of key features like 'mass lesion' or 'abnormal enhancement' strongly support a benign interpretation. While headaches warrant investigation, attributing them to migraine in the absence of imaging findings is a reasonable clinical conclusion. There is no evidence presented to suggest malignancy.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "Headaches attributed to migraine",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 94,
      "timestamp": "2026-01-10T20:50:27.410133"
    },
    {
      "sample_idx": 95,
      "input": "10/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 10/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"Bone density normal\", \"Trauma history consistent\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical review: Could a healing fracture mask an underlying malignancy? Playing devil's advocate: The report explicitly states 'No pathological features' and 'No malignancy identified'. The fracture is described as a 'normal process' consistent with trauma history. While fractures can be pathological, the explicit negative findings and description of a normal healing process strongly argue against malignancy. Reassurance provided by the consultant oncologist further supports a benign conclusion. Cannot conclude malignancy without evidence of pathological features or abnormal findings.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: Could a healing fracture mask an underlying malignancy? Playing devil's advocate: The report explicitly states 'No pathological features' and 'No malignancy identified'. The fracture is described as a 'normal process' consistent with trauma history. While fractures can be pathological, the explicit negative findings and description of a normal healing process strongly argue against malignancy. Reassurance provided by the consultant oncologist further supports a benign conclusion. Cannot conclude malignancy without evidence of pathological features or abnormal findings.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "Bone density normal",
        "Trauma history consistent",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 95,
      "timestamp": "2026-01-10T20:50:27.410153"
    },
    {
      "sample_idx": 96,
      "input": "28/09/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 28/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could lymphadenopathy be reactive (e.g., infection)? However, the presence of a 'bulky' mass, FDG-avid nodes on PET-CT (indicating high metabolic activity often seen in malignancy), and the specific histological diagnosis of 'Classical Hodgkin, nodular sclerosing type' strongly point towards malignancy. While reactive lymphadenopathy is common, a bulky mass with high metabolic activity and a specific Hodgkin Lymphoma subtype makes a benign explanation highly unlikely. Conclusion: Malignancy is strongly suggested by the combination of imaging and histological findings.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could lymphadenopathy be reactive (e.g., infection)? However, the presence of a 'bulky' mass, FDG-avid nodes on PET-CT (indicating high metabolic activity often seen in malignancy), and the specific histological diagnosis of 'Classical Hodgkin, nodular sclerosing type' strongly point towards malignancy. While reactive lymphadenopathy is common, a bulky mass with high metabolic activity and a specific Hodgkin Lymphoma subtype makes a benign explanation highly unlikely. Conclusion: Malignancy is strongly suggested by the combination of imaging and histological findings.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 96,
      "timestamp": "2026-01-10T20:50:27.410171"
    },
    {
      "sample_idx": 97,
      "input": "02/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Glioma.\n\nFrom clinical notes: Brain Tumor - Glioma. Paediatric oncology assessment.\n\nFindings: left temporal lobe infiltrative mass with mass effect. FLAIR hyperintensity. Biopsy confirms diffuse astrocytoma WHO grade II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"Biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"Skeptical analysis: Could the mass be inflammatory or infectious? While infiltrative masses can be inflammatory (e.g., abscess, demyelination), the biopsy result is definitive. The confirmation of 'diffuse astrocytoma WHO grade II' by biopsy directly indicates malignancy. Although grade II is relatively low-grade, it is still a malignant glial tumor. The clinical suspicion of glioma was confirmed pathologically.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical analysis: Could the mass be inflammatory or infectious? While infiltrative masses can be inflammatory (e.g., abscess, demyelination), the biopsy result is definitive. The confirmation of 'diffuse astrocytoma WHO grade II' by biopsy directly indicates malignancy. Although grade II is relatively low-grade, it is still a malignant glial tumor. The clinical suspicion of glioma was confirmed pathologically.",
      "findings": [
        "left temporal lobe infiltrative mass with mass effect",
        "FLAIR hyperintensity",
        "Biopsy confirms diffuse astrocytoma WHO grade II"
      ],
      "fracture_mentioned": null,
      "idx": 97,
      "timestamp": "2026-01-10T20:50:27.410188"
    },
    {
      "sample_idx": 98,
      "input": "29/06/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 29/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC\", \"age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical review: The report explicitly states 'No malignancy identified' and details normal CBC results including age-appropriate values, adequate platelets, normal hemoglobin, and absence of blast cells. While follow-up implies prior concern, the current findings are unequivocally benign. Could there be an undetected lesion? Playing devil's advocate: The provided information points strongly against malignancy. The explicit statement 'No malignancy identified' combined with completely normal hematological parameters offers strong reassurance. Conclusion: Based on the provided report, malignancy is not present.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: The report explicitly states 'No malignancy identified' and details normal CBC results including age-appropriate values, adequate platelets, normal hemoglobin, and absence of blast cells. While follow-up implies prior concern, the current findings are unequivocally benign. Could there be an undetected lesion? Playing devil's advocate: The provided information points strongly against malignancy. The explicit statement 'No malignancy identified' combined with completely normal hematological parameters offers strong reassurance. Conclusion: Based on the provided report, malignancy is not present.",
      "findings": [
        "Normal CBC",
        "age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 98,
      "timestamp": "2026-01-10T20:50:27.410208"
    },
    {
      "sample_idx": 99,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could mediastinal lymphadenopathy be reactive (e.g., infection, inflammation)? However, the presence of a 'bulky' mass, confirmed FDG-avidity on PET-CT (indicating high metabolic activity often associated with malignancy), and the specific histological subtype 'Classical Hodgkin, nodular sclerosing type' strongly point towards malignancy. While reactive nodes exist, the combination of bulk, FDG-avidity, and specific histology makes a benign explanation highly improbable. Conclusion: malignancy confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could mediastinal lymphadenopathy be reactive (e.g., infection, inflammation)? However, the presence of a 'bulky' mass, confirmed FDG-avidity on PET-CT (indicating high metabolic activity often associated with malignancy), and the specific histological subtype 'Classical Hodgkin, nodular sclerosing type' strongly point towards malignancy. While reactive nodes exist, the combination of bulk, FDG-avidity, and specific histology makes a benign explanation highly improbable. Conclusion: malignancy confirmed.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 99,
      "timestamp": "2026-01-10T20:50:27.410225"
    }
  ],
  "num_samples": 100,
  "samples": [
    {
      "sample_idx": 0,
      "input": "02/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"Clinical improvement noted\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical analysis: The report explicitly states 'No malignancy identified' and 'Clinical improvement noted' following a 'Resolved febrile illness' with 'Blood counts normalized'. While a skeptical oncologist always considers occult disease, the provided information strongly points towards a benign resolution. The lack of any abnormal findings, coupled with the explicit negative conclusion by the consulting oncologist, makes malignancy highly unlikely. There is no evidence to support a malignant diagnosis.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical analysis: The report explicitly states 'No malignancy identified' and 'Clinical improvement noted' following a 'Resolved febrile illness' with 'Blood counts normalized'. While a skeptical oncologist always considers occult disease, the provided information strongly points towards a benign resolution. The lack of any abnormal findings, coupled with the explicit negative conclusion by the consulting oncologist, makes malignancy highly unlikely. There is no evidence to support a malignant diagnosis.",
      "findings": [
        "Resolved febrile illness",
        "Blood counts normalized",
        "No organomegaly",
        "Clinical improvement noted",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 0,
      "timestamp": "2026-01-10T20:50:27.408261"
    },
    {
      "sample_idx": 1,
      "input": "26/10/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Skeptical approach: Could the posterior fossa mass be a non-malignant lesion like an abscess or inflammatory process? While enhancement and hydrocephalus can occur in benign conditions, restricted diffusion is highly suggestive of high cellularity, often seen in malignancy. Crucially, the histology explicitly confirms 'High-grade medulloblastoma'. Although skepticism is warranted, the definitive histological diagnosis overrides alternative interpretations. Conclusion: Malignancy confirmed by histology.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical approach: Could the posterior fossa mass be a non-malignant lesion like an abscess or inflammatory process? While enhancement and hydrocephalus can occur in benign conditions, restricted diffusion is highly suggestive of high cellularity, often seen in malignancy. Crucially, the histology explicitly confirms 'High-grade medulloblastoma'. Although skepticism is warranted, the definitive histological diagnosis overrides alternative interpretations. Conclusion: Malignancy confirmed by histology.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 1,
      "timestamp": "2026-01-10T20:50:27.408292"
    },
    {
      "sample_idx": 2,
      "input": "03/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly describes 'reactive lymphadenopathy secondary to viral infection'. While lymphadenopathy can be a sign of malignancy, the report provides strong counter-evidence: decreasing node size (suggesting resolution of the underlying cause), absence of atypical features, and a direct statement 'No malignancy identified'. Although one might question if a viral infection could mask an underlying malignancy, the decreasing size and lack of atypical features argue strongly against this. The conclusion of reactive lymphadenopathy is supported by the clinical context (follow-up post-treatment, no previous oncology history) and the imaging findings. Therefore, despite the presence of lymphadenopathy (an abnormal finding), malignancy is confidently excluded based on the provided report.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly describes 'reactive lymphadenopathy secondary to viral infection'. While lymphadenopathy can be a sign of malignancy, the report provides strong counter-evidence: decreasing node size (suggesting resolution of the underlying cause), absence of atypical features, and a direct statement 'No malignancy identified'. Although one might question if a viral infection could mask an underlying malignancy, the decreasing size and lack of atypical features argue strongly against this. The conclusion of reactive lymphadenopathy is supported by the clinical context (follow-up post-treatment, no previous oncology history) and the imaging findings. Therefore, despite the presence of lymphadenopathy (an abnormal finding), malignancy is confidently excluded based on the provided report.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 2,
      "timestamp": "2026-01-10T20:50:27.408319"
    },
    {
      "sample_idx": 3,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy with mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"High LDH levels\"],\n        \"rationale\": \"Skeptical reasoning: Could lymphadenopathy be reactive? The report explicitly states 'Burkitt lymphoma confirmed on biopsy'. This is a definitive pathological diagnosis, overriding any possibility of reactive changes. High LDH is consistent with high cell turnover seen in aggressive lymphomas like Burkitt. While LDH can be elevated in other conditions, the biopsy confirmation is the key evidence. Conclusion: Malignancy confirmed by biopsy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical reasoning: Could lymphadenopathy be reactive? The report explicitly states 'Burkitt lymphoma confirmed on biopsy'. This is a definitive pathological diagnosis, overriding any possibility of reactive changes. High LDH is consistent with high cell turnover seen in aggressive lymphomas like Burkitt. While LDH can be elevated in other conditions, the biopsy confirmation is the key evidence. Conclusion: Malignancy confirmed by biopsy.",
      "findings": [
        "abdominal lymphadenopathy with mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "High LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 3,
      "timestamp": "2026-01-10T20:50:27.408339"
    },
    {
      "sample_idx": 4,
      "input": "04/05/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 04/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"Pancytopenia\", \"Suspected Acute Lymphoblastic Leukemia\"],\n        \"rationale\": \"Skeptical review: Could 85% lymphoblasts be reactive? Highly unlikely. The specific immunophenotype (B-cell ALL) confirms the malignant lineage. Pancytopenia is a classic symptom of bone marrow failure due to infiltration. The clinical suspicion of ALL aligns with the findings. While always seeking alternative explanations, the combination of high blast percentage, specific immunophenotype, and clinical presentation strongly points to malignancy. Alternative benign causes for such high blast counts are virtually non-existent in this context.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical review: Could 85% lymphoblasts be reactive? Highly unlikely. The specific immunophenotype (B-cell ALL) confirms the malignant lineage. Pancytopenia is a classic symptom of bone marrow failure due to infiltration. The clinical suspicion of ALL aligns with the findings. While always seeking alternative explanations, the combination of high blast percentage, specific immunophenotype, and clinical presentation strongly points to malignancy. Alternative benign causes for such high blast counts are virtually non-existent in this context.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL",
        "Pancytopenia",
        "Suspected Acute Lymphoblastic Leukemia"
      ],
      "fracture_mentioned": null,
      "idx": 4,
      "timestamp": "2026-01-10T20:50:27.408360"
    },
    {
      "sample_idx": 5,
      "input": "17/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 17/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could reactive lymphadenopathy mask an underlying malignancy? While reactive nodes can sometimes be associated with lymphoma, the report explicitly states 'No atypical features', 'No malignancy identified', and importantly, 'Node size decreasing on follow-up'. This decrease is highly suggestive of a resolving inflammatory/infectious process rather than progressive malignancy. The history also notes 'No previous oncology history'. The conclusion of reactive lymphadenopathy secondary to viral infection, supported by the decreasing size and lack of atypical features, makes malignancy highly unlikely. Skepticism satisfied: the evidence strongly points towards a benign process.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could reactive lymphadenopathy mask an underlying malignancy? While reactive nodes can sometimes be associated with lymphoma, the report explicitly states 'No atypical features', 'No malignancy identified', and importantly, 'Node size decreasing on follow-up'. This decrease is highly suggestive of a resolving inflammatory/infectious process rather than progressive malignancy. The history also notes 'No previous oncology history'. The conclusion of reactive lymphadenopathy secondary to viral infection, supported by the decreasing size and lack of atypical features, makes malignancy highly unlikely. Skepticism satisfied: the evidence strongly points towards a benign process.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 5,
      "timestamp": "2026-01-10T20:50:27.408384"
    },
    {
      "sample_idx": 6,
      "input": "11/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Suspected Neuroblastoma\"],\n        \"rationale\": \"Initial skepticism: Could a suprarenal mass be benign? Playing devil's advocate against malignancy: A heterogeneous mass with calcifications could potentially represent a benign adrenal tumor (e.g., adrenal cortical adenoma, although less common in children) or a congenital mass. However, the MIBG avidity is highly characteristic of neuroblastoma, a malignant tumor derived from neural crest cells. Elevated urinary catecholamines further support this diagnosis, as neuroblastomas often secrete these hormones. The clinical suspicion and staging (Stage III) strongly point towards malignancy. While benign possibilities exist, the combination of imaging (heterogeneous mass, calcifications, MIBG avidity) and biochemical findings (elevated catecholamines) makes neuroblastoma the most likely diagnosis, outweighing benign alternatives. Conclusion: Malignancy is strongly suspected and highly likely based on the provided evidence.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a suprarenal mass be benign? Playing devil's advocate against malignancy: A heterogeneous mass with calcifications could potentially represent a benign adrenal tumor (e.g., adrenal cortical adenoma, although less common in children) or a congenital mass. However, the MIBG avidity is highly characteristic of neuroblastoma, a malignant tumor derived from neural crest cells. Elevated urinary catecholamines further support this diagnosis, as neuroblastomas often secrete these hormones. The clinical suspicion and staging (Stage III) strongly point towards malignancy. While benign possibilities exist, the combination of imaging (heterogeneous mass, calcifications, MIBG avidity) and biochemical findings (elevated catecholamines) makes neuroblastoma the most likely diagnosis, outweighing benign alternatives. Conclusion: Malignancy is strongly suspected and highly likely based on the provided evidence.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Suspected Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 6,
      "timestamp": "2026-01-10T20:50:27.408411"
    },
    {
      "sample_idx": 7,
      "input": "21/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The request is to rule out malignancy, which inherently biases towards finding something. However, the report explicitly states 'No malignancy identified' based on imaging findings (normal chest X-ray, clear lungs, no mediastinal mass, normal heart size). While imaging isn't perfectly sensitive, the absence of any focal lesions or suspicious findings, coupled with the explicit negative conclusion by the oncologist, makes malignancy unlikely based on this specific report. Alternative explanation: Could a subtle malignancy be missed? Possible, but the report provides no evidence for it and explicitly states none was found. Conclusion: Based on the provided imaging report, no evidence of malignancy is present.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The request is to rule out malignancy, which inherently biases towards finding something. However, the report explicitly states 'No malignancy identified' based on imaging findings (normal chest X-ray, clear lungs, no mediastinal mass, normal heart size). While imaging isn't perfectly sensitive, the absence of any focal lesions or suspicious findings, coupled with the explicit negative conclusion by the oncologist, makes malignancy unlikely based on this specific report. Alternative explanation: Could a subtle malignancy be missed? Possible, but the report provides no evidence for it and explicitly states none was found. Conclusion: Based on the provided imaging report, no evidence of malignancy is present.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 7,
      "timestamp": "2026-01-10T20:50:27.408444"
    },
    {
      "sample_idx": 8,
      "input": "08/02/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report explicitly states normal CBC, adequate platelets, normal hemoglobin, and absence of blast cells. The consultant paediatric oncologist explicitly states 'No malignancy identified' and provides reassurance. While early or occult malignancy cannot be absolutely ruled out without further investigation in some contexts, based *solely* on this report, there is no evidence supporting malignancy. The findings are consistent with a benign state.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report explicitly states normal CBC, adequate platelets, normal hemoglobin, and absence of blast cells. The consultant paediatric oncologist explicitly states 'No malignancy identified' and provides reassurance. While early or occult malignancy cannot be absolutely ruled out without further investigation in some contexts, based *solely* on this report, there is no evidence supporting malignancy. The findings are consistent with a benign state.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 8,
      "timestamp": "2026-01-10T20:50:27.408467"
    },
    {
      "sample_idx": 9,
      "input": "25/04/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Skeptical review: The report explicitly identifies a 'large heterogeneous left renal mass'. While some renal masses can be benign (e.g., angiomyolipoma, oncocytoma), the clinical context ('Suspected Wilms Tumor', 'Paediatric oncology assessment', 'Wilms Tumor' diagnosis) and biopsy confirmation ('Favorable histology') strongly point towards malignancy. The term 'pseudocapsule' is common in Wilms Tumor. The staging ('Stage II') further supports a malignant process requiring treatment. Although playing devil's advocate, could a benign mass mimic Wilms? Extremely unlikely given the biopsy results confirming favorable histology, characteristic of Wilms Tumor. Therefore, despite the need for skepticism, the evidence overwhelmingly supports malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical review: The report explicitly identifies a 'large heterogeneous left renal mass'. While some renal masses can be benign (e.g., angiomyolipoma, oncocytoma), the clinical context ('Suspected Wilms Tumor', 'Paediatric oncology assessment', 'Wilms Tumor' diagnosis) and biopsy confirmation ('Favorable histology') strongly point towards malignancy. The term 'pseudocapsule' is common in Wilms Tumor. The staging ('Stage II') further supports a malignant process requiring treatment. Although playing devil's advocate, could a benign mass mimic Wilms? Extremely unlikely given the biopsy results confirming favorable histology, characteristic of Wilms Tumor. Therefore, despite the need for skepticism, the evidence overwhelmingly supports malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 9,
      "timestamp": "2026-01-10T20:50:27.408491"
    },
    {
      "sample_idx": 10,
      "input": "26/12/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could mediastinal mass be reactive or infectious (e.g., TB, sarcoidosis)? However, the presence of FDG-avid nodes strongly suggests metabolic activity typical of malignancy. The specific histological subtype (Classical Hodgkin, nodular sclerosing) is highly characteristic of Hodgkin Lymphoma. While other conditions can cause lymphadenopathy, the combination of bulky mass, FDG avidity, and specific histology points towards malignancy. Conclusion: malignancy likely despite considering reactive/infectious causes.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could mediastinal mass be reactive or infectious (e.g., TB, sarcoidosis)? However, the presence of FDG-avid nodes strongly suggests metabolic activity typical of malignancy. The specific histological subtype (Classical Hodgkin, nodular sclerosing) is highly characteristic of Hodgkin Lymphoma. While other conditions can cause lymphadenopathy, the combination of bulky mass, FDG avidity, and specific histology points towards malignancy. Conclusion: malignancy likely despite considering reactive/infectious causes.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 10,
      "timestamp": "2026-01-10T20:50:27.408510"
    },
    {
      "sample_idx": 11,
      "input": "18/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 18/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could the suprarenal mass be a benign adrenal tumor (e.g., adenoma, hemorrhage) or inflammatory process? However, the combination of a large, heterogeneous mass with calcifications (common in neuroblastoma), MIBG avidity (highly specific for neuroblastoma), elevated urinary catecholamines (characteristic biochemical marker), and staging as Stage III strongly points towards malignancy. While benign adrenal masses exist, the constellation of findings, particularly MIBG avidity and catecholamine elevation, makes a benign explanation highly unlikely. The clinical context of suspected neuroblastoma further supports this conclusion.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the suprarenal mass be a benign adrenal tumor (e.g., adenoma, hemorrhage) or inflammatory process? However, the combination of a large, heterogeneous mass with calcifications (common in neuroblastoma), MIBG avidity (highly specific for neuroblastoma), elevated urinary catecholamines (characteristic biochemical marker), and staging as Stage III strongly points towards malignancy. While benign adrenal masses exist, the constellation of findings, particularly MIBG avidity and catecholamine elevation, makes a benign explanation highly unlikely. The clinical context of suspected neuroblastoma further supports this conclusion.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 11,
      "timestamp": "2026-01-10T20:50:27.408532"
    },
    {
      "sample_idx": 12,
      "input": "15/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 15/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Skeptical analysis: Could the hepatic mass be a benign lesion like focal nodular hyperplasia or inflammatory pseudotumor? Could elevated AFP be due to liver regeneration or other non-malignant causes? However, the combination of a large, heterogeneous mass in a child with pancytopenia, markedly elevated AFP (a known tumor marker for hepatoblastoma), specific fetal histology subtype, and staging (PRETEXT II) strongly points towards hepatoblastoma. Alternative benign explanations are less likely given the constellation of findings. Conclusion: Malignancy highly probable, requiring MDT discussion.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical analysis: Could the hepatic mass be a benign lesion like focal nodular hyperplasia or inflammatory pseudotumor? Could elevated AFP be due to liver regeneration or other non-malignant causes? However, the combination of a large, heterogeneous mass in a child with pancytopenia, markedly elevated AFP (a known tumor marker for hepatoblastoma), specific fetal histology subtype, and staging (PRETEXT II) strongly points towards hepatoblastoma. Alternative benign explanations are less likely given the constellation of findings. Conclusion: Malignancy highly probable, requiring MDT discussion.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 12,
      "timestamp": "2026-01-10T20:50:27.408551"
    },
    {
      "sample_idx": 13,
      "input": "26/02/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Langerhans Cell Histiocytosis.\n\nFrom clinical notes: Langerhans Cell Histiocytosis. Paediatric oncology assessment.\n\nFindings: multiple lytic skull lesions with soft tissue component. CD1a and Langerin positive. Multisystem disease. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\", \"Multisystem disease\", \"Suspected Langerhans Cell Histiocytosis\"],\n        \"rationale\": \"Skeptical assessment: Lytic bone lesions are concerning for malignancy, but Langerhans Cell Histiocytosis (LCH) is explicitly mentioned as the suspected diagnosis, supported by the positive CD1a and Langerin markers, which are characteristic of LCH, not typically primary malignancy. While LCH can behave aggressively, it's classified as a non-malignant proliferative disorder, not a cancer. The presence of 'multisystem disease' confirms LCH involvement beyond a single site. Although LCH requires aggressive treatment, the specific immunophenotyping points away from a typical malignancy. Therefore, despite the concerning appearance of lytic lesions, the evidence strongly suggests LCH, a non-malignant condition.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "Skeptical assessment: Lytic bone lesions are concerning for malignancy, but Langerhans Cell Histiocytosis (LCH) is explicitly mentioned as the suspected diagnosis, supported by the positive CD1a and Langerin markers, which are characteristic of LCH, not typically primary malignancy. While LCH can behave aggressively, it's classified as a non-malignant proliferative disorder, not a cancer. The presence of 'multisystem disease' confirms LCH involvement beyond a single site. Although LCH requires aggressive treatment, the specific immunophenotyping points away from a typical malignancy. Therefore, despite the concerning appearance of lytic lesions, the evidence strongly suggests LCH, a non-malignant condition.",
      "findings": [
        "multiple lytic skull lesions with soft tissue component",
        "CD1a and Langerin positive",
        "Multisystem disease",
        "Suspected Langerhans Cell Histiocytosis"
      ],
      "fracture_mentioned": null,
      "idx": 13,
      "timestamp": "2026-01-10T20:50:27.408574"
    },
    {
      "sample_idx": 14,
      "input": "08/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 08/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states 'No malignancy identified' following screening. The findings described (post-viral lymphocytosis, resolving atypical lymphocytes, positive Monospot, confirmed EBV) are classic signs of infectious mononucleosis, a benign condition. While atypical lymphocytes can sometimes raise concern, the context of confirmed EBV infection and resolution strongly points away from malignancy. Alternative explanation considered: Could this be a lymphoma mimicking EBV? The report explicitly rules this out, and the clinical picture fits a self-limiting viral illness. Conclusion: No malignancy based on explicit report statement and characteristic benign findings.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states 'No malignancy identified' following screening. The findings described (post-viral lymphocytosis, resolving atypical lymphocytes, positive Monospot, confirmed EBV) are classic signs of infectious mononucleosis, a benign condition. While atypical lymphocytes can sometimes raise concern, the context of confirmed EBV infection and resolution strongly points away from malignancy. Alternative explanation considered: Could this be a lymphoma mimicking EBV? The report explicitly rules this out, and the clinical picture fits a self-limiting viral illness. Conclusion: No malignancy based on explicit report statement and characteristic benign findings.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 14,
      "timestamp": "2026-01-10T20:50:27.408597"
    },
    {
      "sample_idx": 15,
      "input": "14/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 14/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"Skeptical approach: Could high blast count be reactive? The 70% myeloblast count is significantly elevated beyond reactive states. The specific t(8;21) translocation is a known diagnostic marker for Acute Myeloid Leukemia (AML). While considering alternative diagnoses for bone pain, the combination of high blast percentage and a specific chromosomal abnormality strongly points towards AML. Initial suspicion of AML is confirmed by the report.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical approach: Could high blast count be reactive? The 70% myeloblast count is significantly elevated beyond reactive states. The specific t(8;21) translocation is a known diagnostic marker for Acute Myeloid Leukemia (AML). While considering alternative diagnoses for bone pain, the combination of high blast percentage and a specific chromosomal abnormality strongly points towards AML. Initial suspicion of AML is confirmed by the report.",
      "findings": [
        "myeloblasts 70% of marrow cellularity",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 15,
      "timestamp": "2026-01-10T20:50:27.408613"
    },
    {
      "sample_idx": 16,
      "input": "07/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 07/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Skeptical assessment: Could the mass be inflammatory or infectious? However, the biopsy explicitly identifies Embryonal rhabdomyosarcoma, a malignant tumor. While PAX-FOXO1 negativity might suggest a specific subtype or prognosis, it doesn't negate the malignant diagnosis. The clinical context (unexplained fever, weight loss) and the explicit biopsy result confirm malignancy despite initial skepticism about non-malignant causes of a mass.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical assessment: Could the mass be inflammatory or infectious? However, the biopsy explicitly identifies Embryonal rhabdomyosarcoma, a malignant tumor. While PAX-FOXO1 negativity might suggest a specific subtype or prognosis, it doesn't negate the malignant diagnosis. The clinical context (unexplained fever, weight loss) and the explicit biopsy result confirm malignancy despite initial skepticism about non-malignant causes of a mass.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 16,
      "timestamp": "2026-01-10T20:50:27.408630"
    },
    {
      "sample_idx": 17,
      "input": "06/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states 'No malignancy identified' after screening. While screening tests can miss things, the comprehensive nature of the report (chest radiograph, lung fields, mediastinal mass, heart size) and the definitive statement by the consultant paediatric oncologist argue strongly against malignancy. There are no abnormal findings mentioned. Alternative explanations for potential concerns (e.g., subtle radiographic changes) are implicitly ruled out by the 'normal' and 'clear' descriptions and the final conclusion.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states 'No malignancy identified' after screening. While screening tests can miss things, the comprehensive nature of the report (chest radiograph, lung fields, mediastinal mass, heart size) and the definitive statement by the consultant paediatric oncologist argue strongly against malignancy. There are no abnormal findings mentioned. Alternative explanations for potential concerns (e.g., subtle radiographic changes) are implicitly ruled out by the 'normal' and 'clear' descriptions and the final conclusion.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 17,
      "timestamp": "2026-01-10T20:50:27.408649"
    },
    {
      "sample_idx": 18,
      "input": "23/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 23/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Skeptical reasoning: Could the posterior fossa mass be an inflammatory lesion or abscess? While possible, the enhancement pattern, restricted diffusion (suggesting high cellularity), and definitive histology confirming high-grade medulloblastoma strongly point towards malignancy. Hydrocephalus is a consequence of the mass effect. Although the clinical suspicion was medulloblastoma, the imaging and histology confirm this diagnosis. Alternative explanations for a posterior fossa mass in a child (e.g., pilocytic astrocytoma, ependymoma) are less likely given the 'high-grade medulloblastoma' histology. Conclusion: Malignancy is confirmed by histological evidence, despite considering alternative diagnoses for the mass.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical reasoning: Could the posterior fossa mass be an inflammatory lesion or abscess? While possible, the enhancement pattern, restricted diffusion (suggesting high cellularity), and definitive histology confirming high-grade medulloblastoma strongly point towards malignancy. Hydrocephalus is a consequence of the mass effect. Although the clinical suspicion was medulloblastoma, the imaging and histology confirm this diagnosis. Alternative explanations for a posterior fossa mass in a child (e.g., pilocytic astrocytoma, ependymoma) are less likely given the 'high-grade medulloblastoma' histology. Conclusion: Malignancy is confirmed by histological evidence, despite considering alternative diagnoses for the mass.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 18,
      "timestamp": "2026-01-10T20:50:27.408674"
    },
    {
      "sample_idx": 19,
      "input": "09/07/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could a suprarenal mass be benign (e.g., adrenal adenoma, hemorrhage)? However, the combination of a large, heterogeneous mass with calcifications, MIBG avidity (characteristic of neuroblastic tumors), and elevated urinary catecholamines strongly points towards neuroblastoma. Stage III designation further supports malignancy. While rare benign conditions might mimic some features, the constellation of findings makes malignancy highly probable. Alternative explanations are less likely given the specific combination of imaging and biochemical markers.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a suprarenal mass be benign (e.g., adrenal adenoma, hemorrhage)? However, the combination of a large, heterogeneous mass with calcifications, MIBG avidity (characteristic of neuroblastic tumors), and elevated urinary catecholamines strongly points towards neuroblastoma. Stage III designation further supports malignancy. While rare benign conditions might mimic some features, the constellation of findings makes malignancy highly probable. Alternative explanations are less likely given the specific combination of imaging and biochemical markers.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 19,
      "timestamp": "2026-01-10T20:50:27.408694"
    },
    {
      "sample_idx": 20,
      "input": "18/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial skepticism: Could a large renal mass be something other than Wilms Tumor? Benign renal masses in children are rare but possible (e.g., angiomyolipoma, juxtaglomerular tumor). However, the clinical context (pancytopenia, pediatric oncology assessment) and the specific diagnosis of 'Wilms Tumor' confirmed by biopsy with 'favorable histology' strongly point towards malignancy. The staging (Stage II) further supports a malignant process requiring treatment. Alternative explanations are less likely given the biopsy results. Conclusion: Malignancy confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a large renal mass be something other than Wilms Tumor? Benign renal masses in children are rare but possible (e.g., angiomyolipoma, juxtaglomerular tumor). However, the clinical context (pancytopenia, pediatric oncology assessment) and the specific diagnosis of 'Wilms Tumor' confirmed by biopsy with 'favorable histology' strongly point towards malignancy. The staging (Stage II) further supports a malignant process requiring treatment. Alternative explanations are less likely given the biopsy results. Conclusion: Malignancy confirmed.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 20,
      "timestamp": "2026-01-10T20:50:27.408712"
    },
    {
      "sample_idx": 21,
      "input": "13/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 13/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical approach: Could a subtle malignancy be missed on MRI? The report explicitly states 'No malignancy identified' after evaluating for mass lesions and abnormal enhancement, which are key indicators. Given the context of routine surveillance with no prior history and the explicit negative findings, the conclusion of no malignancy is strongly supported. Alternative explanations for headaches (migraine) are provided. Therefore, despite the inherent limitations of imaging, the report provides no evidence suggestive of malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical approach: Could a subtle malignancy be missed on MRI? The report explicitly states 'No malignancy identified' after evaluating for mass lesions and abnormal enhancement, which are key indicators. Given the context of routine surveillance with no prior history and the explicit negative findings, the conclusion of no malignancy is strongly supported. Alternative explanations for headaches (migraine) are provided. Therefore, despite the inherent limitations of imaging, the report provides no evidence suggestive of malignancy.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 21,
      "timestamp": "2026-01-10T20:50:27.408730"
    },
    {
      "sample_idx": 22,
      "input": "18/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Suspected Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial skepticism: Could a large renal mass be a benign entity like a renal abscess or a complex cyst? However, the clinical suspicion of Wilms Tumor, confirmed by biopsy showing favorable histology, and staging as Stage II strongly points towards malignancy. While pseudocapsules can occur in benign conditions, the overall picture including biopsy results makes malignancy the most likely diagnosis. Alternative benign explanations are less likely given the biopsy findings.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a large renal mass be a benign entity like a renal abscess or a complex cyst? However, the clinical suspicion of Wilms Tumor, confirmed by biopsy showing favorable histology, and staging as Stage II strongly points towards malignancy. While pseudocapsules can occur in benign conditions, the overall picture including biopsy results makes malignancy the most likely diagnosis. Alternative benign explanations are less likely given the biopsy findings.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Suspected Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 22,
      "timestamp": "2026-01-10T20:50:27.408748"
    },
    {
      "sample_idx": 23,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"Headaches attributed to migraine\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical reasoning: Could headaches be a symptom of a subtle brain tumor missed on MRI? Playing devil's advocate against a benign conclusion: The report explicitly states 'No mass lesion' and 'No abnormal enhancement' on a brain MRI. The headaches are attributed to a common benign condition (migraine). The report concludes 'No malignancy identified'. While headaches can be a red flag, the imaging findings are explicitly normal, and a benign cause is identified. No evidence supports malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical reasoning: Could headaches be a symptom of a subtle brain tumor missed on MRI? Playing devil's advocate against a benign conclusion: The report explicitly states 'No mass lesion' and 'No abnormal enhancement' on a brain MRI. The headaches are attributed to a common benign condition (migraine). The report concludes 'No malignancy identified'. While headaches can be a red flag, the imaging findings are explicitly normal, and a benign cause is identified. No evidence supports malignancy.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "Headaches attributed to migraine",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 23,
      "timestamp": "2026-01-10T20:50:27.408766"
    },
    {
      "sample_idx": 24,
      "input": "16/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"Headaches attributed to migraine\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical reasoning: Could the 'normal' MRI miss a subtle malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states 'No mass lesion' and 'No abnormal enhancement', with a concluding statement 'No malignancy identified'. The headaches are attributed to a known benign condition (migraine). While vigilance is necessary, the report provides no objective evidence supporting malignancy. Conclusion: benign findings dominate.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical reasoning: Could the 'normal' MRI miss a subtle malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states 'No mass lesion' and 'No abnormal enhancement', with a concluding statement 'No malignancy identified'. The headaches are attributed to a known benign condition (migraine). While vigilance is necessary, the report provides no objective evidence supporting malignancy. Conclusion: benign findings dominate.",
      "findings": [
        "Normal brain MRI",
        "No mass lesion",
        "No abnormal enhancement",
        "Headaches attributed to migraine",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 24,
      "timestamp": "2026-01-10T20:50:27.408783"
    },
    {
      "sample_idx": 25,
      "input": "16/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could permeative bone destruction and soft tissue mass be due to infection (e.g., osteomyelitis) or inflammatory process? Could onion-skin reaction be reactive? However, the presence of EWSR1 fusion positivity is highly specific for Ewing Sarcoma. While infection can cause bone destruction, the combination of features, especially the genetic marker, strongly points towards malignancy. Alternative benign explanations are unlikely given the specific genetic finding. Conclusion: Malignancy is highly likely.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could permeative bone destruction and soft tissue mass be due to infection (e.g., osteomyelitis) or inflammatory process? Could onion-skin reaction be reactive? However, the presence of EWSR1 fusion positivity is highly specific for Ewing Sarcoma. While infection can cause bone destruction, the combination of features, especially the genetic marker, strongly points towards malignancy. Alternative benign explanations are unlikely given the specific genetic finding. Conclusion: Malignancy is highly likely.",
      "findings": [
        "permeative bone destruction",
        "large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 25,
      "timestamp": "2026-01-10T20:50:27.408801"
    },
    {
      "sample_idx": 26,
      "input": "13/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 13/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"High LDH levels\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states 'Burkitt lymphoma confirmed on biopsy'. While lymphadenopathy can be reactive, the definitive biopsy result overrides this possibility. High LDH is non-specific but consistent with high cell turnover seen in Burkitt lymphoma. The clinical context (pancytopenia, suspected NHL) aligns with the confirmed diagnosis. Conclusion: Despite the need for skepticism, the biopsy confirmation is unequivocal evidence of malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states 'Burkitt lymphoma confirmed on biopsy'. While lymphadenopathy can be reactive, the definitive biopsy result overrides this possibility. High LDH is non-specific but consistent with high cell turnover seen in Burkitt lymphoma. The clinical context (pancytopenia, suspected NHL) aligns with the confirmed diagnosis. Conclusion: Despite the need for skepticism, the biopsy confirmation is unequivocal evidence of malignancy.",
      "findings": [
        "abdominal lymphadenopathy",
        "mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "High LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 26,
      "timestamp": "2026-01-10T20:50:27.408819"
    },
    {
      "sample_idx": 27,
      "input": "25/06/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"Bone density normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: Could a fracture be a pathological fracture masking malignancy? The report explicitly states 'normal process', 'no pathological features', and 'no malignancy identified'. The history is consistent with trauma, and bone density is normal. While vigilance is always necessary, the findings directly contradict malignancy. No evidence supports a malignant interpretation.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: Could a fracture be a pathological fracture masking malignancy? The report explicitly states 'normal process', 'no pathological features', and 'no malignancy identified'. The history is consistent with trauma, and bone density is normal. While vigilance is always necessary, the findings directly contradict malignancy. No evidence supports a malignant interpretation.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "Bone density normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 27,
      "timestamp": "2026-01-10T20:50:27.408835"
    },
    {
      "sample_idx": 28,
      "input": "01/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 01/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states 'No malignancy identified' and describes a resolved benign finding. Could a malignancy be missed? Playing devil's advocate: the imaging shows a resolved benign cyst with no aggressive features and no recurrence. Normal bone density further supports a benign process. While imaging has limitations, the explicit statement of 'no malignancy identified' combined with the benign nature of the findings makes malignancy highly unlikely. No evidence supports a malignant diagnosis.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states 'No malignancy identified' and describes a resolved benign finding. Could a malignancy be missed? Playing devil's advocate: the imaging shows a resolved benign cyst with no aggressive features and no recurrence. Normal bone density further supports a benign process. While imaging has limitations, the explicit statement of 'no malignancy identified' combined with the benign nature of the findings makes malignancy highly unlikely. No evidence supports a malignant diagnosis.",
      "findings": [
        "Benign bone cyst - resolved",
        "No aggressive features",
        "Normal bone density",
        "No recurrence on imaging",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 28,
      "timestamp": "2026-01-10T20:50:27.408853"
    },
    {
      "sample_idx": 29,
      "input": "04/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could a suprarenal mass be benign (e.g., adrenal adenoma, pheochromocytoma)? Could calcifications be incidental? Could MIBG avidity be seen in other conditions? However, the combination of a large, heterogeneous suprarenal mass (characteristic morphology), MIBG avidity (highly specific for neuroblastic tumors), and elevated urinary catecholamines (biochemical marker for neuroblastoma) strongly points towards neuroblastoma. The clinical suspicion and staging further support malignancy. Alternative benign explanations are less likely given the constellation of findings.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a suprarenal mass be benign (e.g., adrenal adenoma, pheochromocytoma)? Could calcifications be incidental? Could MIBG avidity be seen in other conditions? However, the combination of a large, heterogeneous suprarenal mass (characteristic morphology), MIBG avidity (highly specific for neuroblastic tumors), and elevated urinary catecholamines (biochemical marker for neuroblastoma) strongly points towards neuroblastoma. The clinical suspicion and staging further support malignancy. Alternative benign explanations are less likely given the constellation of findings.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 29,
      "timestamp": "2026-01-10T20:50:27.408887"
    },
    {
      "sample_idx": 30,
      "input": "15/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 15/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement\", \"hydrocephalus\", \"restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the posterior fossa mass be a non-malignant lesion like an abscess or inflammatory process? However, the combination of enhancement, restricted diffusion (suggesting high cellularity), hydrocephalus (indicating mass effect), and definitive histology confirming 'High-grade medulloblastoma' strongly points towards malignancy. While imaging findings alone can sometimes be ambiguous, the histological confirmation provides compelling evidence. Alternative benign explanations are highly unlikely given the specific histological diagnosis. Conclusion: malignancy confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the posterior fossa mass be a non-malignant lesion like an abscess or inflammatory process? However, the combination of enhancement, restricted diffusion (suggesting high cellularity), hydrocephalus (indicating mass effect), and definitive histology confirming 'High-grade medulloblastoma' strongly points towards malignancy. While imaging findings alone can sometimes be ambiguous, the histological confirmation provides compelling evidence. Alternative benign explanations are highly unlikely given the specific histological diagnosis. Conclusion: malignancy confirmed.",
      "findings": [
        "posterior fossa mass with enhancement",
        "hydrocephalus",
        "restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 30,
      "timestamp": "2026-01-10T20:50:27.408907"
    },
    {
      "sample_idx": 31,
      "input": "02/04/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: While the report explicitly states 'No malignancy identified' and describes a 'Normal chest radiograph', could subtle findings be missed? Playing devil's advocate: Even with a 'normal' radiograph, microscopic disease or early-stage malignancy might not be visible. However, the report's explicit negative findings ('Clear lung fields', 'No mediastinal mass') combined with the 'Benign presentation' history strongly suggest the absence of detectable malignancy on this imaging modality. Conclusion: Based on the provided report, there is no evidence of malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: While the report explicitly states 'No malignancy identified' and describes a 'Normal chest radiograph', could subtle findings be missed? Playing devil's advocate: Even with a 'normal' radiograph, microscopic disease or early-stage malignancy might not be visible. However, the report's explicit negative findings ('Clear lung fields', 'No mediastinal mass') combined with the 'Benign presentation' history strongly suggest the absence of detectable malignancy on this imaging modality. Conclusion: Based on the provided report, there is no evidence of malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 31,
      "timestamp": "2026-01-10T20:50:27.408926"
    },
    {
      "sample_idx": 32,
      "input": "04/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could the mass be a benign teratoma or a non-malignant germ cell tumor? However, the presence of yolk sac tumor elements is highly indicative of malignancy. Elevated AFP and beta-hCG are tumor markers strongly associated with malignant germ cell tumors, particularly yolk sac tumors and choriocarcinoma components respectively. While some benign germ cell tumors can have elevated markers, the combination of a solid/cystic mass, specific tumor histology (yolk sac), and elevated markers strongly points towards malignancy. Alternative benign explanations are less likely given the specific histological findings and marker elevation.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mass be a benign teratoma or a non-malignant germ cell tumor? However, the presence of yolk sac tumor elements is highly indicative of malignancy. Elevated AFP and beta-hCG are tumor markers strongly associated with malignant germ cell tumors, particularly yolk sac tumors and choriocarcinoma components respectively. While some benign germ cell tumors can have elevated markers, the combination of a solid/cystic mass, specific tumor histology (yolk sac), and elevated markers strongly points towards malignancy. Alternative benign explanations are less likely given the specific histological findings and marker elevation.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 32,
      "timestamp": "2026-01-10T20:50:27.408947"
    },
    {
      "sample_idx": 33,
      "input": "24/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Skeptical reasoning: Could lymphadenopathy be reactive? While reactive lymphadenopathy is common, the presence of a 'bulky anterior mediastinal mass' and 'FDG-avid nodes' on PET-CT strongly suggests a neoplastic process. The specific histological subtype 'Classical Hodgkin, nodular sclerosing type' provides definitive evidence of malignancy. Alternative benign explanations (infection, inflammation) are less likely given the bulky mass and FDG avidity pattern characteristic of lymphoma. Conclusion: malignancy confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical reasoning: Could lymphadenopathy be reactive? While reactive lymphadenopathy is common, the presence of a 'bulky anterior mediastinal mass' and 'FDG-avid nodes' on PET-CT strongly suggests a neoplastic process. The specific histological subtype 'Classical Hodgkin, nodular sclerosing type' provides definitive evidence of malignancy. Alternative benign explanations (infection, inflammation) are less likely given the bulky mass and FDG avidity pattern characteristic of lymphoma. Conclusion: malignancy confirmed.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 33,
      "timestamp": "2026-01-10T20:50:27.408965"
    },
    {
      "sample_idx": 34,
      "input": "07/03/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 07/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical analysis: The report explicitly states 'No malignancy identified' based on a normal CBC, adequate platelets, normal hemoglobin, and absence of blast cells. While routine surveillance might raise suspicion, the findings are unequivocally normal. Could this be a false negative? The report provides no features suggestive of occult disease. The conclusion of 'No malignancy identified' is strongly supported by the presented data. Alternative explanations for the surveillance (e.g., family history, benign cytopenias) are not provided, but the current findings do not indicate malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical analysis: The report explicitly states 'No malignancy identified' based on a normal CBC, adequate platelets, normal hemoglobin, and absence of blast cells. While routine surveillance might raise suspicion, the findings are unequivocally normal. Could this be a false negative? The report provides no features suggestive of occult disease. The conclusion of 'No malignancy identified' is strongly supported by the presented data. Alternative explanations for the surveillance (e.g., family history, benign cytopenias) are not provided, but the current findings do not indicate malignancy.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 34,
      "timestamp": "2026-01-10T20:50:27.408985"
    },
    {
      "sample_idx": 35,
      "input": "04/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign soft tissue mass - lipoma confirmed\", \"Well-circumscribed\", \"No enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a lipoma mimic a malignant tumor? The report explicitly describes a benign soft tissue mass, confirmed as a lipoma, which is well-circumscribed and shows no enhancement. The radiologist explicitly states 'No malignancy identified' and provides reassurance. While skepticism is warranted in ruling out malignancy, the findings are highly characteristic of a benign lipoma, making malignancy extremely unlikely. No further investigation is indicated based on this report.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a lipoma mimic a malignant tumor? The report explicitly describes a benign soft tissue mass, confirmed as a lipoma, which is well-circumscribed and shows no enhancement. The radiologist explicitly states 'No malignancy identified' and provides reassurance. While skepticism is warranted in ruling out malignancy, the findings are highly characteristic of a benign lipoma, making malignancy extremely unlikely. No further investigation is indicated based on this report.",
      "findings": [
        "Benign soft tissue mass - lipoma confirmed",
        "Well-circumscribed",
        "No enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 35,
      "timestamp": "2026-01-10T20:50:27.409003"
    },
    {
      "sample_idx": 36,
      "input": "04/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical review: The report is explicitly for screening with no prior history. Could a screening report miss subtle signs? The findings are overwhelmingly negative: normal chest X-ray, clear lungs, no mass, normal heart size, and a direct statement 'No malignancy identified'. While screening can miss things, the report provides no positive findings to suggest malignancy. The conclusion of 'no malignancy identified' is supported by the lack of any abnormal findings.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: The report is explicitly for screening with no prior history. Could a screening report miss subtle signs? The findings are overwhelmingly negative: normal chest X-ray, clear lungs, no mass, normal heart size, and a direct statement 'No malignancy identified'. While screening can miss things, the report provides no positive findings to suggest malignancy. The conclusion of 'no malignancy identified' is supported by the lack of any abnormal findings.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 36,
      "timestamp": "2026-01-10T20:50:27.409020"
    },
    {
      "sample_idx": 37,
      "input": "02/04/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"Sunburst periosteal reaction\", \"Elevated alkaline phosphatase\"],\n        \"rationale\": \"Skeptical review: Could the destructive lesion be infection (osteomyelitis) or benign bone tumor? The 'sunburst' periosteal reaction is highly suggestive of aggressive bone lesion, often malignancy like osteosarcoma. Elevated alkaline phosphatase is non-specific but common in bone turnover, including malignancy. While infection is possible, the combination of a destructive lesion with a soft tissue component and the classic sunburst pattern strongly points towards osteosarcoma, especially given the clinical suspicion. Alternative explanations like benign fibrous dysplasia are less likely with this aggressive appearance. Conclusion: High suspicion for malignancy, likely osteosarcoma, warrants MDT discussion.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical review: Could the destructive lesion be infection (osteomyelitis) or benign bone tumor? The 'sunburst' periosteal reaction is highly suggestive of aggressive bone lesion, often malignancy like osteosarcoma. Elevated alkaline phosphatase is non-specific but common in bone turnover, including malignancy. While infection is possible, the combination of a destructive lesion with a soft tissue component and the classic sunburst pattern strongly points towards osteosarcoma, especially given the clinical suspicion. Alternative explanations like benign fibrous dysplasia are less likely with this aggressive appearance. Conclusion: High suspicion for malignancy, likely osteosarcoma, warrants MDT discussion.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "Sunburst periosteal reaction",
        "Elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 37,
      "timestamp": "2026-01-10T20:50:27.409041"
    },
    {
      "sample_idx": 38,
      "input": "05/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 05/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"Sunburst periosteal reaction\", \"Elevated alkaline phosphatase\", \"Suspected Osteosarcoma\"],\n        \"rationale\": \"Skeptical assessment: Could the destructive lesion be infectious (osteomyelitis) or inflammatory? Sunburst periosteal reaction is classic for osteosarcoma, but can rarely be seen in other conditions like Ewing sarcoma or infection. Elevated alkaline phosphatase is non-specific, often elevated in growing children or bone healing, but also common in bone tumors. However, the combination of a destructive lesion with a soft tissue component and the highly suggestive 'sunburst' pattern in a pediatric patient with suspected osteosarcoma strongly points towards malignancy. While alternative diagnoses like infection are possible, the overall picture is highly suspicious for osteosarcoma.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical assessment: Could the destructive lesion be infectious (osteomyelitis) or inflammatory? Sunburst periosteal reaction is classic for osteosarcoma, but can rarely be seen in other conditions like Ewing sarcoma or infection. Elevated alkaline phosphatase is non-specific, often elevated in growing children or bone healing, but also common in bone tumors. However, the combination of a destructive lesion with a soft tissue component and the highly suggestive 'sunburst' pattern in a pediatric patient with suspected osteosarcoma strongly points towards malignancy. While alternative diagnoses like infection are possible, the overall picture is highly suspicious for osteosarcoma.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "Sunburst periosteal reaction",
        "Elevated alkaline phosphatase",
        "Suspected Osteosarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 38,
      "timestamp": "2026-01-10T20:50:27.409063"
    },
    {
      "sample_idx": 39,
      "input": "01/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 01/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could atypical lymphocytes be blasts? The report explicitly states 'atypical lymphocytes resolving' in the context of 'post-viral lymphocytosis' and confirmed EBV infection (Monospot positive, EBV serology confirms). While atypical lymphocytes can sometimes mimic blasts, the resolution, confirmed viral etiology, and explicit statement 'No malignancy identified' strongly argue against malignancy. Alternative explanations (e.g., viral infection) are confirmed. Conclusion: No malignancy, despite the presence of atypical lymphocytes which initially require careful consideration.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could atypical lymphocytes be blasts? The report explicitly states 'atypical lymphocytes resolving' in the context of 'post-viral lymphocytosis' and confirmed EBV infection (Monospot positive, EBV serology confirms). While atypical lymphocytes can sometimes mimic blasts, the resolution, confirmed viral etiology, and explicit statement 'No malignancy identified' strongly argue against malignancy. Alternative explanations (e.g., viral infection) are confirmed. Conclusion: No malignancy, despite the presence of atypical lymphocytes which initially require careful consideration.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 39,
      "timestamp": "2026-01-10T20:50:27.409082"
    },
    {
      "sample_idx": 40,
      "input": "26/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass\", \"Suspected Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Skeptical analysis: Could the renal mass be a benign condition like a renal cyst or hamartoma? However, the clinical suspicion of Wilms Tumor, favorable histology on biopsy (characteristic of Wilms), and staging (Stage II) strongly point towards malignancy. While benign renal masses exist, the specific context (pediatric patient, suspected Wilms, biopsy results) makes malignancy the most likely diagnosis despite considering alternatives.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical analysis: Could the renal mass be a benign condition like a renal cyst or hamartoma? However, the clinical suspicion of Wilms Tumor, favorable histology on biopsy (characteristic of Wilms), and staging (Stage II) strongly point towards malignancy. While benign renal masses exist, the specific context (pediatric patient, suspected Wilms, biopsy results) makes malignancy the most likely diagnosis despite considering alternatives.",
      "findings": [
        "large heterogeneous left renal mass",
        "Suspected Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 40,
      "timestamp": "2026-01-10T20:50:27.409099"
    },
    {
      "sample_idx": 41,
      "input": "18/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could lymphadenopathy be reactive? However, the presence of a 'bulky' anterior mediastinal mass, combined with FDG-avid nodes on PET-CT, strongly suggests malignancy. The specific histological subtype 'Classical Hodgkin, nodular sclerosing type' provides definitive evidence. Alternative benign explanations (infection, inflammatory conditions) are less likely given the PET-CT findings and specific histology. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could lymphadenopathy be reactive? However, the presence of a 'bulky' anterior mediastinal mass, combined with FDG-avid nodes on PET-CT, strongly suggests malignancy. The specific histological subtype 'Classical Hodgkin, nodular sclerosing type' provides definitive evidence. Alternative benign explanations (infection, inflammatory conditions) are less likely given the PET-CT findings and specific histology. Conclusion: malignancy confirmed despite initial skepticism.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 41,
      "timestamp": "2026-01-10T20:50:27.409116"
    },
    {
      "sample_idx": 42,
      "input": "20/04/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 20/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: While lymphocytosis and atypical lymphocytes can sometimes be associated with lymphoma (e.g., T-cell lymphoma), the context here is strongly suggestive of a benign process. The positive Monospot test and confirmed EBV serology point directly to infectious mononucleosis, a common cause of these findings. The report explicitly states 'No malignancy identified' and 'resolving' atypical lymphocytes, indicating a transient, self-limiting condition. Despite the potential overlap in morphology, the clinical and serological context overwhelmingly supports a benign infectious etiology rather than malignancy. The conclusion of 'no malignancy' is well-supported by the available evidence.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: While lymphocytosis and atypical lymphocytes can sometimes be associated with lymphoma (e.g., T-cell lymphoma), the context here is strongly suggestive of a benign process. The positive Monospot test and confirmed EBV serology point directly to infectious mononucleosis, a common cause of these findings. The report explicitly states 'No malignancy identified' and 'resolving' atypical lymphocytes, indicating a transient, self-limiting condition. Despite the potential overlap in morphology, the clinical and serological context overwhelmingly supports a benign infectious etiology rather than malignancy. The conclusion of 'no malignancy' is well-supported by the available evidence.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 42,
      "timestamp": "2026-01-10T20:50:27.409137"
    },
    {
      "sample_idx": 43,
      "input": "20/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 20/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"Headaches attributed to migraine\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical analysis: The report explicitly states 'No malignancy identified' based on a normal brain MRI. Could the headaches be a symptom of an undetected brain tumor? While headaches are a common migraine symptom, they can also be associated with brain tumors. However, the MRI, which is the gold standard for detecting brain masses, is normal. The absence of mass lesions or abnormal enhancement makes malignancy highly unlikely. The report concludes with reassurance, further supporting a benign interpretation. The lack of any identified abnormality strongly argues against malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical analysis: The report explicitly states 'No malignancy identified' based on a normal brain MRI. Could the headaches be a symptom of an undetected brain tumor? While headaches are a common migraine symptom, they can also be associated with brain tumors. However, the MRI, which is the gold standard for detecting brain masses, is normal. The absence of mass lesions or abnormal enhancement makes malignancy highly unlikely. The report concludes with reassurance, further supporting a benign interpretation. The lack of any identified abnormality strongly argues against malignancy.",
      "findings": [
        "Normal brain MRI",
        "No mass lesion",
        "No abnormal enhancement",
        "Headaches attributed to migraine",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 43,
      "timestamp": "2026-01-10T20:50:27.409156"
    },
    {
      "sample_idx": 44,
      "input": "22/11/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 22/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could bone destruction be infectious (osteomyelitis) or inflammatory? Could the soft tissue mass be an abscess or hematoma? However, the combination of permeative bone destruction (characteristic of aggressive infiltrative processes), onion-skin periosteal reaction (classic sign of aggressive bone tumors like Ewing Sarcoma), a large soft tissue mass (suggesting local extension), and crucially, the positive EWSR1 fusion gene (a highly specific molecular marker for Ewing Sarcoma family of tumors) makes a benign explanation extremely unlikely. While infection can cause bone destruction, the specific pattern and the genetic marker strongly point towards malignancy. Conclusion: Malignancy confirmed, specifically Ewing Sarcoma, despite considering alternative diagnoses like infection.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could bone destruction be infectious (osteomyelitis) or inflammatory? Could the soft tissue mass be an abscess or hematoma? However, the combination of permeative bone destruction (characteristic of aggressive infiltrative processes), onion-skin periosteal reaction (classic sign of aggressive bone tumors like Ewing Sarcoma), a large soft tissue mass (suggesting local extension), and crucially, the positive EWSR1 fusion gene (a highly specific molecular marker for Ewing Sarcoma family of tumors) makes a benign explanation extremely unlikely. While infection can cause bone destruction, the specific pattern and the genetic marker strongly point towards malignancy. Conclusion: Malignancy confirmed, specifically Ewing Sarcoma, despite considering alternative diagnoses like infection.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis",
        "large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 44,
      "timestamp": "2026-01-10T20:50:27.409179"
    },
    {
      "sample_idx": 45,
      "input": "06/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a subtle malignancy be missed on MRI? Playing devil's advocate against a benign conclusion: the report explicitly states 'Normal brain MRI for age', 'No mass lesion', 'No abnormal enhancement', and directly concludes 'No malignancy identified'. While MRI has limitations, the absence of any suspicious findings, coupled with the explicit negative conclusion by the consulting paediatric oncologist, strongly supports a benign interpretation. There is no evidence presented to suggest malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a subtle malignancy be missed on MRI? Playing devil's advocate against a benign conclusion: the report explicitly states 'Normal brain MRI for age', 'No mass lesion', 'No abnormal enhancement', and directly concludes 'No malignancy identified'. While MRI has limitations, the absence of any suspicious findings, coupled with the explicit negative conclusion by the consulting paediatric oncologist, strongly supports a benign interpretation. There is no evidence presented to suggest malignancy.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 45,
      "timestamp": "2026-01-10T20:50:27.409197"
    },
    {
      "sample_idx": 46,
      "input": "24/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\"],\n        \"rationale\": \"Applying skeptical reasoning: Could physiological splenomegaly mask an underlying malignancy? The report explicitly states 'physiological splenomegaly for age' and 'benign finding'. While splenomegaly can be associated with malignancy, the description 'physiological' strongly suggests a normal variant. The report explicitly rules out malignancy. Conclusion: No malignancy identified based on the report's findings and explicit statement.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could physiological splenomegaly mask an underlying malignancy? The report explicitly states 'physiological splenomegaly for age' and 'benign finding'. While splenomegaly can be associated with malignancy, the description 'physiological' strongly suggests a normal variant. The report explicitly rules out malignancy. Conclusion: No malignancy identified based on the report's findings and explicit statement.",
      "findings": [
        "Physiological splenomegaly for age"
      ],
      "fracture_mentioned": null,
      "idx": 46,
      "timestamp": "2026-01-10T20:50:27.409212"
    },
    {
      "sample_idx": 47,
      "input": "01/02/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 01/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the reactive lymphadenopathy mask an underlying malignancy? Playing devil's advocate against a benign conclusion: the report explicitly states reactive lymphadenopathy secondary to viral infection, which is a common benign cause. Furthermore, the nodes are decreasing in size, which is characteristic of a resolving inflammatory process, not typically seen with malignancy. The absence of atypical features and the explicit statement 'No malignancy identified' strongly support a benign interpretation. While vigilance is always necessary, the current evidence points away from malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could the reactive lymphadenopathy mask an underlying malignancy? Playing devil's advocate against a benign conclusion: the report explicitly states reactive lymphadenopathy secondary to viral infection, which is a common benign cause. Furthermore, the nodes are decreasing in size, which is characteristic of a resolving inflammatory process, not typically seen with malignancy. The absence of atypical features and the explicit statement 'No malignancy identified' strongly support a benign interpretation. While vigilance is always necessary, the current evidence points away from malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 47,
      "timestamp": "2026-01-10T20:50:27.409233"
    },
    {
      "sample_idx": 48,
      "input": "03/10/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Skeptical analysis: Could the destructive lesion be infection (osteomyelitis) or trauma? The sunburst periosteal reaction is highly suggestive of osteosarcoma but can rarely be seen in other conditions. Elevated alkaline phosphatase is non-specific but common in bone turnover, including malignancy. However, the combination of a destructive lesion with a soft tissue component and a sunburst pattern in a pediatric patient with suspected osteosarcoma strongly points towards malignancy. Alternative benign explanations like infection or trauma are less likely given the classic radiographic features described. Conclusion: malignancy highly probable.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical analysis: Could the destructive lesion be infection (osteomyelitis) or trauma? The sunburst periosteal reaction is highly suggestive of osteosarcoma but can rarely be seen in other conditions. Elevated alkaline phosphatase is non-specific but common in bone turnover, including malignancy. However, the combination of a destructive lesion with a soft tissue component and a sunburst pattern in a pediatric patient with suspected osteosarcoma strongly points towards malignancy. Alternative benign explanations like infection or trauma are less likely given the classic radiographic features described. Conclusion: malignancy highly probable.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 48,
      "timestamp": "2026-01-10T20:50:27.409252"
    },
    {
      "sample_idx": 49,
      "input": "05/08/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states reactive lymphadenopathy likely due to viral infection, a common benign cause. The decreasing node size on follow-up further supports a reactive process rather than malignancy. The absence of atypical features and the explicit statement 'No malignancy identified' by the consulting oncologist strongly argue against malignancy. While screening PET-CTs can occasionally miss malignancy, the findings here are classic for a benign reactive process. No evidence points towards malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states reactive lymphadenopathy likely due to viral infection, a common benign cause. The decreasing node size on follow-up further supports a reactive process rather than malignancy. The absence of atypical features and the explicit statement 'No malignancy identified' by the consulting oncologist strongly argue against malignancy. While screening PET-CTs can occasionally miss malignancy, the findings here are classic for a benign reactive process. No evidence points towards malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 49,
      "timestamp": "2026-01-10T20:50:27.409271"
    },
    {
      "sample_idx": 50,
      "input": "02/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"Skeptical review: The report explicitly states 'No malignancy identified' and provides 'Reassurance'. While a single imaging study isn't foolproof, the findings are consistently normal across multiple assessed areas (chest, lungs, mediastinum, heart size). The reason for request was 'Benign presentation' and there's no history of oncology. Playing devil's advocate: Could a subtle malignancy be missed? The report is quite definitive in its negative findings and conclusion. Without any suspicious features described, the conclusion of no malignancy is strongly supported by the provided evidence. Therefore, despite the inherent limitations of imaging, the report provides no basis to suspect malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: The report explicitly states 'No malignancy identified' and provides 'Reassurance'. While a single imaging study isn't foolproof, the findings are consistently normal across multiple assessed areas (chest, lungs, mediastinum, heart size). The reason for request was 'Benign presentation' and there's no history of oncology. Playing devil's advocate: Could a subtle malignancy be missed? The report is quite definitive in its negative findings and conclusion. Without any suspicious features described, the conclusion of no malignancy is strongly supported by the provided evidence. Therefore, despite the inherent limitations of imaging, the report provides no basis to suspect malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 50,
      "timestamp": "2026-01-10T20:50:27.409292"
    },
    {
      "sample_idx": 51,
      "input": "26/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign soft tissue mass - lipoma confirmed\", \"Well-circumscribed\", \"No enhancement\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"Skeptical analysis: The report explicitly states 'No malignancy identified' and confirms the finding as a benign lipoma. While follow-up suggests prior concern, the current findings are definitively benign. Could a lipoma mask a deeper malignancy? Highly unlikely given the well-circumscribed nature and lack of enhancement, typical features of benign lipomas. The report provides clear reassurance. Conclusion: No malignancy based on definitive benign findings.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical analysis: The report explicitly states 'No malignancy identified' and confirms the finding as a benign lipoma. While follow-up suggests prior concern, the current findings are definitively benign. Could a lipoma mask a deeper malignancy? Highly unlikely given the well-circumscribed nature and lack of enhancement, typical features of benign lipomas. The report provides clear reassurance. Conclusion: No malignancy based on definitive benign findings.",
      "findings": [
        "Benign soft tissue mass - lipoma confirmed",
        "Well-circumscribed",
        "No enhancement",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 51,
      "timestamp": "2026-01-10T20:50:27.409309"
    },
    {
      "sample_idx": 52,
      "input": "25/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 25/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Skeptical assessment: Could the renal mass be a benign entity like a congenital mesoblastic nephroma or a renal abscess? The description 'large heterogeneous mass' is concerning. However, the biopsy explicitly states 'favorable histology', which strongly points towards Wilms Tumor, a malignancy. The staging (Stage II) further supports a malignant diagnosis. While benign renal masses exist, the biopsy result is key. Conclusion: Malignancy highly likely given the biopsy result, despite the possibility of benign mimics based solely on imaging.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical assessment: Could the renal mass be a benign entity like a congenital mesoblastic nephroma or a renal abscess? The description 'large heterogeneous mass' is concerning. However, the biopsy explicitly states 'favorable histology', which strongly points towards Wilms Tumor, a malignancy. The staging (Stage II) further supports a malignant diagnosis. While benign renal masses exist, the biopsy result is key. Conclusion: Malignancy highly likely given the biopsy result, despite the possibility of benign mimics based solely on imaging.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 52,
      "timestamp": "2026-01-10T20:50:27.409327"
    },
    {
      "sample_idx": 53,
      "input": "05/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy\", \"Node size decreasing\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: While 'reactive lymphadenopathy' is often benign, could it mask an underlying malignancy? However, the report explicitly states 'Node size decreasing', 'No atypical features', and 'No malignancy identified'. The decreasing size argues against progressive malignancy. The lack of atypical features further reduces suspicion. Conclusion: Despite the presence of lymphadenopathy (an abnormal finding), the report provides strong evidence against malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: While 'reactive lymphadenopathy' is often benign, could it mask an underlying malignancy? However, the report explicitly states 'Node size decreasing', 'No atypical features', and 'No malignancy identified'. The decreasing size argues against progressive malignancy. The lack of atypical features further reduces suspicion. Conclusion: Despite the presence of lymphadenopathy (an abnormal finding), the report provides strong evidence against malignancy.",
      "findings": [
        "Reactive lymphadenopathy",
        "Node size decreasing",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 53,
      "timestamp": "2026-01-10T20:50:27.409344"
    },
    {
      "sample_idx": 54,
      "input": "23/03/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 23/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Skeptical analysis: Could the hepatic mass be benign (e.g., hemangioma, focal nodular hyperplasia)? While these are possibilities in children, the combination of a large, heterogeneous mass, significantly elevated AFP (a known tumor marker for hepatoblastoma), and the specific fetal histology subtype strongly points towards malignancy. PRETEXT staging further supports a malignant process requiring treatment. Alternative benign explanations are less likely given the constellation of findings.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical analysis: Could the hepatic mass be benign (e.g., hemangioma, focal nodular hyperplasia)? While these are possibilities in children, the combination of a large, heterogeneous mass, significantly elevated AFP (a known tumor marker for hepatoblastoma), and the specific fetal histology subtype strongly points towards malignancy. PRETEXT staging further supports a malignant process requiring treatment. Alternative benign explanations are less likely given the constellation of findings.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 54,
      "timestamp": "2026-01-10T20:50:27.409361"
    },
    {
      "sample_idx": 55,
      "input": "31/08/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 31/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical review: The report explicitly states 'No malignancy identified' and describes normal findings throughout the chest and abdomen. While a CT scan can miss small lesions, the comprehensive description of normal anatomy (lungs, mediastinum, heart) and the explicit negative conclusion by the consultant oncologist provide strong evidence against malignancy. Alternative explanations for a 'benign presentation' are not suggested by the imaging. Conclusion: No malignancy identified based on the provided report.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: The report explicitly states 'No malignancy identified' and describes normal findings throughout the chest and abdomen. While a CT scan can miss small lesions, the comprehensive description of normal anatomy (lungs, mediastinum, heart) and the explicit negative conclusion by the consultant oncologist provide strong evidence against malignancy. Alternative explanations for a 'benign presentation' are not suggested by the imaging. Conclusion: No malignancy identified based on the provided report.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 55,
      "timestamp": "2026-01-10T20:50:27.409378"
    },
    {
      "sample_idx": 56,
      "input": "26/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the decreasing lymphadenopathy be masking an underlying malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states 'No malignancy identified' and describes the findings as 'Reactive lymphadenopathy secondary to viral infection' with decreasing node size. While reactive changes can sometimes mimic malignancy, the explicit negative finding and description of a benign cause (viral infection) with resolution strongly support a non-malignant diagnosis. No evidence points towards malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could the decreasing lymphadenopathy be masking an underlying malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states 'No malignancy identified' and describes the findings as 'Reactive lymphadenopathy secondary to viral infection' with decreasing node size. While reactive changes can sometimes mimic malignancy, the explicit negative finding and description of a benign cause (viral infection) with resolution strongly support a non-malignant diagnosis. No evidence points towards malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 56,
      "timestamp": "2026-01-10T20:50:27.409397"
    },
    {
      "sample_idx": 57,
      "input": "24/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"Skeptical assessment: Could the mass be a benign teratoma or other non-malignant developmental anomaly? While germ cell tumors can be benign, the presence of 'Yolk sac tumor elements' is highly suggestive of malignancy. Elevated AFP and beta-hCG are tumor markers strongly associated with germ cell malignancies, particularly yolk sac tumors and embryonal carcinomas. The combination of imaging findings, tumor markers, and histological elements points strongly towards malignancy, despite the potential for benign germ cell components. Alternative explanations (e.g., infection, inflammation) are unlikely given the specific tumor markers and histological description. Conclusion: Malignancy is highly probable.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical assessment: Could the mass be a benign teratoma or other non-malignant developmental anomaly? While germ cell tumors can be benign, the presence of 'Yolk sac tumor elements' is highly suggestive of malignancy. Elevated AFP and beta-hCG are tumor markers strongly associated with germ cell malignancies, particularly yolk sac tumors and embryonal carcinomas. The combination of imaging findings, tumor markers, and histological elements points strongly towards malignancy, despite the potential for benign germ cell components. Alternative explanations (e.g., infection, inflammation) are unlikely given the specific tumor markers and histological description. Conclusion: Malignancy is highly probable.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 57,
      "timestamp": "2026-01-10T20:50:27.409418"
    },
    {
      "sample_idx": 58,
      "input": "01/01/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 01/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could the sacrococcygeal mass be a benign teratoma or congenital cyst? Could elevated tumor markers be due to other causes (e.g., liver disease, ectopic hormone production)? However, the presence of specific 'Yolk sac tumor elements' points strongly towards malignancy. Yolk sac tumors are a type of germ cell tumor, often associated with elevated AFP and beta-hCG. The combination of a mass in a typical location for germ cell tumors, elevated markers, and histological elements consistent with yolk sac tumor makes malignancy highly probable. Alternative benign explanations are less likely given the specific histological findings.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the sacrococcygeal mass be a benign teratoma or congenital cyst? Could elevated tumor markers be due to other causes (e.g., liver disease, ectopic hormone production)? However, the presence of specific 'Yolk sac tumor elements' points strongly towards malignancy. Yolk sac tumors are a type of germ cell tumor, often associated with elevated AFP and beta-hCG. The combination of a mass in a typical location for germ cell tumors, elevated markers, and histological elements consistent with yolk sac tumor makes malignancy highly probable. Alternative benign explanations are less likely given the specific histological findings.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 58,
      "timestamp": "2026-01-10T20:50:27.409438"
    },
    {
      "sample_idx": 59,
      "input": "16/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Pancytopenia\", \"Suspected Rhabdomyosarcoma\", \"Parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"Initial skepticism: Pancytopenia could be due to various causes, including infections or aplastic anemia. However, the clinical suspicion of Rhabdomyosarcoma, confirmed by biopsy showing Embryonal rhabdomyosarcoma, and the presence of a parameningeal mass with intracranial extension strongly point towards malignancy. While pancytopenia itself is non-specific, the context of a confirmed embryonal rhabdomyosarcoma makes it highly likely to be related to bone marrow infiltration or treatment effects (though treatment hasn't started yet). The biopsy result is definitive. Conclusion: Malignancy confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Pancytopenia could be due to various causes, including infections or aplastic anemia. However, the clinical suspicion of Rhabdomyosarcoma, confirmed by biopsy showing Embryonal rhabdomyosarcoma, and the presence of a parameningeal mass with intracranial extension strongly point towards malignancy. While pancytopenia itself is non-specific, the context of a confirmed embryonal rhabdomyosarcoma makes it highly likely to be related to bone marrow infiltration or treatment effects (though treatment hasn't started yet). The biopsy result is definitive. Conclusion: Malignancy confirmed.",
      "findings": [
        "Pancytopenia",
        "Suspected Rhabdomyosarcoma",
        "Parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 59,
      "timestamp": "2026-01-10T20:50:27.409458"
    },
    {
      "sample_idx": 60,
      "input": "08/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"Headaches attributed to migraine\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical review: The primary reason for the request was to rule out malignancy. The report explicitly states 'No malignancy identified' based on a normal brain MRI. While headaches can be a symptom of brain tumors, the MRI findings are normal for age, showing no mass or abnormal enhancement. The headaches are attributed to migraines, a common benign cause. Playing devil's advocate: Could a subtle malignancy be missed? The report states 'normal' and explicitly rules out malignancy. Without any abnormal findings on imaging, concluding malignancy is unwarranted. Conclusion: The report provides clear evidence against malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: The primary reason for the request was to rule out malignancy. The report explicitly states 'No malignancy identified' based on a normal brain MRI. While headaches can be a symptom of brain tumors, the MRI findings are normal for age, showing no mass or abnormal enhancement. The headaches are attributed to migraines, a common benign cause. Playing devil's advocate: Could a subtle malignancy be missed? The report states 'normal' and explicitly rules out malignancy. Without any abnormal findings on imaging, concluding malignancy is unwarranted. Conclusion: The report provides clear evidence against malignancy.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "Headaches attributed to migraine",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 60,
      "timestamp": "2026-01-10T20:50:27.409478"
    },
    {
      "sample_idx": 61,
      "input": "09/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states 'No malignancy identified'. While atypical lymphocytes can be concerning, the context of post-viral lymphocytosis with positive Monospot and confirmed EBV serology points strongly towards a benign reactive process (infectious mononucleosis). The finding of resolving atypical lymphocytes further supports this. Although skepticism demands considering alternative diagnoses, the clear infectious etiology and explicit negative finding for malignancy by the consulting paediatric oncologist make malignancy highly improbable.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states 'No malignancy identified'. While atypical lymphocytes can be concerning, the context of post-viral lymphocytosis with positive Monospot and confirmed EBV serology points strongly towards a benign reactive process (infectious mononucleosis). The finding of resolving atypical lymphocytes further supports this. Although skepticism demands considering alternative diagnoses, the clear infectious etiology and explicit negative finding for malignancy by the consulting paediatric oncologist make malignancy highly improbable.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 61,
      "timestamp": "2026-01-10T20:50:27.409497"
    },
    {
      "sample_idx": 62,
      "input": "08/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical review: The report explicitly states 'No malignancy identified' and attributes the lymphadenopathy to a 'viral infection' with resolution ('decreasing on follow-up'). While ruling out malignancy requires thoroughness, the findings point strongly towards a benign, reactive process. The absence of atypical features further supports this. Alternative explanation (occult malignancy presenting as reactive nodes) is considered but contradicted by the clinical course (decreasing size) and explicit negative findings. Conclusion: No evidence of malignancy based on the provided report.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: The report explicitly states 'No malignancy identified' and attributes the lymphadenopathy to a 'viral infection' with resolution ('decreasing on follow-up'). While ruling out malignancy requires thoroughness, the findings point strongly towards a benign, reactive process. The absence of atypical features further supports this. Alternative explanation (occult malignancy presenting as reactive nodes) is considered but contradicted by the clinical course (decreasing size) and explicit negative findings. Conclusion: No evidence of malignancy based on the provided report.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 62,
      "timestamp": "2026-01-10T20:50:27.409516"
    },
    {
      "sample_idx": 63,
      "input": "04/12/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"Clinical improvement noted\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states 'No malignancy identified' and 'Blood counts normalized'. While routine surveillance might raise suspicion, the findings are explicitly benign. The resolved febrile illness is a common pediatric condition, not indicative of malignancy. The clinical improvement and normalization of blood counts further argue against an underlying malignant process. Despite the context of surveillance, the report provides no positive findings suggestive of malignancy, only reassurance. Therefore, based on the provided text, the conclusion is no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states 'No malignancy identified' and 'Blood counts normalized'. While routine surveillance might raise suspicion, the findings are explicitly benign. The resolved febrile illness is a common pediatric condition, not indicative of malignancy. The clinical improvement and normalization of blood counts further argue against an underlying malignant process. Despite the context of surveillance, the report provides no positive findings suggestive of malignancy, only reassurance. Therefore, based on the provided text, the conclusion is no malignancy.",
      "findings": [
        "Resolved febrile illness",
        "Blood counts normalized",
        "No organomegaly",
        "Clinical improvement noted",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 63,
      "timestamp": "2026-01-10T20:50:27.409536"
    },
    {
      "sample_idx": 64,
      "input": "29/09/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 29/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states 'Reactive lymphadenopathy secondary to viral infection' and 'No malignancy identified'. While lymphadenopathy itself is abnormal, the provided explanation points towards a benign cause. The decreasing node size on follow-up further supports a reactive process rather than malignancy. The explicit statement 'No atypical features' and 'No malignancy identified' by the consultant oncologist strongly suggests a benign conclusion. Despite the initial request to 'Rule out malignancy', the findings and interpretation strongly favor a non-malignant diagnosis. Alternative explanations for lymphadenopathy (e.g., lymphoma) are explicitly ruled out by the report.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states 'Reactive lymphadenopathy secondary to viral infection' and 'No malignancy identified'. While lymphadenopathy itself is abnormal, the provided explanation points towards a benign cause. The decreasing node size on follow-up further supports a reactive process rather than malignancy. The explicit statement 'No atypical features' and 'No malignancy identified' by the consultant oncologist strongly suggests a benign conclusion. Despite the initial request to 'Rule out malignancy', the findings and interpretation strongly favor a non-malignant diagnosis. Alternative explanations for lymphadenopathy (e.g., lymphoma) are explicitly ruled out by the report.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 64,
      "timestamp": "2026-01-10T20:50:27.409558"
    },
    {
      "sample_idx": 65,
      "input": "09/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 09/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Skeptical review: Could the intraocular mass be a benign lesion (e.g., Coats' disease, persistent hyperplastic primary vitreous)? While possible, the presence of calcifications, bilateral involvement, a positive family history, and crucially, the detection of an RB1 germline mutation strongly point towards Retinoblastoma. The RB1 mutation is highly specific for this malignancy. Alternative benign explanations are significantly less likely given the constellation of findings, especially the genetic confirmation. Conclusion: Malignancy highly probable despite considering differential diagnoses.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical review: Could the intraocular mass be a benign lesion (e.g., Coats' disease, persistent hyperplastic primary vitreous)? While possible, the presence of calcifications, bilateral involvement, a positive family history, and crucially, the detection of an RB1 germline mutation strongly point towards Retinoblastoma. The RB1 mutation is highly specific for this malignancy. Alternative benign explanations are significantly less likely given the constellation of findings, especially the genetic confirmation. Conclusion: Malignancy highly probable despite considering differential diagnoses.",
      "findings": [
        "intraocular mass with calcifications",
        "bilateral disease",
        "family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 65,
      "timestamp": "2026-01-10T20:50:27.409577"
    },
    {
      "sample_idx": 66,
      "input": "16/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Skeptical review: A suprarenal mass in a child immediately raises suspicion for neuroblastoma. Could the mass be benign? While other adrenal masses exist (e.g., adrenal hemorrhage, cysts), the heterogeneity, calcifications, and MIBG avidity strongly point towards neuroblastoma. Elevated urinary catecholamines are a classic biochemical marker for this tumor. Stage III implies regional spread, further supporting malignancy. Although benign adrenal masses can occur, the combination of imaging features (heterogeneity, calcification, MIBG uptake) and biochemical evidence (catecholamines) makes a benign explanation highly unlikely. Conclusion: Malignancy (Neuroblastoma) is strongly supported by the evidence.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical review: A suprarenal mass in a child immediately raises suspicion for neuroblastoma. Could the mass be benign? While other adrenal masses exist (e.g., adrenal hemorrhage, cysts), the heterogeneity, calcifications, and MIBG avidity strongly point towards neuroblastoma. Elevated urinary catecholamines are a classic biochemical marker for this tumor. Stage III implies regional spread, further supporting malignancy. Although benign adrenal masses can occur, the combination of imaging features (heterogeneity, calcification, MIBG uptake) and biochemical evidence (catecholamines) makes a benign explanation highly unlikely. Conclusion: Malignancy (Neuroblastoma) is strongly supported by the evidence.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 66,
      "timestamp": "2026-01-10T20:50:27.409599"
    },
    {
      "sample_idx": 67,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a normal CBC mask underlying malignancy, especially post-treatment? The report explicitly states normal CBC with age-appropriate values, adequate platelets, normal hemoglobin, and crucially, no blast cells. The consultant explicitly states 'No malignancy identified'. While post-treatment follow-up warrants vigilance, the current findings provide no objective evidence for malignancy. The absence of abnormal cells or findings makes a conclusion of malignancy unsupported.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a normal CBC mask underlying malignancy, especially post-treatment? The report explicitly states normal CBC with age-appropriate values, adequate platelets, normal hemoglobin, and crucially, no blast cells. The consultant explicitly states 'No malignancy identified'. While post-treatment follow-up warrants vigilance, the current findings provide no objective evidence for malignancy. The absence of abnormal cells or findings makes a conclusion of malignancy unsupported.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 67,
      "timestamp": "2026-01-10T20:50:27.409617"
    },
    {
      "sample_idx": 68,
      "input": "27/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Skeptical review: Could the parameningeal mass be an inflammatory lesion or congenital anomaly? The biopsy explicitly identifies Embryonal rhabdomyosarcoma. While PAX-FOXO1 negativity is noted (relevant for prognosis/subtyping), it doesn't negate the diagnosis. The combination of clinical suspicion (Rhabdomyosarcoma), imaging findings (parameningeal mass with intracranial extension), and definitive histological diagnosis from biopsy strongly indicates malignancy. Alternative benign explanations for a mass with these characteristics and histological features are highly unlikely.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical review: Could the parameningeal mass be an inflammatory lesion or congenital anomaly? The biopsy explicitly identifies Embryonal rhabdomyosarcoma. While PAX-FOXO1 negativity is noted (relevant for prognosis/subtyping), it doesn't negate the diagnosis. The combination of clinical suspicion (Rhabdomyosarcoma), imaging findings (parameningeal mass with intracranial extension), and definitive histological diagnosis from biopsy strongly indicates malignancy. Alternative benign explanations for a mass with these characteristics and histological features are highly unlikely.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 68,
      "timestamp": "2026-01-10T20:50:27.409635"
    },
    {
      "sample_idx": 69,
      "input": "16/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 16/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states 'No malignancy identified' following investigations including a chest radiograph. While a chest X-ray has limitations, the combination of findings (clear lungs, normal heart, no mass) and the explicit conclusion by the consultant oncologist makes malignancy highly unlikely. Alternative explanations for the request (e.g., infection, benign growth) are not suggested by the findings. The report provides reassurance, which aligns with the absence of malignant features.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states 'No malignancy identified' following investigations including a chest radiograph. While a chest X-ray has limitations, the combination of findings (clear lungs, normal heart, no mass) and the explicit conclusion by the consultant oncologist makes malignancy highly unlikely. Alternative explanations for the request (e.g., infection, benign growth) are not suggested by the findings. The report provides reassurance, which aligns with the absence of malignant features.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 69,
      "timestamp": "2026-01-10T20:50:27.409653"
    },
    {
      "sample_idx": 70,
      "input": "29/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 29/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial skepticism: Could intraocular mass be a benign lesion like Coats' disease or persistent fetal vasculature? However, the presence of calcifications, bilateral involvement, positive family history, and confirmed RB1 germline mutation strongly point towards Retinoblastoma. While alternative diagnoses exist for unilateral masses, the combination of findings, particularly the genetic mutation, makes a benign explanation highly improbable. Conclusion: malignancy highly likely, supported by multiple converging pieces of evidence.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could intraocular mass be a benign lesion like Coats' disease or persistent fetal vasculature? However, the presence of calcifications, bilateral involvement, positive family history, and confirmed RB1 germline mutation strongly point towards Retinoblastoma. While alternative diagnoses exist for unilateral masses, the combination of findings, particularly the genetic mutation, makes a benign explanation highly improbable. Conclusion: malignancy highly likely, supported by multiple converging pieces of evidence.",
      "findings": [
        "intraocular mass with calcifications",
        "Bilateral disease",
        "Family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 70,
      "timestamp": "2026-01-10T20:50:27.409671"
    },
    {
      "sample_idx": 71,
      "input": "11/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Skeptical assessment: Could lymphadenopathy be reactive (e.g., infection)? While reactive lymphadenopathy is common, the presence of a 'bulky anterior mediastinal mass', 'FDG-avid nodes' on PET-CT, and the specific histological diagnosis of 'Classical Hodgkin, nodular sclerosing type' strongly points towards malignancy. The nodular sclerosing subtype is a well-recognized variant of Hodgkin Lymphoma. Alternative benign explanations are highly unlikely given the constellation of findings. Conclusion: Malignancy confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical assessment: Could lymphadenopathy be reactive (e.g., infection)? While reactive lymphadenopathy is common, the presence of a 'bulky anterior mediastinal mass', 'FDG-avid nodes' on PET-CT, and the specific histological diagnosis of 'Classical Hodgkin, nodular sclerosing type' strongly points towards malignancy. The nodular sclerosing subtype is a well-recognized variant of Hodgkin Lymphoma. Alternative benign explanations are highly unlikely given the constellation of findings. Conclusion: Malignancy confirmed.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 71,
      "timestamp": "2026-01-10T20:50:27.409689"
    },
    {
      "sample_idx": 72,
      "input": "13/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 13/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the parameningeal mass be inflammatory or infectious? However, the biopsy explicitly identifies Embryonal rhabdomyosarcoma, a specific type of malignant tumor. The intracranial extension further supports a malignant process. While PAX-FOXO1 negative might suggest a specific subtype or prognosis, it does not negate the malignancy diagnosis. The clinical suspicion of Rhabdomyosarcoma is confirmed by pathology. Conclusion: Malignancy is confirmed by biopsy results, overriding any potential alternative benign explanations for the mass.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the parameningeal mass be inflammatory or infectious? However, the biopsy explicitly identifies Embryonal rhabdomyosarcoma, a specific type of malignant tumor. The intracranial extension further supports a malignant process. While PAX-FOXO1 negative might suggest a specific subtype or prognosis, it does not negate the malignancy diagnosis. The clinical suspicion of Rhabdomyosarcoma is confirmed by pathology. Conclusion: Malignancy is confirmed by biopsy results, overriding any potential alternative benign explanations for the mass.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 72,
      "timestamp": "2026-01-10T20:50:27.409708"
    },
    {
      "sample_idx": 73,
      "input": "03/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 03/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\"],\n        \"rationale\": \"Applying skeptical reasoning: Splenomegaly can be associated with malignancy (lymphoma, leukemia). However, the report explicitly states 'physiological splenomegaly for age' and 'benign finding'. While skepticism demands considering malignancy, the explicit description as physiological and benign, coupled with the absence of other suspicious findings (focal lesions, abnormal echo texture), strongly points away from malignancy in this context. The report concludes 'No malignancy identified'. Conclusion: Despite the potential association of splenomegaly with malignancy, the report's description as physiological and benign, with no other supporting evidence, makes malignancy unlikely.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Splenomegaly can be associated with malignancy (lymphoma, leukemia). However, the report explicitly states 'physiological splenomegaly for age' and 'benign finding'. While skepticism demands considering malignancy, the explicit description as physiological and benign, coupled with the absence of other suspicious findings (focal lesions, abnormal echo texture), strongly points away from malignancy in this context. The report concludes 'No malignancy identified'. Conclusion: Despite the potential association of splenomegaly with malignancy, the report's description as physiological and benign, with no other supporting evidence, makes malignancy unlikely.",
      "findings": [
        "Physiological splenomegaly for age"
      ],
      "fracture_mentioned": null,
      "idx": 73,
      "timestamp": "2026-01-10T20:50:27.409726"
    },
    {
      "sample_idx": 74,
      "input": "11/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"Onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could permeative bone destruction be due to infection (osteomyelitis)? Could the soft tissue mass be a benign reactive process? However, the combination of permeative destruction (characteristic of aggressive processes), onion-skin periosteal reaction (highly suggestive of malignancy like Ewing Sarcoma), and crucially, the positive EWSR1 fusion gene (a specific genetic marker for Ewing Sarcoma) strongly points towards malignancy. Alternative benign explanations are unlikely given the constellation of imaging and genetic findings. Conclusion: Malignancy is highly likely despite considering benign differentials.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could permeative bone destruction be due to infection (osteomyelitis)? Could the soft tissue mass be a benign reactive process? However, the combination of permeative destruction (characteristic of aggressive processes), onion-skin periosteal reaction (highly suggestive of malignancy like Ewing Sarcoma), and crucially, the positive EWSR1 fusion gene (a specific genetic marker for Ewing Sarcoma) strongly points towards malignancy. Alternative benign explanations are unlikely given the constellation of imaging and genetic findings. Conclusion: Malignancy is highly likely despite considering benign differentials.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis",
        "large soft tissue mass",
        "Onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 74,
      "timestamp": "2026-01-10T20:50:27.409747"
    },
    {
      "sample_idx": 75,
      "input": "28/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 28/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The report explicitly states 'Reactive lymphadenopathy secondary to viral infection' and 'No malignancy identified'. Although lymphadenopathy is abnormal, the context points towards a benign reactive process. The decreasing node size further supports a reactive, resolving process rather than malignancy. Playing devil's advocate: Could this be an early lymphoma mimicking a reactive process? However, the report explicitly states 'No atypical features' and 'No malignancy identified' by a consultant paediatric oncologist, making malignancy highly unlikely despite the presence of lymphadenopathy. Conclusion: The evidence strongly supports a benign reactive process, ruling out malignancy based on the provided report.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The report explicitly states 'Reactive lymphadenopathy secondary to viral infection' and 'No malignancy identified'. Although lymphadenopathy is abnormal, the context points towards a benign reactive process. The decreasing node size further supports a reactive, resolving process rather than malignancy. Playing devil's advocate: Could this be an early lymphoma mimicking a reactive process? However, the report explicitly states 'No atypical features' and 'No malignancy identified' by a consultant paediatric oncologist, making malignancy highly unlikely despite the presence of lymphadenopathy. Conclusion: The evidence strongly supports a benign reactive process, ruling out malignancy based on the provided report.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 75,
      "timestamp": "2026-01-10T20:50:27.409768"
    },
    {
      "sample_idx": 76,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: Could a benign presentation mask an underlying malignancy? The report explicitly states normal CBC, adequate platelets, normal hemoglobin, and crucially, the absence of blast cells. The oncologist explicitly states 'No malignancy identified' and provides reassurance. While skepticism demands considering occult disease, the provided evidence overwhelmingly points towards a benign condition. No abnormal findings are reported.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: Could a benign presentation mask an underlying malignancy? The report explicitly states normal CBC, adequate platelets, normal hemoglobin, and crucially, the absence of blast cells. The oncologist explicitly states 'No malignancy identified' and provides reassurance. While skepticism demands considering occult disease, the provided evidence overwhelmingly points towards a benign condition. No abnormal findings are reported.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 76,
      "timestamp": "2026-01-10T20:50:27.409785"
    },
    {
      "sample_idx": 77,
      "input": "06/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"Bone density normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical assessment: The primary reason for the request was to rule out malignancy. The report explicitly states 'No pathological features' and 'No malignancy identified'. While a healing fracture itself is a finding, it is described as a 'normal process' consistent with trauma history. Skeptical counterpoint: Could a fracture mask an underlying pathology? The report explicitly denies pathological features and normal bone density, making underlying malignancy highly unlikely. Conclusion: Despite the request to rule out malignancy, the findings strongly support a benign process.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical assessment: The primary reason for the request was to rule out malignancy. The report explicitly states 'No pathological features' and 'No malignancy identified'. While a healing fracture itself is a finding, it is described as a 'normal process' consistent with trauma history. Skeptical counterpoint: Could a fracture mask an underlying pathology? The report explicitly denies pathological features and normal bone density, making underlying malignancy highly unlikely. Conclusion: Despite the request to rule out malignancy, the findings strongly support a benign process.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "Bone density normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 77,
      "timestamp": "2026-01-10T20:50:27.409804"
    },
    {
      "sample_idx": 78,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Initial skepticism: Could the high percentage of lymphoblasts be reactive? However, the specific immunophenotyping confirming B-cell ALL and the bone marrow infiltration pattern strongly suggest malignancy. While CNS involvement is negative, the primary finding of 85% lymphoblasts in the bone marrow is highly indicative of leukemia. Alternative benign explanations are unlikely given the specific cell type and high percentage. Conclusion: malignancy confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the high percentage of lymphoblasts be reactive? However, the specific immunophenotyping confirming B-cell ALL and the bone marrow infiltration pattern strongly suggest malignancy. While CNS involvement is negative, the primary finding of 85% lymphoblasts in the bone marrow is highly indicative of leukemia. Alternative benign explanations are unlikely given the specific cell type and high percentage. Conclusion: malignancy confirmed.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL",
        "CNS involvement negative"
      ],
      "fracture_mentioned": null,
      "idx": 78,
      "timestamp": "2026-01-10T20:50:27.409821"
    },
    {
      "sample_idx": 79,
      "input": "17/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 17/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"Skeptical review: While atypical lymphocytes can sometimes be associated with lymphoma, the context points strongly away from malignancy. The findings explicitly state 'post-viral lymphocytosis', 'resolving' atypical lymphocytes, and positive EBV serology, confirming infectious mononucleosis. The report explicitly states 'No malignancy identified'. Although a skeptical oncologist must always consider malignancy, the clear infectious etiology and resolution pattern strongly argue against it. The 'screening' reason for request might raise a slight flag, but the findings themselves are benign.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: While atypical lymphocytes can sometimes be associated with lymphoma, the context points strongly away from malignancy. The findings explicitly state 'post-viral lymphocytosis', 'resolving' atypical lymphocytes, and positive EBV serology, confirming infectious mononucleosis. The report explicitly states 'No malignancy identified'. Although a skeptical oncologist must always consider malignancy, the clear infectious etiology and resolution pattern strongly argue against it. The 'screening' reason for request might raise a slight flag, but the findings themselves are benign.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms"
      ],
      "fracture_mentioned": null,
      "idx": 79,
      "timestamp": "2026-01-10T20:50:27.409839"
    },
    {
      "sample_idx": 80,
      "input": "18/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 18/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could splenomegaly be reactive to an occult malignancy? The report explicitly states the splenomegaly is 'physiological for age', which is a benign finding. Furthermore, the report explicitly states 'no malignancy identified'. While one might initially question splenomegaly, the description clarifies it's a normal variant. The absence of focal lesions and normal echo texture further support a benign interpretation. Skeptical consideration of malignancy is ruled out by the direct statement and supporting benign findings.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could splenomegaly be reactive to an occult malignancy? The report explicitly states the splenomegaly is 'physiological for age', which is a benign finding. Furthermore, the report explicitly states 'no malignancy identified'. While one might initially question splenomegaly, the description clarifies it's a normal variant. The absence of focal lesions and normal echo texture further support a benign interpretation. Skeptical consideration of malignancy is ruled out by the direct statement and supporting benign findings.",
      "findings": [
        "physiological splenomegaly for age",
        "no focal lesions",
        "normal echo texture",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 80,
      "timestamp": "2026-01-10T20:50:27.409857"
    },
    {
      "sample_idx": 81,
      "input": "11/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign soft tissue mass - lipoma confirmed\", \"Well-circumscribed\", \"No enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a lipoma mask an underlying malignancy? While lipomas are typically benign, the report explicitly confirms it as a benign finding ('lipoma confirmed', 'No malignancy identified'). The description 'well-circumscribed' and 'no enhancement' further support a benign nature. Skeptical consideration: Is the 'benign presentation' mentioned in the history a red herring? However, the biopsy findings directly contradict malignancy. Conclusion: No evidence of malignancy despite the initial reason for request ('Benign presentation' might be interpreted as a trigger for investigation, not necessarily indicative of a problem).\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a lipoma mask an underlying malignancy? While lipomas are typically benign, the report explicitly confirms it as a benign finding ('lipoma confirmed', 'No malignancy identified'). The description 'well-circumscribed' and 'no enhancement' further support a benign nature. Skeptical consideration: Is the 'benign presentation' mentioned in the history a red herring? However, the biopsy findings directly contradict malignancy. Conclusion: No evidence of malignancy despite the initial reason for request ('Benign presentation' might be interpreted as a trigger for investigation, not necessarily indicative of a problem).",
      "findings": [
        "Benign soft tissue mass - lipoma confirmed",
        "Well-circumscribed",
        "No enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 81,
      "timestamp": "2026-01-10T20:50:27.409888"
    },
    {
      "sample_idx": 82,
      "input": "27/12/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 27/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Suspected Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial skepticism: Could a 'large heterogeneous mass' be something other than a tumor? Perhaps an inflammatory process or a benign cyst? However, the clinical context ('Suspected Wilms Tumor', 'Paediatric oncology assessment') and the biopsy result ('Favorable histology') strongly point towards malignancy. While 'favorable histology' is encouraging prognostically, it confirms the presence of a tumor, specifically Wilms Tumor, which is malignant. The staging (Stage II) further supports a malignant diagnosis requiring treatment. Alternative benign explanations are highly unlikely given the biopsy confirmation.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a 'large heterogeneous mass' be something other than a tumor? Perhaps an inflammatory process or a benign cyst? However, the clinical context ('Suspected Wilms Tumor', 'Paediatric oncology assessment') and the biopsy result ('Favorable histology') strongly point towards malignancy. While 'favorable histology' is encouraging prognostically, it confirms the presence of a tumor, specifically Wilms Tumor, which is malignant. The staging (Stage II) further supports a malignant diagnosis requiring treatment. Alternative benign explanations are highly unlikely given the biopsy confirmation.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Suspected Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 82,
      "timestamp": "2026-01-10T20:50:27.409908"
    },
    {
      "sample_idx": 83,
      "input": "05/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Skeptical assessment: Could the destructive lesion be a benign aggressive process like infection (osteomyelitis) or benign bone tumor (e.g., giant cell tumor)? The 'sunburst periosteal reaction' is highly suggestive of osteosarcoma, although it can rarely be seen in other conditions. Elevated alkaline phosphatase is non-specific but consistent with bone turnover seen in osteosarcoma. The combination of a destructive lesion with soft tissue extension and the characteristic sunburst pattern, in the context of a palpable mass and clinical suspicion of osteosarcoma, strongly points towards malignancy. While alternative benign causes are possible, the constellation of findings makes osteosarcoma the most likely diagnosis, warranting MDT discussion.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical assessment: Could the destructive lesion be a benign aggressive process like infection (osteomyelitis) or benign bone tumor (e.g., giant cell tumor)? The 'sunburst periosteal reaction' is highly suggestive of osteosarcoma, although it can rarely be seen in other conditions. Elevated alkaline phosphatase is non-specific but consistent with bone turnover seen in osteosarcoma. The combination of a destructive lesion with soft tissue extension and the characteristic sunburst pattern, in the context of a palpable mass and clinical suspicion of osteosarcoma, strongly points towards malignancy. While alternative benign causes are possible, the constellation of findings makes osteosarcoma the most likely diagnosis, warranting MDT discussion.",
      "findings": [
        "destructive lesion in distal femur",
        "soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 83,
      "timestamp": "2026-01-10T20:50:27.409929"
    },
    {
      "sample_idx": 84,
      "input": "23/11/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 23/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a healing fracture mask an underlying malignancy? The report explicitly states 'No pathological features' and 'No malignancy identified'. The findings are consistent with a benign process (healing fracture) and trauma history. While MRI can miss some lesions, the radiologist's conclusion, given the specific context of a healing fracture with normal bone density and absence of pathological features, strongly points away from malignancy. No evidence supports a malignant interpretation.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a healing fracture mask an underlying malignancy? The report explicitly states 'No pathological features' and 'No malignancy identified'. The findings are consistent with a benign process (healing fracture) and trauma history. While MRI can miss some lesions, the radiologist's conclusion, given the specific context of a healing fracture with normal bone density and absence of pathological features, strongly points away from malignancy. No evidence supports a malignant interpretation.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 84,
      "timestamp": "2026-01-10T20:50:27.409948"
    },
    {
      "sample_idx": 85,
      "input": "14/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 14/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical analysis: Could a subtle malignancy be missed on routine surveillance CT? The report explicitly states 'No malignancy identified' after a thorough review including chest and abdomen. While CT has limitations, the absence of any described abnormalities (masses, lymphadenopathy, infiltrates) and the explicit negative conclusion by the consultant oncologist strongly argue against malignancy. Alternative explanations for potential subtle findings (e.g., inflammation, benign cysts) are not mentioned, reinforcing the negative finding. Conclusion: Based on the provided report, malignancy is not identified.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical analysis: Could a subtle malignancy be missed on routine surveillance CT? The report explicitly states 'No malignancy identified' after a thorough review including chest and abdomen. While CT has limitations, the absence of any described abnormalities (masses, lymphadenopathy, infiltrates) and the explicit negative conclusion by the consultant oncologist strongly argue against malignancy. Alternative explanations for potential subtle findings (e.g., inflammation, benign cysts) are not mentioned, reinforcing the negative finding. Conclusion: Based on the provided report, malignancy is not identified.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 85,
      "timestamp": "2026-01-10T20:50:27.409967"
    },
    {
      "sample_idx": 86,
      "input": "11/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Skeptical review: Could the hepatic mass be a benign tumor (e.g., focal nodular hyperplasia, adenoma) or inflammatory process? However, the combination of a large, heterogeneous mass in a pediatric patient with pancytopenia, significantly elevated AFP (a known tumor marker for hepatoblastoma), specific fetal histology subtype, and PRETEXT staging strongly points towards hepatoblastoma. While benign hepatic lesions exist, they typically do not present with pancytopenia and markedly elevated AFP in this context. Conclusion: malignancy highly likely, despite considering benign differentials.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical review: Could the hepatic mass be a benign tumor (e.g., focal nodular hyperplasia, adenoma) or inflammatory process? However, the combination of a large, heterogeneous mass in a pediatric patient with pancytopenia, significantly elevated AFP (a known tumor marker for hepatoblastoma), specific fetal histology subtype, and PRETEXT staging strongly points towards hepatoblastoma. While benign hepatic lesions exist, they typically do not present with pancytopenia and markedly elevated AFP in this context. Conclusion: malignancy highly likely, despite considering benign differentials.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 86,
      "timestamp": "2026-01-10T20:50:27.409985"
    },
    {
      "sample_idx": 87,
      "input": "16/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 16/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts 70% of marrow\", \"t(8;21) translocation\"],\n        \"rationale\": \"Initial skepticism: Could a high percentage of myeloblasts be reactive or represent a transient phenomenon? However, 70% myeloblasts is highly abnormal for bone marrow and strongly indicative of acute leukemia. The specific t(8;21) translocation is a well-established cytogenetic marker for Acute Myeloid Leukemia (AML). While rare benign conditions might cause increased blasts, the combination of a very high percentage and a specific AML-associated translocation makes a benign explanation highly improbable. Conclusion: malignancy confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a high percentage of myeloblasts be reactive or represent a transient phenomenon? However, 70% myeloblasts is highly abnormal for bone marrow and strongly indicative of acute leukemia. The specific t(8;21) translocation is a well-established cytogenetic marker for Acute Myeloid Leukemia (AML). While rare benign conditions might cause increased blasts, the combination of a very high percentage and a specific AML-associated translocation makes a benign explanation highly improbable. Conclusion: malignancy confirmed.",
      "findings": [
        "myeloblasts 70% of marrow",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 87,
      "timestamp": "2026-01-10T20:50:27.410002"
    },
    {
      "sample_idx": 88,
      "input": "29/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 29/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor diagnosis\", \"Stage II\"],\n        \"rationale\": \"Initial skepticism: Could the renal mass be a benign entity like a congenital mesoblastic nephroma or cystic nephroma? However, the clinical context (pancytopenia, pediatric oncology assessment), the explicit diagnosis of Wilms Tumor (a known pediatric malignancy), and staging (Stage II) strongly point towards malignancy. While favorable histology is noted, Wilms Tumor itself is malignant. The pancytopenia might be related to the tumor or its treatment, but the mass itself is the primary finding indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the renal mass be a benign entity like a congenital mesoblastic nephroma or cystic nephroma? However, the clinical context (pancytopenia, pediatric oncology assessment), the explicit diagnosis of Wilms Tumor (a known pediatric malignancy), and staging (Stage II) strongly point towards malignancy. While favorable histology is noted, Wilms Tumor itself is malignant. The pancytopenia might be related to the tumor or its treatment, but the mass itself is the primary finding indicating malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor diagnosis",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 88,
      "timestamp": "2026-01-10T20:50:27.410020"
    },
    {
      "sample_idx": 89,
      "input": "16/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"Initial skepticism: Could the high percentage of lymphoblasts be reactive? However, the overwhelming proportion (85%) of lymphoblasts, coupled with specific immunophenotyping confirming B-cell ALL, strongly points towards malignancy. Alternative benign explanations, such as a severe reactive process, are highly unlikely given the specific lineage and high percentage. Conclusion: Malignancy confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the high percentage of lymphoblasts be reactive? However, the overwhelming proportion (85%) of lymphoblasts, coupled with specific immunophenotyping confirming B-cell ALL, strongly points towards malignancy. Alternative benign explanations, such as a severe reactive process, are highly unlikely given the specific lineage and high percentage. Conclusion: Malignancy confirmed.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL"
      ],
      "fracture_mentioned": null,
      "idx": 89,
      "timestamp": "2026-01-10T20:50:27.410036"
    },
    {
      "sample_idx": 90,
      "input": "06/09/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial skepticism: Could the intraocular mass be a benign calcified lesion or congenital anomaly? However, the combination of bilateral disease, positive family history, and crucially, the detection of an RB1 germline mutation strongly points towards hereditary retinoblastoma. While calcifications can occur in benign lesions, their presence within a bilateral intraocular mass in this context is highly suspicious. The RB1 mutation is pathognomonic for retinoblastoma. Alternative benign explanations are effectively ruled out by the genetic finding. Conclusion: Malignancy (Retinoblastoma) is confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the intraocular mass be a benign calcified lesion or congenital anomaly? However, the combination of bilateral disease, positive family history, and crucially, the detection of an RB1 germline mutation strongly points towards hereditary retinoblastoma. While calcifications can occur in benign lesions, their presence within a bilateral intraocular mass in this context is highly suspicious. The RB1 mutation is pathognomonic for retinoblastoma. Alternative benign explanations are effectively ruled out by the genetic finding. Conclusion: Malignancy (Retinoblastoma) is confirmed.",
      "findings": [
        "intraocular mass with calcifications",
        "bilateral disease",
        "family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 90,
      "timestamp": "2026-01-10T20:50:27.410057"
    },
    {
      "sample_idx": 91,
      "input": "30/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 30/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"Bone density normal\", \"Trauma history consistent\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a healing fracture mask underlying pathology? The report explicitly states 'no pathological features' and 'no malignancy identified'. The findings are consistent with a benign process (healing fracture) and trauma history. There is no evidence supporting malignancy; the conclusion of reassurance further supports a benign interpretation. Alternative explanations for bone pain (e.g., infection, inflammatory conditions) are not suggested by the report, and the stated findings are consistent with a benign fracture.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a healing fracture mask underlying pathology? The report explicitly states 'no pathological features' and 'no malignancy identified'. The findings are consistent with a benign process (healing fracture) and trauma history. There is no evidence supporting malignancy; the conclusion of reassurance further supports a benign interpretation. Alternative explanations for bone pain (e.g., infection, inflammatory conditions) are not suggested by the report, and the stated findings are consistent with a benign fracture.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "Bone density normal",
        "Trauma history consistent",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 91,
      "timestamp": "2026-01-10T20:50:27.410075"
    },
    {
      "sample_idx": 92,
      "input": "22/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 22/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical review: Could a resolved benign cyst mask underlying malignancy? The report explicitly states 'No malignancy identified' after review. The description of the cyst as 'resolved' and lacking 'aggressive features' supports a benign conclusion. Normal bone density and lack of recurrence further diminish suspicion. While vigilance is necessary, the report provides no evidence for malignancy. The primary finding is the resolution of a known benign condition.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: Could a resolved benign cyst mask underlying malignancy? The report explicitly states 'No malignancy identified' after review. The description of the cyst as 'resolved' and lacking 'aggressive features' supports a benign conclusion. Normal bone density and lack of recurrence further diminish suspicion. While vigilance is necessary, the report provides no evidence for malignancy. The primary finding is the resolution of a known benign condition.",
      "findings": [
        "Benign bone cyst - resolved",
        "No aggressive features",
        "Normal bone density",
        "No recurrence on imaging",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 92,
      "timestamp": "2026-01-10T20:50:27.410094"
    },
    {
      "sample_idx": 93,
      "input": "04/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 04/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture\", \"No pathological features\", \"Bone density normal\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical review: The report explicitly states 'No malignancy identified' and describes findings consistent with a 'Healing fracture - normal process'. While a fracture can sometimes be a pathological fracture secondary to malignancy, the report specifically rules this out ('No pathological features', 'Trauma history consistent'). The finding of normal bone density further argues against malignancy causing bone destruction. The request was for 'Screening' with no prior history, which might raise suspicion, but the report findings are definitively benign. Conclusion: No evidence of malignancy despite the screening context.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: The report explicitly states 'No malignancy identified' and describes findings consistent with a 'Healing fracture - normal process'. While a fracture can sometimes be a pathological fracture secondary to malignancy, the report specifically rules this out ('No pathological features', 'Trauma history consistent'). The finding of normal bone density further argues against malignancy causing bone destruction. The request was for 'Screening' with no prior history, which might raise suspicion, but the report findings are definitively benign. Conclusion: No evidence of malignancy despite the screening context.",
      "findings": [
        "Healing fracture",
        "No pathological features",
        "Bone density normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 93,
      "timestamp": "2026-01-10T20:50:27.410114"
    },
    {
      "sample_idx": 94,
      "input": "05/08/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"Headaches attributed to migraine\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical reasoning: Could a normal MRI miss a subtle malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states 'No malignancy identified' after a specific search for it. Findings are described as 'Normal' and absence of key features like 'mass lesion' or 'abnormal enhancement' strongly support a benign interpretation. While headaches warrant investigation, attributing them to migraine in the absence of imaging findings is a reasonable clinical conclusion. There is no evidence presented to suggest malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical reasoning: Could a normal MRI miss a subtle malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states 'No malignancy identified' after a specific search for it. Findings are described as 'Normal' and absence of key features like 'mass lesion' or 'abnormal enhancement' strongly support a benign interpretation. While headaches warrant investigation, attributing them to migraine in the absence of imaging findings is a reasonable clinical conclusion. There is no evidence presented to suggest malignancy.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "Headaches attributed to migraine",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 94,
      "timestamp": "2026-01-10T20:50:27.410133"
    },
    {
      "sample_idx": 95,
      "input": "10/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 10/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"Bone density normal\", \"Trauma history consistent\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical review: Could a healing fracture mask an underlying malignancy? Playing devil's advocate: The report explicitly states 'No pathological features' and 'No malignancy identified'. The fracture is described as a 'normal process' consistent with trauma history. While fractures can be pathological, the explicit negative findings and description of a normal healing process strongly argue against malignancy. Reassurance provided by the consultant oncologist further supports a benign conclusion. Cannot conclude malignancy without evidence of pathological features or abnormal findings.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: Could a healing fracture mask an underlying malignancy? Playing devil's advocate: The report explicitly states 'No pathological features' and 'No malignancy identified'. The fracture is described as a 'normal process' consistent with trauma history. While fractures can be pathological, the explicit negative findings and description of a normal healing process strongly argue against malignancy. Reassurance provided by the consultant oncologist further supports a benign conclusion. Cannot conclude malignancy without evidence of pathological features or abnormal findings.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "Bone density normal",
        "Trauma history consistent",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 95,
      "timestamp": "2026-01-10T20:50:27.410153"
    },
    {
      "sample_idx": 96,
      "input": "28/09/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 28/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could lymphadenopathy be reactive (e.g., infection)? However, the presence of a 'bulky' mass, FDG-avid nodes on PET-CT (indicating high metabolic activity often seen in malignancy), and the specific histological diagnosis of 'Classical Hodgkin, nodular sclerosing type' strongly point towards malignancy. While reactive lymphadenopathy is common, a bulky mass with high metabolic activity and a specific Hodgkin Lymphoma subtype makes a benign explanation highly unlikely. Conclusion: Malignancy is strongly suggested by the combination of imaging and histological findings.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could lymphadenopathy be reactive (e.g., infection)? However, the presence of a 'bulky' mass, FDG-avid nodes on PET-CT (indicating high metabolic activity often seen in malignancy), and the specific histological diagnosis of 'Classical Hodgkin, nodular sclerosing type' strongly point towards malignancy. While reactive lymphadenopathy is common, a bulky mass with high metabolic activity and a specific Hodgkin Lymphoma subtype makes a benign explanation highly unlikely. Conclusion: Malignancy is strongly suggested by the combination of imaging and histological findings.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 96,
      "timestamp": "2026-01-10T20:50:27.410171"
    },
    {
      "sample_idx": 97,
      "input": "02/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Glioma.\n\nFrom clinical notes: Brain Tumor - Glioma. Paediatric oncology assessment.\n\nFindings: left temporal lobe infiltrative mass with mass effect. FLAIR hyperintensity. Biopsy confirms diffuse astrocytoma WHO grade II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"Biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"Skeptical analysis: Could the mass be inflammatory or infectious? While infiltrative masses can be inflammatory (e.g., abscess, demyelination), the biopsy result is definitive. The confirmation of 'diffuse astrocytoma WHO grade II' by biopsy directly indicates malignancy. Although grade II is relatively low-grade, it is still a malignant glial tumor. The clinical suspicion of glioma was confirmed pathologically.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical analysis: Could the mass be inflammatory or infectious? While infiltrative masses can be inflammatory (e.g., abscess, demyelination), the biopsy result is definitive. The confirmation of 'diffuse astrocytoma WHO grade II' by biopsy directly indicates malignancy. Although grade II is relatively low-grade, it is still a malignant glial tumor. The clinical suspicion of glioma was confirmed pathologically.",
      "findings": [
        "left temporal lobe infiltrative mass with mass effect",
        "FLAIR hyperintensity",
        "Biopsy confirms diffuse astrocytoma WHO grade II"
      ],
      "fracture_mentioned": null,
      "idx": 97,
      "timestamp": "2026-01-10T20:50:27.410188"
    },
    {
      "sample_idx": 98,
      "input": "29/06/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 29/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC\", \"age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Skeptical review: The report explicitly states 'No malignancy identified' and details normal CBC results including age-appropriate values, adequate platelets, normal hemoglobin, and absence of blast cells. While follow-up implies prior concern, the current findings are unequivocally benign. Could there be an undetected lesion? Playing devil's advocate: The provided information points strongly against malignancy. The explicit statement 'No malignancy identified' combined with completely normal hematological parameters offers strong reassurance. Conclusion: Based on the provided report, malignancy is not present.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skeptical review: The report explicitly states 'No malignancy identified' and details normal CBC results including age-appropriate values, adequate platelets, normal hemoglobin, and absence of blast cells. While follow-up implies prior concern, the current findings are unequivocally benign. Could there be an undetected lesion? Playing devil's advocate: The provided information points strongly against malignancy. The explicit statement 'No malignancy identified' combined with completely normal hematological parameters offers strong reassurance. Conclusion: Based on the provided report, malignancy is not present.",
      "findings": [
        "Normal CBC",
        "age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 98,
      "timestamp": "2026-01-10T20:50:27.410208"
    },
    {
      "sample_idx": 99,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could mediastinal lymphadenopathy be reactive (e.g., infection, inflammation)? However, the presence of a 'bulky' mass, confirmed FDG-avidity on PET-CT (indicating high metabolic activity often associated with malignancy), and the specific histological subtype 'Classical Hodgkin, nodular sclerosing type' strongly point towards malignancy. While reactive nodes exist, the combination of bulk, FDG-avidity, and specific histology makes a benign explanation highly improbable. Conclusion: malignancy confirmed.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could mediastinal lymphadenopathy be reactive (e.g., infection, inflammation)? However, the presence of a 'bulky' mass, confirmed FDG-avidity on PET-CT (indicating high metabolic activity often associated with malignancy), and the specific histological subtype 'Classical Hodgkin, nodular sclerosing type' strongly point towards malignancy. While reactive nodes exist, the combination of bulk, FDG-avidity, and specific histology makes a benign explanation highly improbable. Conclusion: malignancy confirmed.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 99,
      "timestamp": "2026-01-10T20:50:27.410225"
    }
  ],
  "end_time": "2026-01-10T20:50:27.410527",
  "duration_seconds": 84.462148
}